Yaya tsawon lokacin da alamun suka kasance?
Kuma duk wani ciwon kirji ya kamata a bi da shi haka musamman a shekarunka.
Kuma da zazzabi.
Kuma za a gwada ka da cholesterol da kuma hawan jini.
Kuma yanzu kana da zazzabi?
Kuma yanzu kana da wannan ciwon kirji?
Kuma kana da wahalar numfashi?
Kuma za ka iya gaya mini wasu alamun da kake da su?
Kuma yawan zafin jikinka ya yi yawa.
Kuma ina da tari.
Kuma ina da ɗan tari.
Kuma ina da ciwon kirji sosai a yau.
Kuma wannan shi ne lokacin da ciyawa take da zazzabi.
Kuma zai iya sa ka ciwon kirji.
Kuma ina jin kamar ina da zazzabi.
Kuma ina so ka bayyana inda ƙirjinka ke ciwo.
Kuma suna da zazzabi.
da kuma tarihin ciwon sukari.
Kuma, ka sani, kamar zai fashe.
Kuma ka san cewa mutane suna ta yin ihu a kaina a koyaushe.
Kuma kana da ciwon kirji.
Kuma kuna cewa yana da matsi a cikin kirjinku.
Akwai wanda ke da ciwon zuciya a cikin iyalin, ciwon zuciya, ciwon zuciya, hawan cholesterol, hawan jini
Ka lura da wasu alamun ko kuma matsaloli da ke tattare da ciwon tsoka?
Akwai wasu marasa lafiya a gidanku da suke da irin wannan ciwon?
Kana da wasu alamu?
Kana da matsala ne a numfashi?
Har yanzu kana da ciwon kirji?
Domin wannan shine lokacin mura.
Amma kuma kada mu manta da ciwon zuciya.
Amma abin da ya fi damuna shi ne ciwon kirji.
Amma kuma ina da matsala wajen numfashi.
Amma na san cewa mutane da yawa sun yi mini ba'a.
Amma dole ne mu ɗauki kowane ciwon kirji da muhimmanci.
Amma ba ka da matsala da numfashi a yanzu, ko?
Na manta da wannan ciwon kirji.
Kamar dai wani yana matsa maka a kirji.
Har yanzu yana numfashi?
Shin sun yi rahoton cewa suna da irin wannan cutar?
Kana da wani ciwo mai tsanani kamar hawan jini ko wani abu makamancin haka?
Kana da wata cuta mai tsanani kamar ciwon sukari?
Kana da numfashi a cikin wannan ciwon kirji?
Kana da hawan jini?
Kana da matsala da numfashi?
Ka san abin da alamunsa suke?
Za ka iya ganin wannan hoton?
Ka sha ruwa mai yawa a yau
Ko da yake na yi gwajin ciwon sukari.
Amma yana da irin wannan alamar.
Yaya zafin jikinka yake?
Yaya hawan jini?
Idan zazzabinka ya yi yawa ko kuma ya yi sanyi
Idan kana da zazzabi mai yawan dari biyu ko fiye
Idan kana ganin kana bukatar a bincika alamun ciwo ko kuma matsalarka sosai
Na yi zazzabi jiya.
Ina da zazzabi.
Na yi zazzabi jiya.
Ina da ciwo mai tsanani a nan cikin kirji.
Ina da ɗan wahalar numfashi.
Zan aiko muku da hoton.
Ina da ciwon kirji a yau.
Ina da ciwon kai da zazzabi a yau.
Ina ganin cewa mura ce.
Ina ganin cewa, yana da ɗan zazzaɓi.
Kamar dai wani mutum mai nauyi yana zaune a kan kirjinka?
Hakan ya soma ne da ciwon kai da kuma zazzabi.
Yana buga ni a tsakiya na kirji.
Yana da kamar ciwon kirji.
Yana cikin kirjina.
Yana tsakiyar kirjina.
Yana tsakiyar kirji.
Ina da ciwon kirji.
Ina matukar damuwa da wannan ciwon kirji.
Ka gaya mini yadda wannan ciwon kirji yake
Kamar hawan jini ko ciwon sukari
Kamar dai a tsakiyar kirji.
Yanzu za ka iya shan tachipirina don zazzabi.
Mary, na tsawon lokaci kake da irin waɗannan alamun?
Kawai dai ka ce kana da ciwon kirji.
Wani lokaci yakan sa ni baƙin ciki a zuci.
Shin kana da wasu alamun cutar da ba na ciwo ba?
Ko kuwa wani yana zaune a kan kirjinka?
Ƙari ga haka, yana da zazzabi da tari, kuma yana ciwon kai da kuma jijiyoyin jiki.
A tsakiyar kirjina.
Ka nuna mini inda kake jin zafi a wannan hoton.
Tun da kana da zazzabi
To, kana ganin wasu daga cikin waɗannan alamun suna da nasaba da yin ciki?
Shin yaranka suna da irin waɗannan alamun?
Ka gaya mini game da ciwonka na kirji.
Zafi yana ƙaruwa da daddare.
Na yi zazzabi na kwana biyu.
Ya fara zafin jiki a daren jiya.
Ni ne likita Porter, na sashen gaggawa na Cibiyar Kula da Lafiya.
Za ka iya gaya mini game da ciwon kirjinka?
Ina da ciwon kirji a gaban jiki.
Ina da ciwon zuciya mai tsanani.
Amma idan na ji ciwon kirji,
Wane irin ciwo ne kake ji a kirji?
Yaushe ne wannan ciwon kirji ya fara?
Ina kirjinka yake ciwo?
Ina kake jin wannan ciwon a cikin kirjinka?
Kamar dai kana da wani matsi a kirjinka.
Ka san cewa ina da ciwon sukari.
Ka ce kana da ciwon kirji.
An samu karuwar yawan kamuwa da cutar coronavirus (COVID-19) a Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Cunkoson cututtukan cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a tsakanin ƙasashen Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya wanda ke tabbatar da cewa duk da cewa akwai matakai daban-daban dangane da ƙasa, cutar ta COVID-19 tana ci gaba cikin sauri a duk ƙasashe.
Dangane da ilimin da aka samu daga Italiya, dole ne ƙasar, asibitoci da na'urorin kulawa mai mahimmanci su haɓaka shirye-shirye don saurin haɓaka marasa lafiya da ke fama da COVID-19 waɗanda ke buƙatar kulawa ta musamman da kulawa mai mahimmanci.
An ba da rahoton wani mummunan yanayin cutar sankarar bargo a Wuhan, lardin Hubei na kasar Sin, a ranar 31 ga Disamba, 2019.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta China ta ba da sanarwar cewa sabon coronavirus a matsayin mai aiki yanzu ana kiransa da cutar coronavirus mai saurin numfashi mai saurin cuta 2 (SARS-CoV-2).
Saboda haka, cutar da ke haifar da SARS-CoV-2 an sanya mata sunan cutar coronavirus (COVID-19).
Bayanai na yau da kullun sun nuna cewa kashi 80% na waɗanda ke da COVID-19 suna da ƙananan cututtuka, wato, kamuwa da numfashi tare da ko ba tare da cutar huhu ba, kuma mafi yawansu sun warke.
A cikin kashi 14 cikin ɗari na waɗanda suka kamu, COVID-19 ya zama mafi tsanani wanda ke buƙatar asibiti, yayin da kashi 6 cikin ɗari suka kamu da rashin lafiya mai tsanani wanda ke buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kusan kashi 4 cikin dari.
A cikin wannan binciken, mun bincika yanayin ƙaruwar COVID-19 a kowace Tarayyar Turai / Ƙasar Tattalin Arzikin Turai (EU/EEA) da Burtaniya (UK) kuma mun kwatanta su da lardin Hubei na China.
Mun kuma gwada adadin mutanen da suka kamu da cutar COVID-19 a ƙasashen EU/EEA da Burtaniya da kuma Italiya tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Al'amuran COVID-19 a ƙasashen EU/EEA da kuma Birtaniya
COVID-19 ya ci gaba da yaduwa a geographical, bayan China, kuma yanayin COVID-19 a sauran yankuna na duniya yanzu yana bin wannan ƙasar.
Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris, 2020.
A cikin fitowar 5 ga Maris na EuroSurveillance 2020, Spiteri da abokansa sun ba da rahoton farkon mutanen Turai da aka tabbatar da cutar COVID-19 bisa ga ma'anar yanayin WHO.
A EU/EEA, Faransa ta sanar da farkon mutane uku da suka tabbatar da cutar a ranar 24 ga Janairu, 2020, a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, COVID-19 ya bayyana a duk ƙasashe 30 na EU/EEA da Burtaniya, tare da rahoton mutum 39,768 da mutuwar 1,727 tun daga ranar 31 ga Disamba, 2019, tare da 17,750 da mutuwar 1,441 a Italiya kadai.
Samun adadin masu kamuwa da cutar COVID-19 da kuma yawan adadin su
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana ba da rahoton ƙididdigar COVID-19 a kowace ƙasa a duniya, wanda aka samo daga ma'aikatun kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki, da kuma tushen gwamnati kamar WHO, wanda aka sabunta a 8:00 na safe kowace rana.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a cikin EU / EEA da Burtaniya da kuma kwatanta shi da abin da ya faru a Italiya.
A matsayin wakili na barkewar cutar COVID-19, mun ƙidaya gajerun kwanaki 14 na COVID-19, ta haka ne la'akari da yanayin COVID-19 a kowace EU/EEA da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma gabatar da adadi mai yawa na lamuran da aka rubuta a kowace ƙasa har zuwa 15 ga Maris, 2020 da karfe 8:00 na safe, kuma mun gwada shi da adadin waɗanda suka kamu da cutar a Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a ƙasashen EU/EEA da Burtaniya
Yanayin kwanan nan na COVID-19 na kwanaki 14 a cikin ƙasashen EU/EEA da Burtaniya ya bi yanayin lardin Hubei (China) gaba ɗaya (Hoto 1).
Ga EU/EEA da Burtaniya gabaɗaya, adadin COVID-19 ya fara ƙaruwa a kusa da 21 ga Fabrairu, sannan ya ƙaru sosai a kusa da 28 ga Fabrairu, 2020 (Supplementary Material).
Wannan ya samo asali ne daga saurin karuwar adadin masu kamuwa da cutar a Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun nuna irin wannan ci gaban a cikin ƙaruwar COVID-19 (kayan aiki).
Hoto na 2 ya nuna kwatancen lambobi a Italiya da kuma adadin adadin COVID-19 a cikin EU/EEA da UK na 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya kamata a lura cewa, a ranar 15 ga Maris, da karfe 8:00 na safe, sauran ƙasashe 15 na EU/EEA da Burtaniya sun riga sun ba da rahoton adadin waɗanda za a iya kwatanta su da Italiya a cikin makonni 3 ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin mutanen da aka sani da cutar COVID-19 na ƙaruwa cikin sauri a EU/EEA da kuma Burtaniya.
Yanayin da ake gani a cikin tarin COVID-19 yana nuna cewa annobar tana ci gaba da sauri a duk ƙasashe.
Wannan duk da cewa ƙasashe suna cikin matakai daban-daban, duk da bambancin halayen lafiyar jama'a na ƙasa, kuma duk da cewa ƙasashe na iya samun ma'anoni daban-daban na waɗanda ke kamuwa da cuta da kuma ka'idoji daban-daban don zaɓin marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da gwajin kamawa.
A farkon watan Maris na 2020, likitoci a yankunan da ke fama da cutar a Italiya sun bayyana halin da ake ciki inda kashi 10% na masu cutar COVID-19 ke buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun nuna cewa asibitoci da na'urorin kulawa mai tsanani a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai game da shigar da masu cutar COVID-19 a asibiti da / ko sashen kulawa mai tsanani a halin yanzu ana samun su ne kawai a kashi 6% da 1% na masu cutar a matakin EU / EEA, bi da bi (ba a nuna bayanan ba).
Koyaya, yakamata a tattara su a hankali don haɓaka bayanan sa ido na yanzu wanda ke mai da hankali kan adadin waɗanda suka kamu da cutar da kuma adadin mutuwar.
Wani bincike da aka gudanar a 2010-11 a cikin tsari na gado 4.2 a kowace 100,000 a Jamus daga 29.2 a Portugal ya nuna bambanci mai girma tsakanin wadatar ingantattun kulawa da matsakaitan kulawa a Turai.
Wannan yana nufin cewa ƙasashe na iya samun ƙasa ko fiye da albarkatu fiye da Italiya (kwana 12.5 na kulawa mai mahimmanci da kuma kulawar matsakaici a kowace mutane 100,000 a 2011)
Tare da yawan adadin COVID-19 da aka kwantar a asibiti a kowace EU/EEA da Burtaniya, yanayin yin ƙirar wadatar kiwon lafiya ya nuna cewa akwai haɗarin > 90% na wucewa ta gado na kulawa mai mahimmanci, wanda aka bayar a cikin sabuntawa na shida na ECDC na COVID-19 Rapid Risk Assessment.
Tun da yake har yanzu akwai ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar
Kwarewa daga Italiya da kuma yanayin da ake ciki a yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba cikin sauri a EU/EEA da kuma Burtaniya.
Saboda haka, ya kamata ƙasashe, asibitoci da na'urorin kulawa mai mahimmanci su shirya kansu don yanayin yaduwar cutar SARS-CoV-2 a cikin al'umma da kuma karuwar adadin marasa lafiya na COVID-19 waɗanda ke buƙatar kiwon lafiya da kulawa mai mahimmanci, kamar yadda ya faru a yankunan da ke fama da cutar a Italiya.
Kamar yadda rahoton ECDC na kwanan nan ya nuna, hanzari, hanzari da kuma cikakkiyar hanyar da za a bi don jinkirta yaduwar cutar SARS-COV-2 yana da mahimmanci, tare da sauyawa daga hanawa zuwa ragewa, tunda idan ba a aiwatar da wuri ba, saurin karuwar da ake tsammani na yawan lamura na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, ɗauka da kuma amfani da martani.
Binciken Hadarin Mai Sauri ya kuma lissafa matakan kiwon lafiya na jama'a don rage tasirin cutar.
Akwai ɗan gajeren lokaci na dama wanda ƙasashe za su iya ƙara ƙoƙarin sarrafawa don rage saurin yaduwar SARS-CoV-2 da rage matsin lamba a kan kiwon lafiya.
Idan ba su yi haka ba, akwai yiwuwar cewa tsarin kiwon lafiya a wasu ƙasashen EU/EEA zai fuskanci karuwar adadin marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki da makonni masu zuwa.
Cutar cutar sankara ta SARS-CoV-2 Coronavirus Disease 2019 (COVID-19) ta kashe mutane 3,000 a China da sauran kasashen duniya, kuma ta kamu da mutane fiye da 80,000, wanda ya kawo bala'i ga bil'adama.
SARS-CoV yana kama da kwayar cutar da ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 kuma ana iya watsa shi daga batutuwan kuma yana haifar da alamun iri ɗaya ta hanyar tsari iri ɗaya.
Koyaya, COVID-19 yana da ƙarancin ƙarfi da mutuwa fiye da SARS amma yana da saurin yaduwa kuma yana cutar da tsofaffi fiye da matasa da maza fiye da mata.
A cikin amsa ga yawancin wallafe-wallafen da ke tasowa game da cututtukan da ke tasowa, wannan labarin ya yi ƙoƙari ya ba da cikakken bayani game da batun bincike mai saurin tasowa.
Za mu rufe abubuwan da suka shafi cututtukan cututtuka, ilimin halittu, ilimin cututtuka, ganewar asali, magani, yanayin cutar, da rigakafi.
Duk da yake akwai tambayoyi da yawa da ake bukatar amsa, muna fatan wannan bita zai taimaka wajen fahimtar cutar da ke haifar da tsoro da kuma kawar da ita.
Bikin bazara na ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa gani ba ga duk mutanen China, waɗanda aka umarce su da su zauna a cikin gidaje tsawon lokacin hutu da makonni da yawa bayan barkewar sabuwar cutar.
Kwayar cutar tana da matukar dacewa da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar mai saurin numfashi (SARS) a 2003; saboda haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta sanya mata suna SARS-CoV-2, kuma ta sanya sunan cutar da ta danganta da cutar CoV-19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin kuma ta yadu cikin sauri zuwa kasar da kuma kasashe 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, an sami ƙarin lamura 80,000 da aka tabbatar da cutar COVID-19 saboda kwayar cutar, tare da sama da marasa lafiya 40,000 da aka warke, kuma sama da marasa lafiya 3,000 suka mutu.
"WHO ta yi gargadin cewa COVID-19 shine ""maƙiyi na mutane na 1"" kuma mai yiwuwa ya fi ta'addanci ƙarfi".
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu tun lokacin da aka fara ba da rahoto a ranar 7 ga Janairu, 2020, an buga sama da labarai 200 kan COVID-19, ciki har da kwayar cuta, cututtukan cututtuka, ilimin lissafi, ganewar asali da magani, wanda ya tsara jerin ƙwayoyin cuta da aka ware daga marasa lafiya da yawa.
Wannan bita yana ƙoƙari ya taƙaita ci gaban bincike a cikin sabon abu mai saurin haɓaka.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da kuma wani cuta mai haifar da CoV, ciwon numfashi na Gabas ta Tsakiya (MERS, annoba a shekarar 2012).
Mun tattauna abin da muka sani game da rigakafin cutar da kuma yadda za a iya tsinkayar cutar, da kuma wasu tambayoyi masu gaggawa da suka rage.
CoVs an tsara su a matsayin cututtukan da ba su da cutarwa ga mutane, wanda ke haifar da kusan kashi 15% na 4 na yawan sanyi.
Koyaya, a wannan karni, mun fuskanci sau biyu masu cutarwa na kwayar cuta ta mutum, SARS-CoV da MERS-CoV, waɗanda suka fara barkewar annoba a China a 2003 da Saudi Arabiya a 2012, bi da bi, kuma waɗanda ba da daɗewa ba suka bazu zuwa wasu ƙasashe da alamun bayyanar cututtuka da mutuwa.
Saboda haka, COVID-19 na yanzu shine fashewar CoV na uku da aka rubuta a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1.1, an fara bayar da rahoton tarin cutar pneumonia daga Wuhan zuwa Hukumar Lafiya ta Kasa ta China a ranar 31 ga Disamba, 2019.
An sake sakin jerin CoVs bayan kwana bakwai.
An ba da rahoton farkon mutuwar a Wuhan a ranar 15 ga Janairu, 2020.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe makwabta.
A ranar 20 ga Janairu, an sanar da masu ba da kiwon lafiya game da kamuwa da cutar, wanda ke nuna cewa ana iya samun kamuwa da cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an rufe birnin Wuhan, kuma an dakatar da dukkan hanyoyin sufuri.
A ranar 24 ga Janairu, binciken farko na cutar ya nuna cewa daga cikin mutane 41 da aka tabbatar da su, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan, inda aka gano cewa cutar ta samo asali ne daga dabbobi da ba a san asalin su ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin wannan rahoton, cutar ta riga ta bazu a China da kuma wasu ƙasashe kusan 50 a duniya (Figure (Figure 2).2).
Yayin da yanayin ke fadada cikin sauri, har yanzu ba a tantance ainihin girman cutar da kuma tsananin cutar ba.
A ranar 11 ga Fabrairu, 2020, binciken da aka yi a cibiyoyi da dama kan marasa lafiya 8,866, ciki har da 4,021 da aka tabbatar da cutar COVID-19, ya gabatar da ƙarin sabuntawar cutar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane a kowane zamani, amma ya fi faruwa a cikin shekarun 30-65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, kaɗan ne ke ƙasa da shekaru 20, kuma 14 ne kawai ke ƙasa da shekaru 10.
SARS-CoV-2 ya kamu da maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya yadu a hankali, musamman a Hubei da kewayenta.
Matsakaicin lokaci daga farkon COVID-19 zuwa ganewar asali shine kwanaki 5 (2-9).
Matsakaicin lokacin rufin cutar shine kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga farkon cutar zuwa mutuwa ya kasance kwanaki 9.5 (4.8-13).
Lambar haifuwa ta farko (R0) ta kasance 3.77 (CI 95%: 3.51-4.05), kuma daidaitaccen R0 ya kasance 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin manyan zirga-zirga kafin bikin bazara na kasar Sin.
Yawan mutuwar da aka tabbatar da shi ya kasance 1.44% (95% CI: 1.10-1.86%) kuma yawan mutuwar da aka haɗa tsakanin dukan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku na haɗarin COVID-19 sune jinsi (maza), shekaru (≥60) da kuma ciwon huhu mai tsanani.
CoVs wani ƙaramin rukuni ne na ƙwayoyin cuta masu girma da kuma rufi waɗanda ke ɗauke da tsari ɗaya na RNA mai ma'ana.
Ana iya rarraba su zuwa nau'i hudu ko jinsi, wato, alpha, beta, gamma da delta, wanda aka san cewa alpha da beta CoVs suna cutar da mutane.
Glycoprotein na kewayawa (S) don SARS-CoV da MERS-CoV, bi da bi, yana ɗaure da mai karɓar kwayar halittar angiotensin-converting enzyme 2 (ACE2) da dipeptidal peptidase 4 (DPP4) sannan kuma yana haɗuwa da membrane.
Kwayar cutar RNA ta kwayar halitta tana sakin jiki a cikin cytoplasm; bayan kwayar cutar ta kwayar halitta ta kwayar halitta, envelope glycoproteins da nucleocapsid sun hada da sunadaran genomic RNA don samar da vesicles ko glands masu dauke da varion, wanda daga baya ya hada da membrane na plasma don sakin kwayar cutar.
An ba da rahoton farkon yanayin genomic na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 wani sabon nau'in beta-CoV ne wanda ke da asalin asalin asalin cutar a cikin 99.98% na asalin kwayoyin halittar samfurin 10 da aka tattara daga kasuwar abincin teku ta Hunan a Wuhan.
SARS-CoV-2 yana da kamanceceniya da SARS-CoV fiye da MES-CoV.
Ta hanyar binciken microscopy na lantarki, an gano SARS-CoV-2 a cikin wani yanki mai kyau na epithelium na numfashin mutum.
An lura cewa ACE2 na mutum shine mai karɓa a cikin SARS-CoV-2 da kuma SARS-CoV.
Koyaya, sunadarai na S na SARS-CoV-2 suna da rauni sosai ga ACE2 na ɗan adam fiye da SARS-CoV, wanda ya yi daidai da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 yana samar da sabon ƙaramin furotin wanda ke ƙunshe da orf3b, kuma yana iya samar da furotin wanda ke ƙunshe da orf8.
SARS-CoV-2 na iya taka rawa a cikin yiwuwar haifar da cutar kwayar cuta da kuma hana bayyanar IFNβ; duk da haka, orf8 ba shi da sanannen filin aiki ko tsari.
A ranar 18 ga Fabrairu, 2020, Zhou da sauransu sun ba da rahoton tsarin cryo-EM na cikakken tsawon mutum ACE2 a cikin kayan haɗin tare da mai jigilar amino acid B0AT1 a ƙuduri 2.9 Å.
Sun gano cewa an haɗa haɗin haɗin haɗin buɗe da rufe don zama dimer, kuma haɗin ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ke ba da tabbaci don ganewa da watsawa na CoV.
Don rage kamuwa da SARS-CoV-2, B0AT1 na iya zama makasudin magani don gwajin magani.
Babban da kuma matsakaici
An gano cewa SARS-CoV da MERS-CoV sun samo asali ne daga bat kuma sun yadu ga mutane ta hanyar cats da raƙuma, bi da bi.
Ta hanyar yin kwatancen kwayar halitta ta SARS-CoV-2 tare da sauran CoVs, an yi la'akari da cewa batirin ne mai ɗaukar nauyin SARS-CoV-2 saboda sabon kwayar cutar tana da daidaito na 96% tare da SARS-like CoVs biyu da aka samo daga bat bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ba a san ko wane mai watsa shiri ne ya taimaka wa kwayar cutar ta tsallaka shingen nau'in don cutar mutane ba kuma har yanzu ana bayyana hanyoyin watsawa.
Ji da sauransu sun gabatar da maciji a matsayin mai ɗaukar kwayar cutar daga batsa zuwa ɗan adam wanda ke da alaƙa da sake haɗuwa tsakanin homologous a cikin S sunadarai.
A wani binciken da aka gudanar, masu bincike a Guangzhou, China sun nuna cewa pangolins masu dogon tsalle, waɗanda galibi ana amfani da su a maganin gargajiya na kasar Sin, sune masu ɗaukar hoto na SARS-CoV-2 tsakanin masu shayarwa masu shayarwa da kuma 99% na CoVs da aka gano a cikin pangolins bisa ga daidaiton kwayoyin halittar SARS-CoV-2.
Duk da haka, bambancin 1% da ke cikin kwayoyin halittar biyu har yanzu babban bambanci ne; saboda haka har yanzu ana jiran sakamakon ƙarshe don tabbatar da tabbaci (Fig. (Fig.33)).
Ba a san yawancin abubuwan da ke cikin ƙwayar cutar SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa har zuwa kwanaki 5 a cikin yanayi mai bushewa na tsawon sa'o'i 48 a waje da jikin mutum, a yanayin zafi na kasa da 20 °C da zafi na 40%-50%.
SARS-CoV-2 na iya samun halaye masu kama da na SARS-CoV-2.
An ba da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da hasken ultraviolet da zafi a 56 °C na tsawon mintuna 30; ether, 75% ethanol, maganin kashe ƙwayoyin cuta mai dauke da chlorine, paracetic acid, chloroform, da sauran mai narkewa banda chlorhexidine na iya kashe kwayar cutar yadda ya kamata.
Dukan mutane suna da rashin garkuwar jiki ga SARS-CoV-2, kuma suna iya kamuwa da cutar.
Babu cikakken bincike game da maganin rigakafin SARS-CoV-2 a halin yanzu.
Saboda haka, za mu iya duba binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Figure 4).
A yadda aka saba, bayan kamuwa da cuta ta shiga cikin kwayar cuta, ana fara gano ta ta hanyar tsarin ganowa ta hanyar masu karɓar kwayar cuta. Waɗannan masu karɓar sun haɗa da masu karɓar C-type lectin, mai karɓar Toll-like (TLR), mai karɓar NOD-like, da mai karɓar RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar cututtukan kumburi, tsufa na ƙwayoyin dendritic, da kuma haɓakar nau'in I interferons (IFNs) wanda ke hana yaduwar kwayar cutar da kuma hanzarta macrophage phagocytosis na kwayar cutar.
Amma, N-protein na SARS-CoV na iya taimakawa kwayar cutar ta tsira daga amsawar garkuwar jiki.
Ba da daɗewa ba, maganin rigakafi mai amfani ya shiga cikin yaƙi da kwayar cutar.
T lymphocytes, ciki har da CD4+ da CD8+ T cells suna taka muhimmiyar rawa wajen hana cutar.
CD4+ T sun motsa B sun samar da ƙwayoyin cuta masu ƙayyadadden kwayar cutar, kuma CD8+ T sun kashe ƙwayoyin cuta kai tsaye.
Kwayoyin T masu taimako suna samar da sinadarin proinflammatory cytokines don taimakawa kwayoyin cuta.
Koyaya, CoVs na iya hana T-cell aiki ta hanyar haifar da mutuwar T-cell.
Tsarin rigakafin jiki tare da kari kamar C3a da C5a da kuma rigakafin jiki ma yana da mahimmanci don yaƙar kamuwa da kwayar cuta.
Misali, ƙwayoyin cuta da aka ware daga marasa lafiya da suka warke sun hana MERS-CoV.
A wani bangare kuma, yawan ƙwayar cuta na jikin mutum yana haifar da yawan 'yan radicals a gida wanda zai iya haifar da mummunar lalacewar huhu da sauran gabobin jiki, kuma a mafi munin yanayi, na iya haifar da nakasa gabobin jiki da yawa ko ma mutuwa.
Cutar SARS-CoV-2 da ke da alamun farawa a cikin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin.
Yana da kyau a lura cewa mutanen da suka kamu da ƙwayoyin cuta masu yawa ko kuma waɗanda suke da ƙarancin garkuwar jiki suna iya kamuwa da cutar fiye da sauran mutane.
Bisa ga binciken farko na 425 a Wuhan, an kiyasta matsakaicin lokacin incubation na SARS-CoV-2 na kwanaki 1-14, a mafi yawan lokuta kwanaki 3-7.
Amma, binciken da aka yi a kan mutane 1,099 ya nuna cewa lokacin da cutar ta yi tsufa ya kai kwanaki 3 kuma tsawon lokacin ya kai kwanaki 0 zuwa 24.
Wani binciken da aka yi kwanan nan, kamar yadda aka bayyana a sama, ya nuna cewa cutar ta shafe kwanaki 4.8 (3.0-7.2) bisa ga yawan mutane 8,866 da suka kamu da cutar.
Daidai da lokacin keɓewa bisa ga lokacin bayyanar cutar mafi dacewa yana da mahimmanci ga hukumomin kiwon lafiya don hana yaduwar kwayar cutar daga mutane masu kamuwa da cutar amma ba tare da alamun cutar ba.
A matsayin al'ada, mutanen da ke da cutar ko kuma suka sadu da ita suna buƙatar keɓewa na kwanaki 14.
Shin akwai bukatar a kara tsawon lokacin killacewar zuwa kwanaki 24?
A mafi yawan lokuta, zazzabi shine babban bayyanar cutar COVID-19, wanda ba shi da alamun bayyanar cututtuka ko kuma wasu alamun bayyanar cututtuka kamar su tari mai bushewa, numfashi mai wuya, ciwon tsoka, rashin jin daɗi, ciwon kai, ciwon makogwaro, rhinorrhea, ciwon kirji, zawo, amai da amai.
Wasu marasa lafiya sun ji dyspnea (ƙunci a numfashi) da / ko hypoxemia bayan mako guda bayan fara cutar.
A cikin mawuyacin hali, marasa lafiya suna da saurin ci gaba da ciwon ƙwayar numfashi mai tsanani, haɗarin haɗari, acidic acid da kuma coagulopathy.
Ana buƙatar gwajin kwayar cutar a farkon ganewar asali ga marasa lafiya da ke da zazzabi da / ko alamun numfashi da kuma zazzabi mai tsanani, koda kuwa ba su da wani abu da ya saba da tsarin kimantawar huhu.
Wani binciken alƙaluma a ƙarshen Disamba na 2019 ya nuna cewa kashi 98% na alamun cutar zazzabi ne, kashi 76% busassun tari, kashi 55% dyspnea ne, kuma kashi 3% na ciki ne; kashi 8% na marasa lafiya suna buƙatar taimakon iska.
An kuma bayar da rahoton irin wannan binciken a wasu binciken da aka yi kwanan nan a kan cutar da ke faruwa a cikin iyali da kuma a cikin mutane marasa alamun cutar.
Ta hanyar kwatantawa, binciken alƙaluma a cikin 2012 ya nuna cewa manyan alamun cututtukan marasa lafiya na MERS-CoV sun kasance zazzabi (98%), busassun tari (47%) da dyspnea (55%).
Koyaya, sun buƙaci tallafin iska a kashi 80%, wanda ya fi na marasa lafiya na COVID-19 yawa kuma ya dace da ƙimar mutuwar MERS fiye da COVID-19.
An kuma lura da zawo (26%) da ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A cikin marasa lafiya na SARS, an nuna cewa zazzabi (99% -100%), busassun tari (29% -75%), dyspnea (40% -42%), diarrhea (20-25%), da ciwon makogwaro (13) -25%) sune manyan alamun cutar, kuma kusan 14% -20% na marasa lafiya suna buƙatar taimakon iska.
A ranar 14 ga Fabrairu, adadin mutuwar COVID-19 a duniya ya kai kashi 2 cikin ɗari, yayin da adadin waɗanda aka tabbatar sun kai 66,576.
A kwatankwacin, SARS yana da yawan mutuwar mutane 8,096 da aka tabbatar da su, kashi 10 cikin 100 na waɗanda suka kamu da cutar a watan Nuwamba na 2002.
Ga MERS, yawan mutuwar mutane a cikin binciken alƙaluma a watan Yunin 2012 ya kai kashi 37 cikin ɗari na 2,494 da aka tabbatar da cutar.
Wani binciken da ya gabata ya nuna cewa R0 na SARS-CoV-2 tare da 95% na lokacin amincewa (CI) na 5.71-7.23 ya yi daidai da 6.47, inda R0 na SARS-CoV kawai ya kasance daga 2 zuwa 4.
An gabatar da kwatancen MERS-CoV da SARA-CoV tare da SARS-CoV-2 dangane da bayyanar cututtuka, yawan mutuwa, da R0 a cikin tebur 1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 yana da damar yada kamuwa da cutar fiye da MERS-CoV da SARS-CoV, amma ba shi da cutar fiye da sauran biyun.
Saboda haka, sarrafa cutar SARS-CoV-2 ya fi ƙalubale fiye da na MERS-CoV da SARS-CoV.
Cluster-infarction sau da yawa yana faruwa a cikin iyali ɗaya ko daga rukuni ɗaya ko daga motoci kamar jiragen ruwa.
Yawancin marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu wuraren kamuwa da cutar ko kuma sun kasance tare da mutane masu kamuwa da cutar ko marasa lafiya a cikin makonni biyu da suka gabata.
Amma an samu rahoton cewa mutane na iya ɗaukar kwayar cutar sama da makonni biyu ba tare da wata alama ba, kuma masu warkewa da aka sallame daga asibiti na iya sake ɗaukar kwayar cutar, wanda ke ba da gargadi don tsawaita lokacin keɓewa.
A farkon lokacin, marasa lafiya suna da ƙarancin ƙwayoyin jini (musamman lymphocytes) a cikin iyakar.
Misali, an gano lymphopenia da kuma hawan aspartame aminotransferase da kuma viremia tare da lambobin lymphocytes <1 × 109 / L a cikin marasa lafiya 1,099 na COVID-19. Misali, an gano lymphopenia da kuma hawan aspartame aminotransferase da kuma viremia tare da lambobin lymphocytes <1 × 109 / L a cikin marasa lafiya 1,099 na COVID-19.
Wasu marasa lafiya sun sami ƙaruwar hanta da ƙwayoyin tsoka da kuma myoglobin a cikin jini, kuma mafi yawan marasa lafiya sun sami ƙaruwar C-reactive protein da kuma ƙarancin ƙwayoyin cuta a cikin jini.
A cikin marasa lafiya masu tsanani, an samu karuwar D-dimer, wanda shine mai lalata fibrin a cikin jini, kuma an samu raguwar yawan kwayoyin lymphocytes.
Yawancin marasa lafiya na COVID-19 suna da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Yawancin lokaci marasa lafiya suna fama da ciwon huhu mara alama, ciwon huhu mai tsanani da kuma cututtukan numfashi mai tsanani (ARDS).
Idan ARDS ta faru, kumburi da ke faruwa, da kuma ci gaba da ciwon hauka suna iya sa iska ta yi sanyi sosai.
Rashin aiki na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Saboda haka, ana yawan ganin cututtukan da suka fi muni a cikin ƙirjin.
A ranar 18 ga Fabrairu, 2020, bincike na cutar COVID-19 ya nuna cewa akwai ƙwayar cuta mai yawa a cikin huhu, wanda ke nuna cewa akwai ƙwayar cuta mai yawa a cikin huhu, wanda ke nuna cewa akwai ƙwayar cuta mai yawa a cikin huhu, wanda ke nuna cewa akwai ƙwayar cuta mai yawa a cikin huhu, wanda ke nuna cewa akwai ƙwayar cuta mai yawa a cikin huhu, wanda ke nuna cewa akwai ƙwayar cuta mai yawa a cikin huhu, wanda ke nuna cewa akwai ƙwayar cuta mai yawa a cikin huhu.
An yi amfani da SARS-CoV-2 RNA ganowa ta hanyar juyawa-transcriptase polymerase chain reaction (RT-PCR) a matsayin babban ma'auni don gano COVID-19.
Koyaya, saboda yawan ƙarancin kuskuren kuskure, wanda zai iya haifar da annobar, daga ranar 13 ga Fabrairu, 2020, a China, an fara amfani da bayyanar asibiti ko na bincike don ganewar asali (wanda ba ya dogara da RT-PCR kawai).
Haka ma yanayin cutar SARS.
Saboda haka, haɗin tarihin cutar, bayyanar cututtuka, gwajin gwaje-gwaje da binciken radiological yana da mahimmanci kuma dole ne don ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, Feng Zhang Group ya bayyana yarjejeniya ta amfani da dabarun CRISPR-based Sherlock don gano SARS-CoV-2, wanda ke gano ɓangarorin SARS-CoV-2 RNA na roba a cikin ƙasa da awa ɗaya ta amfani da dipstick daga 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafi 10-100 na kowace microliter a shigarwa) ba tare da buƙatar kayan aiki ba.
Ana sa ran cewa sabon fasaha zai iya haɓaka ƙwarewa da fa'ida sosai yayin da aka bincika samfuran bincike.
Saboda rashin ƙwarewa game da sabon CoV, likitoci na iya ba da kulawa mai mahimmanci ga marasa lafiya na COVID-19 tare da wasu CoV-compounds kamar SARS-CoV da MERS-CoV da sauran cututtukan da ke haifar da ƙwayoyin cuta (tebur (tebur 2).2) waɗanda aka yi amfani da su a baya ko kuma sun gwada wasu magunguna da aka ba da shawarar.
Wannan maganin ya hada da maganin rigakafin cutar, maganin hana kamuwa da cuta, maganin steroids, maganin plasma na masu warkewa, maganin kasar Sin, da kuma taimakon tunani na yanzu da kuma na gaba.
An kuma ba da shawarar yin amfani da jini daga marasa lafiya da suka warke don magani.
Kamfanonin harhada magunguna sun shiga gasar samar da rigakafi da allurar rigakafi kan cutar.
SARS-CoV-2 yana kaiwa ga huhu da farko kuma yana iya kaiwa ga wasu gabobin da ke nuna ACE2 a ƙananan matakan, kamar tsarin gastrointestinal da koda.
Duk da haka, rashin ƙarfi da nakasa na numfashi sune manyan barazanar da kuma manyan abubuwan da ke haifar da mutuwa ga marasa lafiya.
Ta haka, taimakon numfashi na da muhimmanci wajen rage alamun cutar kuma yana ceton rai, kuma ya haɗa da maganin oxygen na yau da kullum, iskar oxygen mai yawa, iska mai guba, da kuma iska mai guba, wanda ya dogara da tsananin cutar.
Ya kamata a tallafa wa marasa lafiya da ke da cututtukan numfashi mai tsanani da maganin extracorporeal membrane oxygenation (ECMO), wanda shine ingantaccen fasahar bugun zuciya da bugun jini, wanda ake amfani dashi wajen magance cututtukan zuciya ko kuma rashin numfashi.
Hakanan yana da mahimmanci a cikin marasa lafiya na SARS-CoV-2, don kiyaye daidaiton lantarki, hanawa da magance kamuwa da cuta ta hanyar kai tsaye da kuma cutar ta hanyar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut.
An kuma gano cewa cutar cytokine ta haifar da hawan jini daga yawan maganin rigakafi a cikin marasa lafiya da SARS da MERS.
Cytokine disruption wani nau'i ne na tsarin kumburi wanda ya faru ta hanyar sakin nau'ikan cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan kwayoyin suna fitar da ƙwayoyin cuta masu yawa ta hanyar ƙwayoyin cuta, wanda shine babban dalilin ARDS da kuma cututtukan gabobin jiki.
Rashin amsawar rigakafi yana da mahimmanci wajen magance cutar cytokine, musamman a cikin marasa lafiya masu tsanani.
Ana amfani da maganin corticosteroid da tosilezumab, wanda shine anti-IL6 monoclonal antibody, don magance matsalar cytokine.
Sauran maganin hana amsawa ga lalacewar cytokine sun hada da gyaran amsawar rigakafin T-cell; hana IFN-γ, IL-1, da TNF; rage JAK; blinatumomab; mai hana siginar cytokine 4; da kuma HDAC masu hanawa.
Ana amfani da steroids a matsayin maganin rigakafi a cikin maganin SARS don rage tsananin lalacewar kumburi.
Duk da haka, steroids a manyan allurai ba su da amfani ga cututtukan huhu masu tsanani a cikin SARS da COVID-19 marasa lafiya.
Maimakon haka, suna iya haifar da mummunar illa, musamman osteonecrosis na avascular, wanda ke shafar yiwuwar warkewa sosai.
Duk da haka, an ba da shawarar yin amfani da gajeren lokacin shan maganin corticosteroid a ƙananan zuwa matsakaici a cikin marasa lafiya masu cutar COVID-19 masu tsanani.
Babu wani maganin rigakafin cutar da aka tabbatar da inganci a lokacin rubuce-rubuce.
Koyaya, maganin remdesivir, tare da analog na nucleotide, ya tabbatar da inganci ga wani mai haƙuri na Amurka tare da COVID-19.
Remdesivir wani magani ne na rigakafin cutar Ebola wanda Gilead ta fara kirkirarsa don magance cututtukan da ke haifar da cutar Ebola da Marlburg.
Daga baya, Remdesivir ya nuna yiwuwar rigakafin wasu ƙwayoyin cuta masu amfani da RNA guda ɗaya, ciki har da MERS da SARS.
Dangane da wannan, Gilead ta ba da mahaɗin ga China don gudanar da gwaji guda biyu a kan mutanen da ke dauke da cutar SARS-CoV-2, kuma ana tsammanin sakamakon.
Baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin suna da shawarar a matsayin yiwuwar magani ga marasa lafiya da ke da alamun cututtukan numfashi.
Cutar da aka hada da lopinavir/ritonavir na iya haifar da zawo, amai, kumburi, cutar hanta da sauran cututtuka.
Ana bukatar a lura da hulɗar wannan magani da sauran magunguna da ake amfani da su a cikin marasa lafiya.
Samar da jini da kuma ƙwayoyin cuta daga marasa lafiya da suka warke
Akwai dogon tarihi na karɓar jini daga marasa lafiya da suka warke daga cututtuka masu yaduwa don magance wasu marasa lafiya da ke da cutar ko kuma hana mutane masu lafiya kamuwa da cutar.
Hakika, marasa lafiya da suka warke suna da ƙwayoyin cuta masu yawa a cikin jinin su.
Kwayoyin rigakafi sune immunoglobulin (Ig) da kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwa na waje, kuma suna gano ƙwayoyin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Bisa ga wannan, an tattara jini daga jinin wani rukuni na marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar a cikin marasa lafiya 10 masu fama da cutar.
Alamar cutar ta inganta cikin sa'o'i 24, tare da rage kumburi da kwayar cutar da kuma ingantaccen iskar oxygen a cikin jini.
Koyaya, ba a riga an haɓaka takamaiman hanyoyin magani ba kuma ana buƙatar tabbatarwa da bayyanawa kafin a ba da shawarar hanyoyin amfani da su a kan manyan sikelin.
Bugu da ƙari, a cikin sharuddan tasirin magani, wasu matsaloli masu alaƙa da plasma ya kamata a yi la'akari da su a hankali.
Alal misali, ƙwayoyin cuta suna iya sa rigakafin jiki ya yi tsattsauran ra'ayi kuma su sa a yi cututtukan cytokine, wanda zai iya sa mutum ya yi mutuwa.
Yawan rigakafin jini ba shi da yawa, kuma ana bukatar plasma sosai don kula da marasa lafiya masu ciwo mai tsanani.
Yana da wahala a samu da kuma samar da rigakafi cikin hanzari a wasu matakai na yaki da annobar duniya.
Saboda haka, gano kwayoyin halittar don ware kwayoyin B daga marasa lafiya da suka warke da kuma duba kwayoyin cutar da ke aiki a kan sunadarai da ake bukata na kwayar cutar ko kuma yin amfani da kwayar cutar don yin amfani da ita ya fi muhimmanci da kuma amfani.
Ta wannan hanyar, za mu iya ƙara yawan ƙwayoyin cuta.
An yi amfani da TCM a cikin Sin don magance cututtuka da yawa na shekaru dubbai.
Koyaya, tasirinsa ya dogara da haɗuwa da abubuwa da yawa a cikin ƙira wanda ya bambanta dangane da ganewar asali bisa ka'idar TCM.
Yawancin abubuwan da ke aiki ba a san su ba ko kuma ba su da tabbas, saboda irin waɗannan abubuwan ko kuma haɗuwa da su yana da wuya a cire su kuma a tabbatar da su.
A halin yanzu, saboda rashin ingantaccen magani na COVID-19, TCM ya zama babban zaɓi na magani ga marasa lafiya masu saurin bayyanar cututtuka ko waɗanda suka dawo daga mawuyacin yanayi.
Misali, an gano cewa Shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri wajen maganin COVID-19.
Jihohi da yawa a China, inda aka yi amfani da TCM a kashi 87% na marasa lafiya, sun sami mafi yawan adadin warkewa, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, inda aka yi amfani da TCM a kashi 30% na marasa lafiya na COVID-19, ya sami mafi ƙarancin adadin warkewa (13%).
Koyaya, wannan kwatancen ne mai ɗan faɗi saboda yawancin abubuwan da ke tasiri kamar yawan marasa lafiya da tsananin su ya kamata a haɗa su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun buga wani bincike da ke kwatanta hadawar WM da TCM da maganin Magungunan Yammacin Turai (WM).
Sun lura cewa lokacin da ake buƙata don dawo da zafin jiki, kawar da bayyanar cututtuka, da kuma shigar da asibiti ya yi ƙasa da ƙasa a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai.
Mafi ban sha'awa, yawan lalacewar alamomi (mai sauƙi zuwa mai tsanani) ya kasance ƙasa da WM + TCM kawai (7.4% vs. 46.2%) kuma yawan mutuwar ya kasance ƙasa da WM + TCM kawai (8.8% vs. 39%).
Duk da haka, inganci da amincin TCM suna jiran ƙarin gwaji mai kyau a manyan wurare da cibiyoyi.
Zai kuma kasance da ban sha'awa a gano tsarin aiki kuma, idan ya yiwu, a bayyana abubuwan da ke aiki na maganin TCM ko haɗuwa da su.
Yawancin waɗanda ake zargi ko tabbatacce na COVID-19 suna jin tsoron cutar mai saurin yaduwa har ma da mutuwa, kuma waɗanda ke keɓewa suna jin haushi, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, hypoxia, tari, da kuma cututtukan magani kamar rashin bacci da ake samu daga maganin corticosteroid na iya haifar da ƙarin damuwa da damuwa.
A farkon barkewar cutar SARS, an bayar da rahoton bayyanar cututtukan ƙwaƙwalwa da yawa, gami da ciwon hawan jini, damuwa, tashin hankali, tashin hankali, bayyanar cututtukan ƙwaƙwalwa, ɓacin rai, hauka, har ma da tunanin kashe kansa.
A matsayin wani ɓangare na amsar lafiyar jama'a ga ɓarkewar COVID-19, tilas na tuntuɓar mutum da keɓewa na iya haifar da ƙarin damuwa da laifi game da tasirin kamuwa da cuta, keɓewa, da kuma gurɓata danginsu da abokan su.
Saboda haka, ya kamata a samar da kulawar lafiyar hankali ga waɗanda ke da COVID-19, waɗanda ake zargi da cutar, da waɗanda suka haɗu da su, da kuma sauran mutanen da ke da bukata.
Tallafin tunani ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiya na hankali daga fannoni daban-daban na ilimin likita, tare da sadarwa mai kyau tare da sabuntawa na yau da kullun da daidai game da ɓarkewar SARS-CoV-2 da shirin magani da kuma amfani da kayan aikin lantarki na ƙwararru da aikace-aikace don guje wa haɗuwa da juna.
Ana buƙatar allurar rigakafi masu tasiri don hana jerin cututtuka daga dabbobi masu ruwa da mutane masu kamuwa da cuta zuwa masu saurin kamuwa da cuta, kuma galibi suna dacewa da maganin rigakafin cutar a cikin rigakafin annoba da cutar ta haifar.
An yi ƙoƙari don haɓaka allurar rigakafin S-protein don samar da ƙwayoyin cuta masu ƙarfi da na dogon lokaci da / ko samar da rigakafin rigakafi ga SARS-CoV.
An gwada allurar rigakafin kai tsaye a cikin samfurin dabbobi na SARS.
Amma kafin a fara nazarin asibiti, ba a tantance tasirin waɗannan masu neman rigakafin a cikin tsofaffi ba kuma a cikin ƙirar ƙalubalen haɗari, da kuma kariya daga kamuwa da kwayar cutar daga asalin dabbobi zuwa ɗan adam.
Wannan na iya kasancewa saboda SARS ta ƙare shekaru 17 da suka gabata kuma babu wani sabon kamuwa da cutar da aka ruwaito tun daga lokacin.
Akasin haka, bazuwar cutar da annobar MERS ta ci gaba da faruwa a Gabas ta Tsakiya kuma ta bazu zuwa wasu yankuna saboda kasancewar asalin cutar a cikin yankin da cutar ta shafa.
An tsara dabarun rigakafi don MERS ta amfani da ƙwayoyin cuta masu kashewa, plasma na DNA, masu ɗaukar hoto na kwayar cuta, nanoparticles, ƙwayoyin cuta masu kama da kwayar cuta da kuma ƙwayoyin sunadarai masu sake haɗawa, kuma an kimanta wasu a cikin samfurin dabbobi.
Samar da maganin alurar riga kafi mai lafiya da tasiri akan SARS-CoV-2 ga mutanen da ba su da rigakafi na da muhimmanci da kuma gaggawa wajen shawo kan annobar.
Koyaya, wannan ƙalubalen yana da ƙalubale saboda tsayi mai tsawo (matsakaici na watanni 18) da ake buƙata don haɓaka allurar rigakafi da kuma sauye-sauye na CoV.
A matsayin sabon abu, cikakkiyar hanyar gano cutar ta COVID-19 ta fara ne kawai a cikin dubban marasa lafiya.
A yawancin lokuta, marasa lafiya da ba su da wata cuta na farko suna iya samun sauƙi a hankali.
Amma kamar SARS da MERS, COVID-19 yana da alaƙa da rashin lafiya da mutuwa a cikin marasa lafiya masu tsanani.
Saboda haka, yana da mahimmanci ga hukumomin kiwon lafiya su samar da samfurin hasashen cutar, musamman a yankunan da ke da iyakantaccen albarkatu.
Dangane da binciken da aka ruwaito ya zuwa yanzu, waɗannan abubuwan na iya shafar ko kuma haɗawa da alamun cutar a cikin marasa lafiya na COVID-19 (tebur (tebur 33):
Shekaru: Shekaru shine babban abin da ke haifar da sakamakon cutar SARS, kuma hakan gaskiya ne ga COVID-19.
A cikin binciken da aka yi na mutane 8,866 da aka ambata a sama, 47.7% na waɗanda suka wuce shekaru 50 sun kamu da COVID-19 a cikin shekarun 30-65.
Marasa lafiya da ke buƙatar kulawa mai mahimmanci sun fi saurin samun wasu cututtuka da rikitarwa kuma sun fi sauran tsufa (matsakaiciyar shekaru 66 vs. matsakaiciyar shekaru 51), wanda ke nuna shekaru a matsayin mai nuna alamar cutar don sakamakon COVID-19 mai haƙuri.
Jima'i: Maza sun fi mata kamuwa da cutar SARS-CoV-2 (0.31/100,000 vs. 0.27/100,000), kamar yadda aka bayyana a sama.
Rashin lafiya da rikitarwa: Marasa lafiya da ke da COVID-19 da ke buƙatar kulawa mai tsanani suna da haɗarin kamuwa da bugun zuciya mai tsanani da arrhythmia.
Har ila yau, cututtukan zuciya sune babban dalilin mutuwar marasa lafiya na SARS.
An kuma bayar da rahoton cewa SARS-CoV-2 na iya ɗaure zuwa ACE2-positive cholangiocytes, wanda zai iya haifar da rashin aiki na hanta a cikin marasa lafiya na COVID-19.
Ya kamata a tuna cewa shekaru da cututtukan da ke tattare da su suna da alaƙa sosai kuma suna iya shafar juna.
Bayanan da ba a saba gani ba: Matsakaicin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin da aka yi wa nama kuma an ba da shawarar a matsayin mai nuna alamar cutar, amsawa ga magani da kuma yiwuwar cutar ta warke.
An kuma ba da shawarar alaƙar CRP da tsananin COVID-19 da kuma tsinkaya.
Bugu da ƙari, ƙaruwa na lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da kuma creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana nuna waɗannan abubuwa masu saurin motsa jiki a wurare da yawa, musamman a zuciya da hanta, kuma ana fitar da su a lokacin da aka yi wa ƙwayoyin cuta rauni.
Saboda haka, waɗannan su ne alamun da suka saba da su na rashin aiki na zuciya ko na hanta.
Babban bayyanar cututtuka: Radiography na kirji da ci gaban lokaci na bayyanar cututtuka dole ne a yi la'akari da sauran matsaloli don tsinkaya rikitarwa da sakamakon COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune magungunan rigakafi da aka saba amfani dasu a matsayin magani na gaba don cututtukan cututtukan cututtuka.
Tun da yake ana amfani da magungunan maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Saboda haka, idan ya cancanta, ana amfani da steroids a ƙananan allurai da gajeren lokaci a cikin marasa lafiya na COVID-19.
Damuwa: Kamar yadda aka bayyana a sama, a lokacin annobar COVID-19, marasa lafiya da yawa sun sami damuwa ta musamman saboda yawan keɓewa da matsanancin rashin tabbas da kuma ganin danginsu da abokan aikin su sun mutu.
Ba da shawara ta hankali da kuma taimakon dogon lokaci na da muhimmanci wajen taimakawa marasa lafiya su warke daga damuwa da dawowa cikin rayuwa ta al'ada.
A cewar binciken alƙaluma na yanzu, yanayin cutar COVID-19 ya bambanta da na SARS.
Baya ga yin kwafi a cikin ƙananan ƙwayoyin cuta, SARS-CoV-2 na iya yin kwafi a cikin ƙwayoyin cuta a cikin ƙananan ƙwayoyin cuta kuma yana haifar da rashin bayyanar cututtuka ko rashin bayyanar cututtuka a farkon matakan kamuwa da cuta, wanda yayi kama da sauran CoVs da ke da alhakin cutar sanyi.
Saboda haka, marasa lafiya da ke kamuwa da cutar a farkon lokaci ko kuma lokacin da cutar ta fara yaduwa, wanda ke haifar da wahalar sarrafa cutar, na iya samar da kwayar cutar a cikin adadin da ya kamata a cikin aikin yau da kullun.
Koyaya, ana ɗaukar cutar SARS-CoV a matsayin kamuwa da cuta idan marasa lafiya suka yi rashin lafiya, yayin da yawancin kamuwa da cuta ba sa faruwa a farkon matakin.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS tsanani kuma tana da wuyar sarrafawa.
A halin yanzu ana kokarin yin gagarumar yunkuri a kasar Sin, ciki har da kulle Wuhan da biranen da ke kewaye da ita da kuma keɓewar kusan dukkanin al'umma, da fatan hana yaduwar cutar SARS-CoV-2.
Duk da yake waɗannan matakan sun yi mummunan tasiri ga tattalin arziƙi da sauran ɓangarorin ƙasar, adadin sabbin masu cutar yana raguwa, yana nuna jinkirin cutar.
Mafi kyawun hasashe shine cewa cutar za ta ƙare a watan Maris, kuma yanayin raguwar cutar zai ɗauki watanni 3-4.
Amma wasu masana ba su da bege.
Paul Hunter da sauransu sun yi hasashen cewa COVID-19, wanda ke nuna cewa yana da kamuwa da cuta fiye da SARS, ba zai ƙare ba a shekarar 2020.
Ira Longini da sauransu sun kafa samfurin da zai iya hango sakamakon cutar, kuma sun nuna cewa SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan jama'ar duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin mid-terbine da kuma laurels na hanci na marasa lafiya da suka warke kuma aka sallame su makonni 2 da suka gabata, wanda ke nuna cewa sabon kamuwa da cutar zai zama kamar yadda yake a cikin cutar mura.
Koyaya, akwai alamun fata a cikin China dangane da raguwar sabbin lamuran, wanda ke nuna cewa dabarun yanzu na iya aiki.
An fara hasashen cewa cutar za ta yi sanadiyar kamuwa da cutar har miliyan daya, tare da mutuwar mutane miliyan biyar.
Amma, ta hanyar tsauraran matakan killacewa da keɓewa, an sami nasarar sarrafa cutar.
Hakanan yana yiwuwa cewa kamar SARS-CoV, SARS-CoV-2 na iya zama mai rauni a cikin kamuwa da cuta kuma a ƙarshe ya mutu ko kuma ya zama mai ƙarancin kamuwa da cuta a cikin hulɗa da mutane.
An kwatanta SARS da MERS da annobar COVID-19 a ƙasa (Figure (Figure 55)).
SARS-CoV-2 yana da yaduwa sosai ta hanyar tari ko sneezing da kuma ta hanyar hulɗa kai tsaye da abubuwan da cutar ta gurɓata.
An gano kwayar cutar a cikin fitsari, wanda ke nuna sabon yiwuwar kamuwa da fitsari ta hanyar bakin.
Wani binciken da aka yi kwanan nan a kan mutane 138 da suka kamu da cutar ya nuna cewa kashi 41% na cutar na iya zama sanadiyyar kamuwa da cutar nasocomial (na asibiti), wanda ya hada da marasa lafiya 17 da suka kamu da wasu cututtuka da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, mutane, musamman ma masu kula da lafiya, ma'aikatan zamantakewa, danginsu, abokan aiki, har ma da waɗanda ke kusa da marasa lafiya ko waɗanda ke da cutar, suna buƙatar yin taka tsantsan don kare su.
Ana iya amfani da sanya abin rufe fuska a matsayin matakin farko na kariya don rage haɗarin kamuwa da cuta; amfani da abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (jerin # 1860s) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Takunkumin fuska na tiyata yana hana ƙananan ɗigon ruwa daga mai yiwuwa mai kamuwa da cuta daga yaduwa ta iska ko tsayawa a saman abu, daga inda za su iya yaduwa ga wasu.
Koyaya, kawai N95 (jerin # 1860s) masks na iya ba da kariya daga karamin kwayar cuta kamar 10 zuwa 80 nm, kawai 5% na ƙwayoyin cuta suna iya shiga gaba ɗaya; SARS-CoV-2 yayi daidai da SARS-CoV kuma duka suna da kusan 85 nm.
Tun da ƙwayoyin cuta na iya shiga cikin masks na tiyata guda biyar a jere, masu ba da kiwon lafiya waɗanda ke hulɗa kai tsaye da marasa lafiya ya kamata su sa N95 (jerin # 1860s) maimakon abin rufe fuska.
Bugu da ƙari, masu ba da kiwon lafiya ya kamata su sanya tufafin keɓewa don rage haɗuwa da kwayar cutar.
Hakanan za a iya samun kwayar cutar ta hanyar ido.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; mai yiwuwa kwayar cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, masu kula da lafiyar jama'a su ma ya kamata su sanya abin rufe fuska ko tabarau masu haske yayin da marasa lafiya ke aiki.
A cikin al'umma a cikin yankuna da ke fama da cutar ko kuma waɗanda za su iya kamuwa da cutar, an ba da shawarar sosai ga kowa da kowa su wanke hannayensu da sabulu mai kashe ƙwayoyin cuta fiye da yadda ya kamata, su yi ƙoƙarin kasancewa a cikin gida don keɓe kansu, da kuma iyakance hulɗa da mutanen da ke da cutar.
Ana ganin ya fi dacewa mutum ya kasance nesa da mai cutar da ke da nisan kafa uku.
Wannan matakin na taimakawa wajen rage haɗarin kamuwa da cutar da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya zo duniyar ɗan adam a matsayin sabon kwayar cuta, ya kamata a yi taka tsantsan a China bisa zurfin ƙwaƙwalwar ƙwaƙwalwar cutar SARS ta 2003 saboda babban kamaninta da SARS-CoV, kamar yadda rahoton Janairu 7, 2020 ya nuna.
Koyaya, har zuwa 19 ga Janairu, 2020, Daraktan Cibiyar Kula da Cututtuka ta Wuhan ya ta'azantar da 'yan ƙasa cewa kwayar cutar ba ta da saurin yaduwa kuma ba ta da iyakantaccen haɓakar mutum-zuwa-mutumin, kuma babu wata matsala a cikin rigakafin cutar da sarrafa ta.
Wannan sakon ya sauƙaƙa fargabar jama'a, musamman a lokacin da duk ƙasar ke shirin bikin bazara, kuma an ɓata lokaci mai mahimmanci a Wuhan don sarrafa cutar zuwa mafi ƙarancin.
Hukumomin kula da cututtuka na kasar Sin na iya koyon darasi daga wannan mummunan yanayin kuma suyi ci gaba da ingantawa a nan gaba.
Misali, waɗannan hukumomin (1) dole ne su yi taka tsantsan yayin sanar da jama'a saboda kowane kalma zai sa 'yan ƙasa suyi la'akari kuma hakan na iya canza halayensu da yanke shawara; (2) ya kamata su zama masu saukin kai da kuma amsawa ga bayanan da ba a so daga asibitoci ba tare da jiran rahoton hukuma daga likitoci ko jami'ai ba; (3) ya kamata su zama masu sarrafawa sosai don hana yiwuwar annoba a farkon matakai maimakon ƙoƙarin kwantar da hankalin jama'a; da (4) ya kamata a aiwatar da ayyuka masu ma'ana da tasiri tare da nufin haɓaka wayar da kan jama'a game da annobar cutar da kuma gwadawa da inganta yanayin amsawar al'umma a lokaci.
Cutar COVID-19 da kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya yaɗu a duk ƙasar Sin, kuma a lokacin rubuta wannan rahoton, ya yaɗu zuwa kusan ƙasashe 50 a duniya.
Tun da yake kwayar cutar ta yi kama da SARS-CoV kuma akwai kamanceceniya tsakanin bayyanar COVID-19 da bayyanar SARS, barkewar COVID-19  ya haifar da jin daɗin dawowar SARS.
Koyaya, akwai wasu mahimman bambance-bambance tsakanin COVID-19 da SARS waɗanda suke da mahimmanci don hana annobar da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa da maza fiye da mata, kuma yawan cutar da mutuwa sun fi na matasa.
Matsayin mutuwar SARS ya fi na COVID-19 (10.91% zuwa 1.44%).
Marasa lafiya na COVID-19 suna iya yada cutar ba tare da bayyanar cututtuka ba, yayin da marasa lafiya na SARS suna iya yin hakan a cikin mawuyacin yanayi, wanda ke sa ya fi wahalar shawo kan cutar COVID-19 fiye da SARS.
Wannan ya bayyana a wani ɓangare dalilin da yasa SARS-CoV-2 ya yadu da sauri kuma ya fi SARS-CoV.
Ana iya yin gwajin RNA na yau da kullun don SARS-CoV-2 mara kyau a wasu marasa lafiya na COVID-19.
A wani bangare kuma, masu warkewa na iya sake nuna cewa sun kamu da cutar.
Wadannan binciken sun kara hadarin yaduwar kwayar cutar sosai.
A cikin wannan saurin ci gaba a cikin binciken COVID-19, akwai wasu mahimman abubuwa da za a magance:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano kashi 96% na kwayoyin halittar SARS-CoV-2 da SARS-CoVs guda biyu, ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga bat.
Shin akwai wasu dabbobi da suka shiga tsakanin masu amfani da cutar, kamar su bat, da suka kai cutar ga mutane?
Idan ba mu san amsoshin tambayoyin 1 da 2 ba, ba za mu iya rage yaduwar cutar ba kuma za ta iya dawowa a kowane lokaci.
Kodayake samfurin kwayoyin halitta da kimantawar kwayoyin sun nuna cewa SARS-CoV-2 yana ɗaure da ACE2, ta yaya ainihin cutar ta shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na ilimin lissafi?
Shin kwayar cutar tana hana kwayar cutar ACE2 a wasu sassan jiki?
Idan ba tare da amsar wannan tambayar ba, ba za mu iya samun ganewar asali da kuma magani mai inganci ba.
Har yaushe za a ci gaba da annobar?
Ta yaya kwayar cutar take yaduwa a cikin kwayoyin halittar mutum?
Shin za ta zama annoba ta duniya, ko kuma za ta sake barkewa kamar cutar SARS?
Yana da muhimmanci, amma ana bukatar lokaci don samun amsoshin waɗannan tambayoyin da wasu.
Amma ko da menene farashin da ake nema, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu ga al'ada.
Tushen dabbobi na kwayar cutar korona ta mutum
Juyin halittar halittu da kuma daidaitawa sun haifar da juyin halittar kwayar cutar corona (CoV) da kuma masu dauke da ita, ciki har da dan adam, tsawon dubban shekaru.
Kafin 2003, an san cewa mutum biyu CoVs (HCoVs) suna haifar da rashin lafiya mai sauƙi kamar sanyi.
Barikin ya juya baya don nuna yadda cutar HCoV za ta iya zama mai ɓarna da mutuwa, yayin da ake ci gaba da barkewar cutar cututtukan numfashi mai tsanani (SARS) da kuma cutar MERS ta Gabas ta Tsakiya.
Yunƙurin SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake kawo CoVs a saman tattaunawa kuma ya ba mu mamaki, yana nuna babban yaduwa da ƙarancin cutarwa fiye da ɗan'uwansa SARS-CoV.
HCoV kamuwa da cuta ce ta dabbobi, kuma fahimtar asalin HCoV zai iya taimaka mana.
Yawancin HCoVs sun samo asali ne daga batutuwan da ba su da cutar.
An kuma gano wasu masu watsa kwayar cutar HCoVs.
Gano ƙwayoyin cuta na dabbobi yana da tasiri kai tsaye a kan rigakafin mutum.
Binciken musayar CoV-shelter a cikin dabbobi na iya ba da mahimman bayanai game da cutar CoV a cikin mutane.
A cikin wannan bita, muna ba da taƙaitaccen ilimin da ake da shi game da kwayar cutar HCoV guda bakwai, tare da mai da hankali kan tarihin gano su da kuma tushen dabbobi da kuma yaduwar su.
Muhimmanci, muna kwatanta da kuma kwatanta HCoVs daban-daban daga mahangar juyin halitta na kwayar cuta da kuma sake fasalin kwayoyin halitta.
A wannan mahallin, an tattauna game da cutar COVID-19 na yanzu.
Bugu da ƙari, ana nuna bukatar sauya mai tallafi mai nasara da kuma tasirin juyin halitta na cutar a kan yanayin cutar.
Coronavirus (CoV-s) na cikin dangin coronaviridae, wanda ya ƙunshi rukuni na ɓoyayyun, masu saurin ji, ƙwayoyin cuta guda ɗaya na RNA.
"Wadannan ƙwayoyin cuta da ke da kwayar halitta mai girman kilobace 26 zuwa 32 a cikin ƙwayoyin RNA, an sanya musu suna ""CoV"" saboda tsarin da ke kama da kambi a ƙarƙashin allon lantarki".
A tsarin, CoVs suna da kwayoyin halittar da suke da tsari iri ɗaya.
Kusan kashi biyu bisa uku na kwayoyin halitta suna da manyan manyan open reading frames (ORF1a da ORF1b), wanda aka fassara zuwa pp1a da pp1ab.
Ana sarrafa polyproteins don samar da wasu 16 da ba su da tsari, wanda aka sanya wa suna nsp1~16.
Sauran kwayoyin suna da ORFs don gina jiki sun hada da kelic (S), wrapping (E), membrane (M), da nucleoproteins (N).
Wasu layin-takamaiman kayan haɗin sunadarai ma suna ɓoye ta hanyar layin daban-daban na CoVs.
Dangane da bambancin jerin sunayen sunadarai, an rarraba CoVs zuwa nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan (A, wato: A, A, A, B, B, B, B, B, C, C, C, da kuma D).
Shaidar jinsi ta nuna cewa damisa da beraye suna aiki a matsayin tushen kwayoyin halitta na alpha-CoVs da beta-CoVs, yayin da tsuntsaye su ne tushen tushen gama-CoVs da Delta-CoVs.
A cikin dubun dubatan shekaru, CoVs sun ci gaba da ƙetare shingen jinsuna kuma sun bayyana a matsayin wasu manyan cututtukan ɗan adam.
Ya zuwa yanzu, an gano kwayar cutar mutum guda bakwai (HCoV-s).
Daga cikin su, HCoV-229E da HCoV-NL63 sune alpha-CoV.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar coronavirus mai saurin numfashi (SARS-CoV), cutar coronavirus na numfashi na Gabas ta Tsakiya (MERS-CoV), da kuma SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da ƙananan alamomi kamar su sanyi da / ko zawo.
A gefe guda, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 sun haifar da kamuwa da cutar ta ƙananan ƙwayoyin cuta a cikin marasa lafiya da ke da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
An samo kwayar HCoV-229E ta farko, B814 daga hanci na marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin da aka yi a kan HCoV-229E da HCoV-OC43, waɗanda duka biyu ke haifar da alamun da ke iyakance kansu.
A zahiri, har zuwa barkewar SARS, an yarda da cewa watsa HCoVs ba shi da lahani.
Barkewar SARS a 2003 na daya daga cikin munanan a tarihin kwanan nan, inda ya kamu da mutane 8,000, kuma yawan mutuwar da aka yi ya kai kusan 10%.
Shekaru goma bayan haka, barkewar cutar MERS ta Gabas ta Tsakiya ta ci gaba da yaduwa a yankin Larabawa kuma ta bazu zuwa sauran duniya.
2019 novel HCoV (2019-nCoV), wanda aka sake masa suna SARS-CoV-2, shine mai aiki na cutar coronavirus ta yanzu ta 2019 (COVID-19), wanda ya yi sanadiyar mutuwar mutane sama da 3,120 da kuma kamuwa da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
An yi gargadin cewa za a iya samun annobar SARS-CoV-2 a duniya.
Kowane ɗayan nau'ikan HCoV guda bakwai yana da asalin dabba daga bat, bera ko dabbobi.
Shaida da yawa suna tallafawa asalin juyin halitta na duk HCoVs daga bat, inda ƙwayoyin cuta suka daidaita kuma suka nuna bambancin kwayoyin halitta mai ban mamaki amma ba mai cutarwa ba.
Cutar COVID-19 ta gabatar da manyan kalubale na likita, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin dabbobi na HCoVs yana ba da tsari don fahimtar abubuwan da ke haifar da tarihin halitta, abubuwan motsa jiki, da ƙuntatawa na tsalle-tsalle daga nau'in zuwa nau'in.
Wannan zai iya jagorantar binciken tushen, matsakaici da kuma masu watsa dabbobi na SARS-CoV-2, tare da mahimman abubuwan da ke tattare da rigakafin ɓarkewar nan gaba.
A cikin wannan bita, muna gabatar da taƙaitaccen bayanin asalin dabbobi, watsawa tsakanin jinsuna, da kuma cutar HCoVs.
Musamman, muna son kawo wannan yanayin na kowa da kowa kuma mu tattauna cewa ƙwayoyin cuta na HCoV-suna da rashin lafiya a cikin mahaifansu na asali amma suna da cututtuka bayan sun shiga cikin sabon mahaifinsu.
Mun kuma bincika yanayin juyin HCoVs inda yawanci cutar ta ragu yayin da yaduwar cutar ke ƙaruwa.
An kuma tattauna sakamakon barkewar cutar SARS-CoV-2 a wannan mahallin.
An san game da CoVs a cikin dabbobi tun ƙarshen 1930s.
An tattara nau'ikan CoV-s a cikin dabbobi da yawa masu kamuwa da cutar, gami da turkey, beraye, shanu, aladu, kuliyoyi, da karnuka, kafin a fara tattara B814 na kwayar HCoV-229E daga ɓoyayyen hanci na marasa lafiya da ke fama da sanyi.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
Takaitaccen tarihin gano HCoVs a cikin jerin lokuta (Table 1) zai zama mai bayani da kuma ilimi.
An gano kwayar HCoV-229E ta farko a cikin hanyoyin numfashi na marasa lafiya da ke fama da kamuwa da cutar numfashi a cikin 1966, kuma an daidaita ta don haɓaka cikin layin ƙwayoyin huhu na WI-38.
A cikin marasa lafiya da ke dauke da HCoV-229E, an sami alamun sanyi da yawa, ciki har da ciwon kai, tari, rashin jin daɗi da ciwon makogwaro, kuma a cikin kashi 10 zuwa 20 cikin dari, zazzabi da tari.
Daga baya a 1967, an gano HCoV-OC43 daga al'adun kwayoyin halitta da kuma daga baya daga maimaita haɓakar kwayar cutar a cikin kwakwalwar berayen da ke shayarwa.
Halittu na asibiti na kamuwa da HCoV-OC43 suna kama da alamun da HCoV-229E ke haifarwa, wanda ba za a iya bambanta shi da kamuwa da wasu cututtukan numfashi kamar su cutar Influenza A da rhinovirus ba.
Dukansu HCoV-229E da HCoV-OC43 suna yaduwa a duniya kuma ana yaduwa a cikin yanayin sanyi a cikin yanayin zafi.
A yadda aka saba, bayyanar cututtukan biyu na cutar ba ta wuce mako guda ba, sannan kuma kusan makonni biyu na rashin lafiya.
Wani binciken da aka yi a kan masu sa kai na mutane ya nuna cewa, mutane masu lafiya da ke dauke da cutar HCoV-229E sun samu ciwon sanyi.
An lura da cututtukan ƙananan ƙwayoyin cuta a cikin wasu marasa lafiya da ke da rigakafin rigakafi.
"SARS, wanda kuma ake kira ""atypical pneumonia"", shi ne annoba ta farko da aka rubuta a tarihin ɗan adam, kuma wanda ya haifar da cutar shi ne SARS-CoV, wanda shine HCoV na uku da aka gano".
An gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
An samu rahotanni na 8,096 da suka shafi cutar SARS, tare da mutuwar mutane 774 a kasashe da nahiyoyi da dama.
Baya ga masu yaduwa, an kiyasta cewa kowane yanayi zai iya haɓaka kusan biyu na haɗuwa tare da lokacin incubation na kwanaki 4 zuwa 7 da bayyanar bayyanar bayyanar siginar ƙwayar cuta a ranar 10th na rashin lafiya.
A cikin marasa lafiya da ke dauke da SARS-CoV, ana samun ciwon tsoka, ciwon kai, zazzabi, rashin jin daɗi, da kuma sanyi, da kuma ciwon numfashi, tari, da kuma ciwon numfashi.
Lymphopenia, gwajin cutar hanta da kuma kara yawan sinadarin creatine sune cututtukan da aka saba gani a SARS.
An kuma lura da lalacewar alveolar da aka fitar, yaduwar ƙwayoyin mahaifa, da kuma ƙaruwa na macrophages a cikin marasa lafiya da SARS.
Kusan kashi 20-30% na marasa lafiya suna buƙatar kulawa mai tsanani da kuma iska mai iska.
Baya ga ƙananan hanyoyin numfashi, wasu gabobin jiki da suka hada da gastrointestinal tract, hanta da koda na iya kamuwa da cutar a cikin mawuyacin hali, yawanci suna tare da rikicewar cytokine wanda zai iya zama mai tsanani musamman ga marasa lafiya da ke da rashin ƙarfi.
An fara samun kwayar cutar ne daga nazarin huhu na wani dangin wani mai cutar da ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen binciken HCoV.
An tattara HCoV-NL63 daga jariri mai wata 7 a Netherlands a ƙarshen 2004.
An fara samunsa a cikin yara ƙanana, tsofaffi, da kuma marasa lafiya masu fama da cututtukan numfashi da ke da ƙarancin garkuwar jiki.
Cutar da HCoV-NL63 ke haifarwa a cikin ɓacin rai, ƙyamar ido, zazzabi da kuma ciwon huhu.
Wani bincike na daban ya bayyana tarin kwayar cutar daga hanci na wani yaro dan wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi ne a Netherlands, ya yadu a duniya.
An kiyasta cewa HCoV-NL63 yana haifar da cutar a kusan kashi 4.7% na cututtukan numfashi na yau da kullun kuma yana da mafi yawan lokuta a lokacin bazara, bazara da farkon hunturu.
HCoV-NL63 yana da alaƙa da cutar larynxitis, wanda kuma ake kira CROUP.
A wannan shekarar, an tattara HCoV-HKU1 daga wani mutum mai shekaru 71 da ke fama da ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
Baya ga cutar sankarar bargo da kuma cutar sankarar bargo, an kuma bayar da rahoton cewa HCoV-HKU1 yana da alaƙa da cututtukan asma mai tsanani.
HCoV-HKU1, wanda yake kama da HCoV-NL63, HCoV-229E da HCoV-OC43, an gano shi a duniya, wanda ke haifar da rashin lafiya na numfashi.
Dukkanin waɗannan nau'ikan HCoVs huɗu da aka samo sun dace da ɗan adam kuma galibi ba su da yuwuwar canzawa don haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cututtukan cuttuk
A yadda aka saba, idan HCoVs suka sami damar yaduwa da kuma ci gaba da kasancewa a cikin mutane, to ba sa cutarwa ko kuma yaduwa.
A shekarar 2012 ne aka fara samun kwayar cutar MERS-CoV a cikin huhu na wani mutum mai shekaru 60 da haihuwa wanda ya kamu da cutar sankarar huhu da kuma rashin abinci a Saudiyya.
Duk da yake yawancin lab-tabbatar da lamuran sun samo asali ne daga Gabas ta Tsakiya, an sami rahotanni na wasu lokuta daga kasashen Turai da Tunisia, tare da wani lokaci na biyu a cikin kusanci.
Wani barkewar cutar ta biyu a Koriya ta Kudu a shekarar 2015 inda aka tabbatar da mutane 186.
An nuna alamar cutar ciwon huhu mai tsanani, bayyanar cutar MERS tana kama da SARS.
Ban da SARS, yawancin marasa lafiya da ke dauke da cutar MERS sun kuma sami mummunan rauni na koda, wanda har yanzu ba shi da bambanci ga cutar MERS a cikin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun cututtukan ciki kamar zawo da amai.
Ya zuwa ranar 14 ga Fabrairu, 2020, fiye da dakunan gwaje-gwaje 2500 sun tabbatar da cewa cutar ta kashe mutane sama da kashi 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi cutar mutum.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano rukunin marasa lafiya da ke fama da cutar sankarar bargo a Wuhan, lardin Hubei na kasar Sin, saboda yanayin da ke tattare da cutar SARS-CoV-2.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar sankarar numfashi da SARS-CoV-2 ke haifarwa a matsayin gaggawa ta lafiyar jama'a ta duniya, kuma ta sanya sunan cutar COVID-19.
Ya zuwa 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duniya, tare da mutuwar kusan 3.4%.
A cikin kasar Sin, Hubei na da kashi 4.2 cikin dari na wadanda suka mutu, yayin da sauran kasashen duniya ke da kashi 1.2 cikin dari.
SARS-CoV-2 yana haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV waɗanda aka gabatar da su azaman zazzabi, tari da kuma numfashi.
Wasu marasa lafiya ma suna da zawo.
Cutar huhu na daga cikin alamun cutar da ke iya kaiwa ga ciwon numfashi mai tsanani.
Kodayake suna da kamanceceniya da SARS-CoV da SARS-CoV-2 saboda yawan adadin nucleotide mai yawa na 82% da suke da su, sun haɗu a cikin rassa daban-daban na bishiyar jinsi.
SARS-CoV-2 ba shi da cutarwa sosai amma yana da yaduwa fiye da SARS-CoV da MERS-CoV.
An samu rahoton cututtuka marasa alamun cutar SARS-CoV-2 kuma yana iya taimakawa wajen saurin yaduwar cutar a duniya.
Kwatanta SARS-CoV-2 da sauran HCoVs shida da kuma bambance-bambance na nuna kamance da bambance-bambance masu ban sha'awa.
Na farko, lokaci na fitowar kwayar cuta da kuma lokacin cutar HCoV suna da kamanceceniya sosai.
A wannan batun, SARS-CoV-2 yana bin tsarin da sauran HCoVs shida suka saba.
Na biyu, tsananin bayyanar cututtukan COVID-19 ya kasance tsakanin SARS-CoV da kuma HCoVs huɗu da ke kamuwa da jama'a (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye waɗanda galibi ba su da mahimmanci, tare da ɗan ƙaramin ko ma bayyanar cututtukan da ba a bayyana ba yayin kamuwa da HCoVs da aka samo a cikin al'umma.
A gefe guda, ƙananan ƙananan lokuta na COVID-19 suna nuna alamun kamuwa da SARS-CoV, kodayake ƙananan rabo.
Na uku, SARS-CoV-2 ya nuna alamun alamun HCoVs da SARS-CoVs da aka samu.
A gefe guda, SARS-CoV-2 yana da cutarwa kamar yadda HCoVs masu tarin yawa suke.
A gefe guda, ana ci gaba da tantancewa ko SARS-CoV-2 ya rage yaduwar cutar bayan yaduwar mutum kamar yadda SARS-CoV da MERS-CoV suka yi.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurin goro.
Ko cutar SARS-CoV-2 ta hanyar fitsari tana taka rawa a cikin wasu yanayi, kamar SARS-CoV, har yanzu yana da sauran bayani daga binciken da za a yi nan gaba.
Yana da matukar sha'awa a ga ko SARS-CoV-2 yana nuna irin wannan yanayin na yanayi kamar yadda yake tare da HCoVs da aka samu a cikin al'umma.
Duk da haka, fasalin SARS-CoV-2, gami da yaduwar cutar, cutar, da kuma ci gaba da yaduwa bayan ya wuce tsakanin mutane, zai yi tasiri a ƙarshen barkewar COVID-19.
Dukkanin nau'ikan HCoVs huɗu da ke haifar da bayyanar cututtuka masu sauƙi sun dace da ɗan adam.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun daidaita da kyau ga waɗannan HCoVs huɗu.
A wasu kalmomi, duka biyun na iya zama masu amsawa ga tsohuwar cutar HCoV.
An kashe HCoVs da ke haifar da mummunar cuta a cikin mutane da kuma waɗanda suka ci gaba da cutar HCoV mai tsanani.
Don hakan ya faru, HCoVs dole ne suyi kwafi a cikin mutane da yawa don tara bambance-bambancen da ke yaƙi da abubuwan da ke iyakance mai masaukin baki.
A wannan ma'anar, yayin da barkewar SARS-CoV-2 ta daɗe kuma mutane da yawa suka kamu da ita, zai fi dacewa da daidaitawa ga mutane.
Idan aka daidaita shi, zai yi wuya a hana yaduwar cutar a jikin mutane ta hanyar keɓewa ko wasu matakan sarrafa cutar.
Shekaru da yawa, CoVs huɗu da aka samu sun bazu cikin al'ummar ɗan adam, suna haifar da sanyi-cough na yau da kullun a cikin marasa lafiya masu ƙarancin rigakafi.
Waɗannan ƙwayoyin cuta ba sa bukatar tushe na dabba.
Akasin haka, SARS-CoV da MERS-CoV masu cutarwa ba su daidaita da kyau a cikin mutane ba kuma ba za su iya ci gaba da yaduwa a cikin mutane ba.
Suna buƙatar kiyayewa da kuma yada su a cikin tushen zoonotic kuma suna iya neman damar yadawa ga maƙasudin ɗan adam ta hanyar ɗayan ko fiye na matsakaici da masu haɓaka.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV/MERS-CoV da kuma HCoVs huɗu da aka samu a cikin al'umma.
Aƙalla har zuwa yanzu, yana da yaduwar yaduwa kamar HCoVs da aka samu a cikin al'umma.
Koyaya, yana da cutarwa fiye da nau'in HCoVs da aka samo asali kuma ba shi da cutarwa fiye da SARS-CoV ko MERS-CoV.
Dole ne a ga ko ya dace da mutane kuma ya ci gaba da yaduwa tsakanin mutane ba tare da tushe ko kuma mai rarrafe na dabbobi ba.
Kafin mu tattauna game da asalin dabbobi na HCoVs, za mu amfana daga tattauna ma'anar da kuma halaye na masu ba da izini na juyin halitta, na halitta, na asali, na tsaka-tsaki da na haɓaka na HCoVs.
Dabba na iya zama mai ɗaukar hoto na HCoV idan ya sami asalin da ya dace ta hanyar raba mafi girman daidaituwa a matakin jerin nucleotide.
Kwayar cutar ta saba da zama mai kyau a cikin mai masaukin kuma ba ta da cutar.
Hakanan, mai ba da tushe yana ba da HCoVs a kai a kai kuma na dogon lokaci.
A duka biyun, masu ba da izinin suna kamuwa da cutar ta halitta kuma su ne masu ba da izinin HCoV ko kuma kwayar cutar da ta haifa.
Akasin haka, idan HCoV ya shiga cikin wani mai watsa shiri na tsaka-tsaki kafin ko kusa da mutum, ba zai dace da sabon mai watsa ba kuma yana haifar da cuta.
Wannan matsakaiciyar mai ɗaukar hoto na iya zama tushen kwayar cutar ɗan adam kuma yana iya zama mai ɗaukar hoto mai haɓaka don yin kwayar cutar ta ɗan lokaci sannan kuma ta hanyar yaduwar cutar zuwa jikin ɗan adam.
Idan HCoVs ba su iya ci gaba da yaduwa a cikin mai watsawa na tsakiya ba, za a iya dakatar da yaduwar.
Akasin haka, HCoVs na iya daidaitawa da matsakaiciyar kwayar halitta kuma su fara yaduwa na dogon lokaci.
A wannan yanayin, matsakaiciyar hanyar shiga ta zama hanyar shiga ta hanyar tushe.
Bayanan cututtuka sun nuna cewa akwai tarihin hulɗa da dabbobi masu farauta tare da alamun SARS.
Binciken da aka yi na gaba ya nuna cewa akwai ƙarin barkewar cutar anti-SARS-CoV IgG a cikin dillalan dabbobi fiye da na jama'a.
An gano wani kare raccoon a kasuwannin dabbobin daji (Pyguma larvata) da kuma rayayyun dabbobi don ɗaukar kwayar cutar SARS-CoV wanda ya yi kama da SARS-CoV.
An kuma tabbatar da hakan ne ta hanyar bayanan da aka samu cewa babu wani sabon cutar SARS da aka samu bayan an kashe dukkan masu shan ƙanshi a kasuwa.
Amma an ba da rahoton cewa masks na dabbobi masu rai ko na gonaki ba tare da hulɗa da kasuwar dabbobi ba sun kasance masu ƙarancin cutar SARS CoV, wanda ke nuna cewa masks na dabbobi masu ƙanshi na dabbobi za su yi aiki ne kawai a matsayin matsakaiciyar hanyar haɓaka amma ba a matsayin tushen SARS-CoV ba.
Abin lura, tunda kashi 80% na nau'ikan dabbobi a kasuwar Guangzhou suna da rigakafin SARS-CoV, ba za a iya kawar da yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa na iya zama matsakaiciyar hanyar watsa SARS-CoV ba.
Dukkanin waɗannan ana ɗaukarsu a matsayin masu ɗaukar SARS-CoV.
Binciken da aka yi a cikin dabbobi masu shayarwa na SARS-CoV ya bayyana wani CoV mai alaƙa da bat, SARS-related Rhinelophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin bat na China. Binciken da aka yi a baya ya bayyana wani bat CoV mai alaƙa da bat, SARS-related Rhinelophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin bat na China.
Wadannan fararen hula sun nuna cewa suna da kwayar cutar SARS-CoV da kuma SARSr-Rh-BatCoV HKU3 wanda ke da kwayar cutar.
Wannan da sauran CoVs na bat sun raba kashi 88-92% na nucleotide sequence homology tare da SARS-CoV.
Wannan bincike ya kafa sabon ra'ayi cewa damisa na iya zama mafakar cututtukan da ke haifar da cutar mutum.
An gano wasu nau'ikan CoV masu kama da SARS (SL-CoV-type) daga batura, amma babu wanda za'a iya tattara shi azaman kwayar cutar mai rai sai dai WIV1 da aka zaɓa.
An san enzyme mai canza angiotensin na mutum 2 (ACE2) a matsayin mai karɓar SARS-CoV.
An nuna cewa WIV1 da aka samo daga samfurin fitsari na batutuwan da aka samo daga batutuwan, da kuma na mutum ACE2 suna amfani da su a matsayin masu karɓa don shiga cikin ƙwayoyin.
Abin sha'awa, maganin SARS da aka yi amfani da shi a cikin marasa lafiya da suka warke ya hana WIV1.
Ya zuwa yanzu, WIV1 yana wakiltar mafi kusanci ga tsohuwar SARS-CoV a cikin beraye, tare da raba kashi 95% na daidaiton jerin nucleotide.
Kodayake akwai babban matakin daidaituwa tsakanin waɗannan ƙwayoyin cuta guda biyu, ana yawan gaskata cewa WIV1 ba shine kwayar cutar SARS-CoV na nan take ba kuma cewa batirin ba shine tushen tushen SARS-CoV ba.
Binciken filagenetic ya sanya MERS-CoVs a cikin rukuni ɗaya kamar Bat CoV-HKU4 da Bat CoV-HKU5.
Bat CoV-HKU4 da MERS-CoV suna amfani da mai karɓar bakuncin guda ɗaya, dipoptidyl peptidase 4 (DPP4), don shiga cikin kwayar cutar.
Tsarin RNA polymerase na RNA-da ke dogara da MERS-CoV yana da kusanci da tsarin kwayoyin halitta na bat beta-CoVs da aka gano daga Turai da Afirka.
Ya zuwa yanzu, ba a gano MERS-CoV mai rai a cikin damisa ba.
MERS-CoV da kuma dangin sa na kusa CoV-HKU25 suna da kashi 87% na daidaiton jerin nucleotide.
Saboda haka, ba za a iya cewa barayi ne tushen MERS-CoV ba.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman da ke da ƙwayoyin cuta sun kasance masu karɓa ga takamaiman ƙwayoyin cuta na MERS-CoV, kamar yadda raƙuman da ke Gabas ta Tsakiya suka kasance a ƙasashen Afirka da yawa.
An tattara kwayar cutar MERS-CoV mai kama da kwayar cutar da aka samu a cikin mutane daga kwayar hanci na raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Ya kuma nuna cewa an gano cewa raƙuman da ke da cutar MERS-CoV a gwaji suna da ƙananan alamun cutar, amma suna da ƙwayar cutar.
Abin lura, raƙuman da ke dauke da cutar ba kawai suna yada cutar ta hanyar numfashi ba, har ma ta hanyar hanci da baki, wanda shine babban hanyar watsa cutar daga bat.
Koyaya, tambayoyi sun kasance saboda yawancin waɗanda aka tabbatar da cutar MERS ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, mai yiwuwa hanyar kamuwa da cutar daga mutum zuwa mutum ko kuma hanyar kamuwa da cutar da ke tattare da nau'in dabbobi da ba a sani ba waɗanda ke ɗaukar MERS-CoV.
Bat CoV RaTG13 da aka tattara daga Rhinelophus affinis bat yana da daidaituwa na 96.2% tare da daidaiton nucleotide na SARS-CoV-2.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin jerin abubuwa tsakanin SARS-CoV-2 da RaTG13 ya fi ƙarfin tantance dangantakar iyaye.
Wannan yana nufin cewa, idan ba a sami nau'in bat CoV mai kama da juna ba a nan gaba, to, ba za a iya samun wasu nau'ikan masu ɗaukar SARS-CoV-2 kai tsaye ba.
Wataƙila, matsakaicin dabbobi na SARS-CoV-2 ya kamata su kasance daga cikin dabbobin da aka sayar da kashe su a kasuwar abincin teku ta Hunan, wanda yawancin shari'o'in COVID-19 na farko suka danganta, wanda ke nuna yiwuwar cutar ta dabba zuwa mutum.
Yawancin binciken da aka yi kwanan nan bisa layin metagenomic sun ba da shawarar cewa wani rukuni na ƙananan dabbobi masu shayarwa da ke cikin hatsari da ake kira Bonrhui (Manis javanica) na iya ɗaukar beta-CoVs na SARS-CoV-2 masu alaƙa.
85-92% na kwayar nucleotide na wannan sabon kwayar cutar ta Bonrui CoV ta kama da SARS-CoV-2.
Amma suna da alaƙa da RaTG13 tare da kusan kusan 90% kama a matakin jerin nucleotide.
Sun haɗu a cikin rukuni biyu na ƙwayoyin cuta kamar SARS-CoV-2 a cikin bishiyar jinsi, wanda ɗayan ya raba maɓallin ɗaure mai karɓa (RBD) tare da SARS-CoV-2 tare da 97.4% amino acid jerin alamomi.
Akasin haka, RBDs na SARS-CoV-2 da RaTG13 sun fi karkata, kodayake jerin homology suna da girma sosai a cikin kwayoyin halitta.
Wani binciken da ya gabata a kan Bonrui da ke fama da cutar ya kuma bayar da rahoton gano jerin kwayoyin cutar da ke ci gaba da yaduwa daga samfurorin huhu, wanda ya nuna cewa yana da alaƙa da SARS-CoV-2.
Wannan binciken ya ɗauki hanyoyi daban-daban na tattarawa da kuma gabatar da hannu don ƙirƙirar jerin ɓangaren genomes tare da kusan kashi 86.3 cikin ɗari na cikakken tsayin kwayar cutar.
Ba za mu iya yin watsi da yiwuwar cewa pangolin yana ɗaya daga cikin masu amfani da SARS-CoV-2 ba.
Koyaya, babu wata hujja a halin yanzu don tallafawa asalin kai tsaye na SARS-CoV-2 a cikin Bonrui saboda bambancin tsari tsakanin SARS-CoV-2 da kuma SARS-CoV-2 masu alaƙa da beta-CoV.
Bugu da ƙari, nisa tsakanin SARS-CoV-2 da RaTG13 ya fi ƙasa da na SARS-CoV-2 da kuma Bonroe SARS-CoV-2 masu alaƙa da beta-CoV-clusters.
Ba a kafa hanyar juyin halittar SARS-CoV-2 a cikin damisa, pangolins da sauran dabbobi masu shayarwa ba.
Kodayake an gano mafi yawan daidaiton daidaituwa tsakanin SARS-CoV-2 da RBDs na Bonrue, beta-CoVs masu alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi yawan daidaiton daidaiton daidaiton genomic.
Yana da matukar hangen nesa cewa Bonnrouy yana da babban kama tsakanin zaɓin-tsakanin juyin halitta tsakanin beta-CoVs da SARS-CoV-2 da ke da alaƙa da RBD.
Wani shawarwari na gaba shine a sake haɗuwa tsakanin Bonrui SARS-CoV-2-da ke da alaƙa da beta-CoV da RaTG13 a cikin nau'in dabbobi na daji na uku.
A matsayin abin motsa juyin halitta, sake haɗuwa tsakanin beta-CoVs ya yadu.
Har yanzu ba a san ainihin asalin SARS-CoV-2 ba.
Baya ga HCoVs masu cutarwa, an kuma bincika tushen dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Shaidar filagenetic ta nuna cewa duka HCoV-NL63 da HCoV-229E sun samo asali ne daga bat CoVs, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin beraye.
An bayar da rahoton cewa wani CoV bat, mai suna ARCoV.2 (Appalachian Ridge CoV), wanda aka gano a cikin wani ɗan biri mai launin toka a Arewacin Amurka, ya nuna dangantaka ta kusa da HCoV-NL63.
A gefe guda, HCoV-229E ya kasance yana da alaƙa da wani nau'in CoV mai suna Hipposideros / Ganakovam / 19/2008, kodayake ana zargin cewa kamelids ma suna da matsakaiciyar hanyar ɗaukar hoto.
Don nuna gaskiya, an taƙaita tushen dabbobi na sanannun HCoVs a cikin hoto na 1 da tebur na 2.
Nazarin jinsi ya ba da tabbacin abubuwan da suka faru na watsawa tsakanin nau'in CoVs a tarihi.
An yi annobar cutar numfashi a cikin shekarun 1890 lokacin da HCoV-OC43 ya wuce jinsuna zuwa mutane daga dabbobi.
Tarihin watsawa tsakanin nau'in HCoV-229E ba shi da tabbas.
An gano alpha-CoVs na bat da ke da alaƙa da HCoV-229E.
Daga cikinsu akwai wani nau'in alpaca-alpha CoV.
Akwai shaidu da dama da ke nuna cewa cutar ta iya yaduwa daga batutuwan zuwa ga mutane.
Na farko, rabon yanayin da ake samu na iya zuwa ne daga hulɗar da damisa take yi da mutane amma ba tare da alpacas ba.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, batirin da ke da alaƙa da HCoV-229E ya bambanta tsakanin batirin alpha-CoVs kuma ba shi da lafiya, yayin da alpaka ke haifar da ɓarkewar cututtukan numfashi a cikin dabbobi da ke da cutar alpha-CoV.
A ƙarshe, ba a gano alpha-CoV na alpaca a cikin daji ba.
Saboda haka, ba za a iya yin watsi da yiwuwar alpacas su sami HCoV-229E-da ke da alaƙa da alpha-CoV daga mutane ba.
A gaskiya ma, damisa ce tushen cututtukan da ke haddasa cutar mutum, ciki har da cutar rabi, cutar Ebola, cutar Nipah da kuma cutar Hendra.
Saboda haka ba abin mamaki ba ne cewa damisa na iya kaiwa mutane HCoV-229E kai tsaye.
A gefe guda, batirin alpha-CoV-kungiya suna aiki a matsayin wurin samar da kwayoyin HCoV-229E, yayin da alpacas da raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
MERS-CoV ya zama misali mai kyau na yaduwar kamuwa da kwayar cutar tsakanin jinsuna daga bat zuwa raƙumi da kuma daga raƙumi zuwa mutum.
An san asalin MERS-CoV daga batirin a farkon ganowa kuma an tabbatar da shi ta hanyar binciken da aka yi.
A bayyane yake cewa batirin yana samar da ingantaccen tushe na nau'in kwayar cutar don musayar kwayar halittar kwayoyin halitta da kuma kamuwa da cuta tsakanin jinsuna.
Tsawon rayuwa, tarin ƙwayoyin cuta, hulɗa da juna da kuma iyawar tashi suna ba da damar zama mai yaduwar cutar.
A gefe guda, an gano MERS-CoV ne shekaru da dama da suka gabata a cikin wani kamal mai tsutsa.
Ya dace da waɗannan raƙuman da suka zama matsakaici daga matsakaici zuwa matsakaici da kuma matsakaici na asali.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan ƙimar watsawa a cikin waɗannan dabbobi.
Yaduwar cutar a tsakanin mutane ba zato ba tsammani ne, kuma mutane su ne masu kare MERS-CoV na ƙarshe saboda ba za a iya hana shi ba.
Sabanin rawar da raƙuma ke takawa wajen kamuwa da cutar MERS-CoV, bangolin na da wani muhimmin rawa a kamuwa da cutar SARS-CoV-2.
Musamman, pangolin beta-CoVs suna da cutarwa sosai a cikin pangolin.
Suna iya zama ƙarshen mafaka ga SARS-CoV-2-da ke da alaƙa da beta-CoVs, waɗanda suke kama da ƙanshin ƙanshi a cikin SARS-CoV.
Za a iya haɗa ko kuma ƙyale yiwuwar SARS-CoV-2 na yaduwa daga dabbobi zuwa mutane a cikin binciken nan gaba.
Da farko, damisa na iya zama tushen kwayar cutar SARS-CoV-2, wanda ya yi kama da SARS-CoV-2.
Mutane za su iya raba abubuwan da ke tattare da muhalli da namomin kaza ta hanyar yin hawan gawayi ko kuma hakar kwal.
Na biyu, Bonrwi zai iya zama ɗayan matsakaitan masu haɓaka wuraren da aka gabatar da sabon kwayar cutar SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar cin naman da aka yi musu yanka.
Yana yiwuwa cewa dabbobi masu shayarwa da dama, ciki har da dabbobin gida, ba su da kariya ga SARS-CoV-2.
An tabbatar da binciken dabbobi da namun daji don maganin rigakafi.
Na uku, kamar yadda aka ambata a sama, sake daidaitawa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Ana ci gaba da gano asalin dabbobi na SARS-CoV-2.
Baya ga masu ba da gidajen dabbobi iri-iri, manyan abubuwan da ke haifar da kwayar cutar guda uku suna da mahimmanci wajen taimakawa CoVs su shawo kan shingen tsakanin jinsuna.
Na farko, suna da yawan bambancin hali a cikin kwayar RNA.
"Kamar yadda yake tare da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar ƙimar canji na CoV-kungiyoyi za a iya ɗauka a matsayin ""matsakaici"" zuwa ""high"" dangane da shekarun daidaitawa na CoV na sabon mai ɗaukar hoto, kuma matsakaicin maye gurbin shine ~10-4 maye gurbin 2 a kowace shekara a kowane wuri".
CoVs suna da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Abin sha'awa, an gano cewa wannan kwayar cutar ta CoV ta hanyar rage exoribonuclease da RNA-dependent RNA polymerase na nucleotide analogue Remdesivir.
Remdesivir shine ɗayan abubuwan da ke iya zama anti-SARS-CoV-2 da aka gwada a cikin gwaji.
Duk da haka, yawan kamuwa da kwayar cutar CoV ya ninka na masu kula da su sau miliyan.
Bugu da ƙari, yawan canji yakan kasance mai girma idan CoVs ba su daidaita da masu ɗaukar hoto ba.
Idan aka kwatanta da SARS-CoVs masu yawan canji, SARS-CoV-2 yana da ƙananan canji, wanda ke nuna cewa yana da sauƙin daidaitawa ga mutane.
Wataƙila, ya riga ya daidaita da wani mai kula da mutane.
Haka kuma SARS-CoV-2 da MERS-CoV, wanda ya dace da raƙuman raƙuman ruwa.
A ka'ida, ba shi yiwuwa cewa SARS-CoV-2 zai iya kawar da allurar rigakafi da maganin rigakafi da sauri.
Na biyu, babban RNA na CoV yana amfani da ƙarin sassauci a cikin bambancin kwayar halitta don canzawa da sake haɗawa, yana ƙara yiwuwar juyin halitta tare da haɗin kai, wanda ke da fa'ida ga fitowar CoV-kungiyoyi lokacin da yanayi ya dace.
Ana tallafawa ta hanyar ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗimbin ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ ɗ
"Na uku, CoVs suna canza samfuran yayin yin kwafin RNA ta hanyar tsari na musamman na ""kwafin-zaɓi"" ba zato ba tsammani".
Sau da yawa sauya zaren yana faruwa yayin kwafin CoV RNA a cikin mai ba da izinin da ke aiki azaman kwandon haɗuwa.
RNAs masu cikakken tsawon da kuma subgenome mai girma na iya sake haɗawa don ƙirƙirar sabbin CoVs.
An sami shaidar phylogenetic na sake daidaitawa ta halitta tsakanin HCoV-HKU1 da HCoV-OC43 da kuma tsakanin CoV-dabbobi kamar su bat SL-CoV da batCoV-HKU9.
Haɗin kai tsakanin ƙwayoyin cuta da masu kula da su game da kamuwa da cuta
Baya ga abubuwan da aka ambata a sama guda uku, hulɗar kwayar cuta da mai karɓar mai watsa shiri wani babban abu ne da ke tasiri a cikin kamuwa da kwayar cutar tsakanin jinsuna.
A cikin wannan, an ɗauki sake dawo da SARS-CoV a matsayin misali mai kyau, wanda kuma ya nuna shaidar zaɓi mai kyau yayin yaduwar nau'in.
Dangane da kwatancen bincike tsakanin tarin SARS-CoV na mutum da na ƙanshi, SARS-CoV yana iya daidaitawa da sauri zuwa canji na RBD a tsakanin masu ba da izini daban-daban, musamman na S-protein.
A al'ada, wani CoV yana hulɗa da mai karɓar RBD a cikin S-protein kuma ana zaɓar shi ta hanyar amsawar kwayar cutar mai masaukin baki.
A cikin SARS-CoV, RBD yana cikin 318th zuwa 510th amino acid a cikin S1 fragment wanda ke ɗaure da ACE2 na ɗan adam da kuma masu karɓar sa don shiga kwayar cuta.
RBD na SARS-CoV yana iya gane masu karɓar ACE2 na dabbobi daban-daban, ciki har da damisa, civets, berayen da karnukan raccoon, wanda zai iya haifar da yaduwar kwayar cutar tsakanin jinsuna.
A zahiri, kawai ragowar amino acid 6 ne aka gano sun bambanta da na kwayar cutar ta scent a cikin mutane da RBD, kuma 4 daga cikinsu suna cikin ƙirar mai ɗaukar kwayar cuta don hulɗa tare da mai karɓar ACE2.
CIVET SARS-CoV RBD yana da K479N da S487T maye gurbi, wanda zai iya haɓaka ƙimar musayar protein mai ƙarfi tare da mai karɓar ACE2 a cikin mutane.
A wasu kalmomi, maye gurbin waɗannan amino acid biyu na iya zama mahimmanci ga daidaitawar kwayar cutar a cikin mutane.
Ya kamata a lura cewa masu amfani da kwayar cutar SARS-CoV da SARS-CoV-2 suna da kama.
Bambanci na 30% tsakanin S1 na SARS-CoV-2 da SARS-CoV ya nuna cewa halayen S na haɗin kai tare da ACE2 na ɗan adam na iya canzawa.
A zahiri, wani binciken Cryo-EM ya nuna cewa haɗin kai ya ninka sau 10 zuwa 20 na yadda yake tsakanin kwayar ACE2 na ɗan adam da SARS-CoV S.
Hakanan yana da mahimmanci a tantance ko ana buƙatar wani mai karɓar SARS-CoV-2 don yaduwa.
Abin damuwa, HCoV-NL63 kuma yana da alaƙa da ACE2 amma tare da wani ɓangare na S.
Akwai wasu masu karɓar HCoVs da yawa, kamar aminopoptidase N don HCoV-229E da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan suna iya zama sanadin nasarar daidaitawa ga CoVs a cikin mutane bayan kamuwa da su daga mai ba da rai.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon kamuwa da kwayar HCoV-kungiya ta hanyar sauran abubuwan dogara da kuma abubuwan da ke iyakance su.
Rarraba waɗannan sunadarai masu watsawa tsakanin mutane da masu kula da HCoVs na halitta kamar su bat, raƙumi mai raƙumi, da beraye na iya hana yaduwar nau'ikan.
HCoVs dole ne su mallaki abubuwan dogara da masu ba da izini don samun nasarar watsawa tsakanin jinsuna kuma su lalata abubuwan da ke haifar da iyakancewar mai ba da izini.
A wannan yanayin, har yanzu akwai ƙayyadaddun ƙwayoyin cuta da za a iya ganowa da kuma bayyana su a cikin wannan muhimmin yanayin na musayar kwayar cutar.
Yin amfani da fasahar zamani ta CRISPR, nuna rashin daidaituwa na sararin samaniya da kuma ƙuntatawa ga SARS-CoV-2 na iya zama mai amfani.
Hawan sabon nau'in HCoV: koma inda aka fara
Bambancin bat CoV-kungiyoyi yana ba da dama ga fitowar sabon HCoV-kungiyoyi.
A wannan ma'anar, bat CoVs suna aiki azaman ɗakunan kwayoyin HCoVs.
Bugu da ƙari, saurin canji da kuma sake haɗuwa na kwayoyin halitta suna motsa juyin HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, ƙwayoyin cuta masu ƙirar ƙwayoyin cuta suna da ikon gyara ƙwayar cuta da aka samu ko kuma aka rasa.
A cikin sunadarai masu alaƙa da SARS-CoV, ORF8 an ga yana da mahimmanci a daidaitawa ga ɗan adam saboda akwai tarin ƙwayoyin cuta masu alaƙa da SARS-CoV amma an gano cewa suna ɓoye sunadarai na ORF8 masu bambanci.
An gano fasalin kawar da kwayar cuta 29-nucleotide na SARS-CoVs a cikin nau'ikan da aka tattara a farkon cutar ta ɗan adam.
Wannan maye gurbin ya raba ORF8 zuwa ORF8a da ORF8b kuma ya zama kamar bambancin daidaitawa wanda ke ƙarfafa canjin wurin zama.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗuwa tare da ƙwayoyin alpha- da gamma-CoV, inda aka gano ƙananan ƙananan yankuna masu sake haɗawa a cikin RNA mai dogara da RNA polymerase.
An kuma gano wuraren sake haɗawa a cikin nsp9, yawancin nsp10 da sassan nsp14.
Hakazalika, an nuna cewa annobar ta MERS-CoV ta shiga cikin yanayin sake haɗuwa tsakanin ƙwayoyin cuta, wanda ya faru a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Baya ga SARS-CoV da MERS-CoV, an lura da abubuwan da suka faru na sake daidaitawa a cikin sauran HCoVs, inda HCoVs ke sake daidaitawa tare da CoV-s na wasu dabbobi a cikin ƙwayoyin cuta waɗanda ba su da tsari.
Ya kamata a kuma yi la'akari da cewa zaɓin wucin gadi na iya ba da gudummawa ga canje-canje na son rai a cikin kwayar cutar, mai yiwuwa sakamakon sakin ƙwayoyin cuta daga matsin lamba na zaɓin kamar tsarin garkuwar jiki na mai masaukin baki.
Misali na waɗannan tasirin shine asarar cikakken tsawon ORF4 a cikin HCoV-229E samfurin tsari saboda cirewar binucleotide.
Kodayake ana iya ganin ORF4 mara kyau a cikin ƙwayoyin cuta masu alaƙa da HCoV-229E a cikin bat da raƙuman raƙuman raƙuman ruwa, Alphaca alfa-CoV ya nuna an sanya shi a cikin nucleotide guda ɗaya, sakamakon da aka gani a cikin tsarin.
A ƙarshe amma mafi mahimmanci, juyin halittar sabbin HCoVs kuma ana sarrafa shi ta hanyar matsin lamba na zaɓi a cikin asalin su.
Lokacin da CoV ya kamu da batsa, ba su da alamun ko kuma sun gano alamun haske ne kawai, wanda ke nuna daidaituwa tsakanin CoV-complex da batsa.
An gano cewa damisa suna da kyau a cikin asalin da kuma tsarin jiki don daidaitawa da CoV-sets.
Misali, kurakuran kunnawa na amsawa ga kumburi a cikin beraye yana rage tasirin cutar cuta ta CoV-complex.
Bugu da ƙari, ƙananan matakan bayyanar ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
Bugu da ƙari, ƙwayoyin oxygen mai saurin amsawa (ROS) waɗanda ke haifar da babban aikin metabolism na batutuwan na iya yin duka biyun, ta hanyar hana kwayar cutar CoV da kuma shafar proofreading ta exoribonucleases, don haka samar da matsin lamba na zaɓi don samar da nau'ikan kwayar cutar lokacin da suka haɗu da sabon mai ba da izini.
Hakanan za a iya samar da ƙarin cututtukan CoV ta hanyar sake haɗuwa wanda ke haifar da samun sabon furotin ko halayen furotin don daidaitawar mai masaukin baki.
Saboda haka, yiwuwar fitowar sabbin kwayar cutar HCoV guda uku a cikin shekaru ashirin da suka gabata ba daidaituwa ba ce.
CoVs suna haifar da rashin lafiya ko kuma a cikin mahaifansu kamar batutuwan da raƙuma.
Suna girma da ƙarfi ba tare da amsa mai ƙarfi daga mai ba da mafaka ba.
Wannan shine asirin dalilin da yasa masu ɗaukar hoto marasa alamun cutar ke faruwa da kuma abin da ke haifar da mummunan cutar a cikin mutane.
Alamun cutar suna da yawa saboda yawan kunnawar amsawar rigakafi da kuma tashin sitokin da ke haifar da mummunan rauni, inda yawan karfin amsawar rigakafin ke kara tsanantawa.
Akasin haka, a cikin masu dauke da cutar marasa alamun cutar, an rarrabe maganin rigakafi daga kwayar cutar CoV.
Irin wannan dabarar na kashe haɗin amsawar rigakafi na iya samun tasiri mai amfani a maganin anti-SARS-CoV-2.
Amsar da ke tsakanin abubuwa tana da ƙarfi sosai a cikin kunama.
Saboda haka, ya kamata a yi amfani da maganin Type I aƙalla a farkon kamuwa da SARS-CoV-2 a cikin mutane.
Bugu da ƙari, ƙwayoyin NLRP3 masu kumburi a cikin batsa ba su da kyau.
Ta wannan hanyar, NLRP3 mai hana kumburi tare da MCC950 na iya zama mai tasiri wajen magance COVID-19.
Yunƙurin SARS-CoV-2 ya bi abubuwan da suka haifar da SARS-CoV da MERS-CoV.
An gano wani kwayar cutar beta-CoV wanda ke musayar kashi 95% na nucleotide homology tare da SARS-CoV, yayin da kuma wani kwayar cutar beta-CoV wanda ke musayar kashi 96% na nucleotide homology tare da SARS-CoV-2.
Kodayake an bayar da rahoton cewa tsirrai da sauran dabbobi da aka samo a kasuwa sun sami wuraren zama na ƙwayoyin cuta masu kama da SARS-CoV, ba a gano wuraren zama na tsakiya na gaggawa don SARS-CoV-2 ba.
An gano wasu nau'ikan beta-CoVs na Bonrhui da ke da alaƙa da SARS-CoV-2, wanda ke nuna cewa Bonrhui zai iya zama ɗayan masu ba da mafaka na tsaka-tsaki ko kuma Bonrhui beta-CoVs na iya ba da gudummawar sassan gene ga ƙarshen SARS-CoV-2.
Duk da cewa ana ta tambaya, babu wata hujja da ta nuna cewa SARS-CoV-2 ya kasance da gangan ko kuma ta hanyar haɗari.
CoVs sun sake zama abin tattaunawa saboda barkewar cutar SARS-CoV-2.
Nazarin CoVs a cikin bat da sauran dabbobi ya canza ra'ayinmu game da mahimmancin tushen dabbobi da tushen dabbobi na HCoVs a cikin kamuwa da ɗan adam.
Shaida mai yawa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da tushen bature kuma suna yaduwa tsakanin mutane ta hanyar matsakaiciyar hanyar shiga.
Tun da SARS-CoV ya samo asali ne daga hulɗa tsakanin mutane da ƙwayoyin cuta a kasuwa, kashe ƙwayoyin cuta a can ta hanyar rufe kasuwar wet zai iya kawo ƙarshen cutar ta SARS.
Ta hanyar wannan hujja, ya kamata a cire pangolins daga kasuwannin nama don hana yaduwar dabbobi, saboda gano wasu nau'ikan pangolin beta-CoVs waɗanda ke da alaƙa da SARS-CoV-2.
Koyaya, abin da kuma yadda SARS-CoV-2 ke yaduwa ga mutane ta hanyar tsuntsaye da sauran dabbobi masu shayarwa har yanzu yana cikin bincike na gaba.
A gefe guda, MERS-CoV ya kasance a cikin raƙuman raƙuman ruwa na dogon lokaci.
Baya ga muhimman kayan sufuri, waɗannan raƙuman suna aiki a matsayin babban tushen nama, madara, fata da ulu ga mazauna yankin.
Sun yadu a Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a yi hadaya da dukkan raƙuma don sarrafa MERS ba, kamar yadda aka yi a kasuwar dabbobin daji a China don hana SARS-CoV da SARS-CoV-2.
Don dakatar da sake barkewar cutar MERS, ya kamata a bi cikakkiyar hanyar samar da allurar rigakafin MERS-CoV a cikin raƙuman raƙuman ruwa tare da sauran hanyoyin sarrafa kamuwa da cuta.
Idan ba mu iya kawar da wadannan ƙwayoyin cuta ba, za mu iya haifar da sabon nau'in kwayar halitta.
Akwai nau'ikan CoVs da yawa da ke yaduwa a cikin yanayi.
Musamman, bat CoVs, tare da yiwuwar dabbobi, suna da bambanci sosai.
Akwai damar da yawa na waɗannan CoVs na zoonotic don haɓaka da sake haɗuwa, wanda zai haifar da sabon CoVs wanda zai iya zama mai yaduwa da / ko mai mutuwa a cikin mutane a nan gaba.
Ya kamata a daina cin namun daji a wasu yankunan kasar Sin domin rage hulda da dabbobi.
Tare da gwajin SARS, MERS da COVID-19, ya kamata a sami kyakkyawan shiri da shirin amsawa.
Yawancin ƙwayoyin cuta sun daɗe suna wanzuwa a duniya.
Suna zama a kan nasu tushe na halitta har sai sun sami damar yadawa.
Kodayake akwai halaye da yawa na batirin da ke haifar da yaduwar kwayar cutar, amma za a iya rage haɗuwa da mutane da batirin da sauran nau'in namun daji idan an sanar da mutane su guje su.
Ana buƙatar ci gaba da lura da dabbobi masu shayarwa don samun kyakkyawar fahimta game da yanayin CoVs da kuma mahaifansu na halitta, wanda zai iya zama mai tasiri wajen hana yaduwar cutar daga dabbobi zuwa mutane da kuma barkewar cutar nan gaba.
A ƙarshe, hanya mafi inganci don hana cututtukan da ke yaduwa daga dabbobi zuwa mutane ita ce nisantar da su daga yanayin da ke haifar da ƙwayoyin cuta na dabbobi.
Wasu ɓangarorin maɓallin asalin dabbobi na SARS-CoV-2 har yanzu ba a gano su ba.
Da farko, idan batutuwan sun watsa kwayar cutar SARS-CoV-2 ta hanyar Bonrue, za a ga a wane yanayi ne batutuwan da Bonrue za su iya raba wannan yanayin muhalli.
Na biyu, idan damisa na taka rawa kai tsaye wajen yaduwar cutar ga mutane, ya kamata a tantance yadda mutane ke hulɗa da damisa.
Na uku, idan wani dabba na uku yana aiki a matsayin mai cin abinci na gaskiya, dole ne a bayyana yadda yake hulɗa da nau'o'i daban-daban, ciki har da mutane, butterflies, da pangolins.
A ƙarshe, saboda yawancin dabbobi masu shayarwa, gami da dabbobin gida, na iya zama masu saukin kamuwa da SARS-CoV-2, ya kamata a yi duka sa ido da kuma gwajin kamuwa da cuta.
Ko dai shi damisa ne, pangolin ko wani dabba mai shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma kusan irin wannan kwayar cutar za a gano a cikin masu kula da ita na halitta a nan gaba.
Bincike mai gudana a cikin wannan yanayin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, wanda zai iya samun mahimman tasiri kan rigakafin COVID-19 a cikin mutane.
Yana da mahimmanci a sabunta ma'aunin gano cutar COVID-19 da aka yi zato.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta fitar da jagorar ba da shawara mai sauri don ganowa da maganin kamuwa da cutar coronavirus 2019 (2019-nCoV), kuma wannan jagorar ta ba da kwarewarmu kuma ta samar da kyakkyawan tunani don yaƙar cutar a duniya.
Duk da haka, saboda cutar Coronavirus Disease 2019 (COVID-19) sabuwar cuta ce, iliminmu da wayewarmu suna ƙaruwa a hankali bisa ga binciken da ake yi a kan cutar da kuma kwarewar asibiti, saboda haka ana ci gaba da sabunta hanyoyin ganewa da magani.
A cikin wannan wasikar, mun amsa wani sharhi game da jagorarmu kuma mun samar da sabon ma'aunin bincike na "kasu da ake zargi" da kuma "kasu da aka tabbatar", bisa ga sabon jagorar bincike da magani na COVID-19 da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, cutar coronavirus (2019-nCoV) ta fashe, wanda aka sanya masa suna Coronavirus Disease 2019 (COVID-19) kuma an sake sanya wa cutar sunan Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta tsara jagorar shawarwari na gaggawa kuma an buga shi a kan layi a cikin Military Medical Research a ranar 06 ga Fabrairu, 2020.
Tun bayan da aka buga shi, ya sami karbuwa sosai.
Ka tuna cewa COVID-19 sabon cuta ne, kuma iliminmu yana ƙaruwa a hankali bisa ga binciken da ake yi a kan cutar da kuma kwarewar asibiti, don haka ana sabunta hanyoyin ganewa da magani.
Alal misali, a cikin littafin Diagnostic and Therapeutic Guidelines on COVID-19 (http://www.nhc.gov.cn/), wanda Kwamitin Lafiya na Jiha na Jamhuriyar Jama'ar Sin ya fitar, daga 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, an buga juzu'i bakwai, kowannensu tare da wasu canje-canje masu mahimmanci.
Yanzu da Zhou da abokan aikinsa suka yi tsokaci game da wannan jagorar, sun ba da shawarar yin amfani da ƙididdiga mai sauƙi bisa ga kwarewarsu ta asibiti.
Aikin su ya ba da sabon tabbaci ga jagorarmu kuma ya samar da mahimman bayanai game da cutar a duniya.
Muna godiya da kuma amincewa da irin wannan aiki mai girma da suka yi.
Koyaya, dole ne su sabunta ayyukansu don daidaitawa da sabon jagorar bincike da magani na COVID-19 (Gwaji na 7) da kuma binciken da aka yi kwanan nan.
Bisa ga na bakwai (3 Maris 2020), don tabbatar da yanayin da ake zargi, dole ne a sami alamun asibiti guda biyu tare da ɗaya daga cikin halayen tarihin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Tarihin cututtukan cututtuka: (1) mazauna birnin Wuhan da kewaye, ko tarihin tafiya zuwa wurin, ko kuma wasu al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin haɗuwa da masu cutar SARS-CoV-2 (tabbatar da gwajin nucleic acid); (3) tarihin haɗuwa da marasa lafiya da zazzabi ko cututtukan numfashi a birnin Wuhan ko kewaye, ko kuma sauran al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtukan; (4) tarihin haɗuwa da tabbataccen mutane (a cikin makonni 2 da ƙananan yankuna kamar gidaje, ofisoshi, makarantu, da sauransu, da kuma waɗanda ke da zazzabi / numfashi ≥ 2 K).
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da fasalin hoto na kamuwa da COVID-19; (3) jimlar ƙididdigar ƙwayoyin jini a matakin farko na ƙaruwa suna nuna ƙimar lymphocyte na al'ada, raguwa ko raguwa.
Don tabbatar da cutar bisa ga yanayin da ake zargi, dole ne a sami ɗayan waɗannan alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Mun lura cewa a cikin na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020), an haɗa da gwajin PCR na ainihi na ƙwayoyin cuta da kuma samfurin jini.
An ƙara gano cutar daga samfurin jini a cikin na huɗu (Janairu 27, 2020) da na biyar (Fabrairu 8, 2020); kuma an ƙara hujja ta serological a cikin na bakwai.
Waɗannan canje-canjen sun dogara ne akan ci gaba da aikin masu bincike na gano cewa samfurin numfashi tare da samfurin jini don bincika ingantaccen kayan gano nucleic acid don saurin ganewa, wanda ke haɓaka wadatar samfuran daban-daban kuma wanda ke taimakawa kawo tabbataccen sakamako mai kyau na takamaiman antibody.
Bugu da ƙari, akwai ƙarin tabbaci da ke tunatar da mu mu mai da hankali ga marasa lafiya da ke da alamun rashin ciwo da marasa alamun ciwo.
Saboda haka, ya kamata a sabunta jerin abubuwan da Zhou da abokan aikinsa suka yi, domin sun rarraba mutanen da ba su da alamun asibiti a matsayin masu "ƙarancin haɗari".
Hakanan ana buƙatar tabbatar da tsarin ƙididdigar a cikin ayyukan asibiti da karatu na gaba.
A ƙarshe, muna fatan ƙarin tabbaci kai tsaye zai zo kuma masu karatu za su kira don ra'ayoyinsu.
Don tantance waɗanda ake tsammani sun kamu da cutar da kuma tabbatar da cutar, muna ba da shawarar gano su kuma bi sabbin jagororin ƙasarku.
Ƙungiyarmu za ta ci gaba da sabunta jagororinmu a kan lokaci don taimaka muku.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar a kowace rana.
A jiya, Bangladesh ta tabbatar da sabbin mutuwar COVID-19 guda biyar a wannan rana.
Wannan shi ne adadin mutane da suka mutu a rana guda saboda cutar.
A jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton cewa adadin waɗanda suka kamu da cutar sun haɗa da masu aiki 114, da masu warkewa 33 waɗanda ke gida.
An samu mutuwar mutane 17.
A wani rahoto da aka fitar ta yanar gizo, Daraktan IEDCR, Dr Meerjady Sabrina Flora ta ce, mutane hudu maza da mace ne suka mutu.
A cewar Dr. Mirjaddi, mutum biyu sun haura shekaru 60, biyu suna tsakanin shekaru 51 da 60, kuma daya yana tsakanin shekaru 41 da 50.
Ya kuma ce biyu daga cikin wadanda suka kamu da cutar daga Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengal, wanda aka kula da shi a asibitin Kuwait Maitri.
A cikin wani bidiyo na yanar gizo a ranar Asabar, Ministan Sufuri da Bridges na Bangladesh Obaidul Kadare ya ce har zuwa ranar Asabar za a dakatar da zirga-zirgar jama'a fiye da yadda aka tsara.
An fara dakatar da sufuri a ranar 26 ga Maris kuma an shirya za a kammala ranar Asabar, 4 ga Afrilu.
Har ila yau, an ba da izinin jigilar kayayyaki masu mahimmanci kamar magani, mai da abinci.
An sami mutum na farko da ya kamu da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, a tsakanin mutane biyu da suka dawo daga Italiya da matar ɗaya daga cikinsu.
A ranar 19 ga Maris, har yanzu, dukkansu uku sun warke.
Mutane miliyan daya ne ke dauke da cutar SARS-CoV-2 a duniya
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa jimillar adadin masu kamuwa da cutar SARS-CoV-2 a duniya ya zarce miliyan daya a ranar Alhamis.
Akalla 52 000 na mutuwar sun danganta ne da cutar COVID-19, cutar da ke haifar da kwayar cutar coronavirus.
Wannan muhimmin abu ya faru ne a ranar da Malawi ta tabbatar da kamuwa da cutar ta farko da kuma mutuwar farko da ta shafi cutar ta Zambia.
Har zuwa ranar Alhamis, Koriya ta Arewa ta yi ikirarin cewa tana cikin 'yan kasashen da suka rage da ba su kamu da cutar ba.
A jiya, Hukumar Lafiya ta Duniya ta rubuta 1,051,635 da suka tabbatar da cutar, ciki har da 79,332 a cikin awanni ashirin da huɗu da suka gabata a ranar 4 ga Afrilu, 10 da safe (0800 UTC).
A Amurka, an sami sama da 244,000 na kamuwa da cutar coronavirus tare da mutuwar mutane 5,900.
CBS News ta ruwaito cewa fiye da mutane 1,000 ne suka mutu a Amurka sakamakon cutar coronavirus a ranar Laraba, ta nakalto bayanan jami'ar Johns Hopkins.
A duk duniya, kasashe sun ba da sanarwar tsaurara matakan hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow, Sergei Sobyanin, ya tsawaita dokar kulle birnin har zuwa ranar 1 ga watan Mayu.
A kasa baki daya, Shugaba Vladimir Putin ya sanar da cewa za a ci gaba da biyan kudin har sai an kammala biyan kudin har zuwa ranar 30 ga watan Afrilu, duk da cewa Rasha ba za ta yi aiki ba.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci na tsawon kwanaki 15, inda aka samu kuri'u 215 a kan wannan shawara, 10 a kan ba za a ba da izini ba, da kuma daya a kan ba za a ba da izini ba.
Saudiyya ta kara wa birnin Makka da Madina dokar hana fita da ta shafe tsawon yini guda, tun da dokar ta fara aiki ne daga karfe 3 na yamma zuwa karfe 6 na safe.
Thailand ta shirya aiwatar da dokar hana fita tsakanin karfe 10 na dare zuwa karfe 4 na safe.
Gwamnan Ohio, Mike DeWine ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga watan Mayu.
Shaguna a Australia sun rage yawan takardar wanka da za a iya sayarwa
A ranar Lahadi da Asabar da yamma, shagunan sayar da kayayyaki na Australia Wolworths da Coles sun rage iyakar sayen takardar bayan gida a kowane ma'amala a duk shagunan su a kasa zuwa biyu da kunshin daya, bi da bi.
Bugu da ƙari, a ranar Lahadi, ALDI ta gabatar da iyakar fakitin.
An sanya waɗannan ƙuntatawa a matsayin saƙo a wurin biya da kuma a shafukan Facebook na sarkar.
An bayar da rahoton cewa masu siye suna adana kaya saboda tsoron COVID-19 saboda tsoron cewa mutane zasu keɓe kansu.
A ranar Laraba, Woolworths ta kuma rage sayar da takarda ta gida don isar da kaya zuwa gida, ta shirya daya a kowane oda.
Waɗannan canje-canjen sun biyo bayan ƙuntatawa na fakiti huɗu bayan ma'amala ta baya wanda Woolworths da Coles suka ƙaddamar a ranar 4 da 5 ga Maris, bi da bi.
"A ranar 8 ga watan Maris, Coles ya gabatar da sanarwar cewa an fara hana sayar da fakiti huɗu a wurare da dama, amma "a yawancin shagunan har yanzu ana sayar da komai a cikin awa ɗaya na isar da kayayyaki", suna mai da wannan bukatar "marasa misali", kuma a cikin wani sakon Facebook a ranar Talata a ALDI, sun kira ta "ba zato ba tsammani".
A makon da ya gabata, tallace-tallace sun yi tashin gwauron zabi, a cewar wani mai magana da yawun kamfanin Woolworths.
An kuma ba da izinin yin amfani da fakiti biyu a kantin Costco da ke Canberra a makon da ya gabata.
Don rage ƙarancin, Coles ta ba da umarni mafi girma daga masu samarwa da kuma ƙara yawan maimaitawa, Woolworths ya ba da umarnin ƙarin kaya, inda ALDI ke samar da kaya a gaba don wani shirin musamman na Laraba.
Russell Zimmerman, babban daraktan kungiyar 'yan kasuwar Australiya, ya ce 'yan kasuwar suna kokarin kara yawan kayayyaki, amma takunkumin majalisar na kawowa ta hanyar motoci na kawo cikas.
Yayin da masu samar da kayayyaki ke kokarin biyan bukatar, ya yi tsammanin farashin samarwa zai karu.
ALDI ta sanar a ranar Talata cewa bayan da aka riga an kwashe kayayyakin, wasu shagunan ba za su iya gudanar da siyarwar musamman ta ranar Laraba ba.
A wani rahoto na News.com.au, wani masanin sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, Dr Gary Mortimer ya ce, shaguna suna cika kayansu a kowane dare.
Ya yi sharhi cewa takardar bayan gida abu ne mai nauyi wanda ke sa tarin sa ya yi kadan kuma idan aka sayar da shi, manyan ɗakunan da ke kan ɗakunan suna zama fanko, yana ƙara ƙarfafa ra'ayin ƙarancin.
"ABC News ta ruwaito cewa, "Ra'ayin Coles da Woolworths shi ne, idan mutum yana da abubuwa da yawa, kamar su takardar wanka da kayan wanki, kuma yana da isassun abubuwa, to, watakila zai rage wannan tsoron", in ji Russell Zimmerman".
Kamfanin da ke kera takarda mai tsabtace gida mai sake amfani da ita, Hu Gives a Crap, ya ce a ranar Laraba cewa kayayyakin da ke cikinsa za su kare.
Kamar yadda News.com.au ta ruwaito, Kimberly-Clark, wanda ke kera kayan wanka na Clinex da takardar takarda ta rana, wanda ke samar da kayan shafawa, ya nace cewa suna aiki 24/7 don kiyaye wadatar.
Wani shafin sayar da kayayyaki mai suna Domain.com ya ruwaito cewa wasu masu sayar da kayayyaki a Melbourne suna ba da takardar wanka kyauta ga masu fara yin gwanjo, wasu kuma saboda masu sayen sun yi hutu a karshen mako na ranar aiki.
A wannan fitowar ta Alhamis ta NT News da ake bugawa a Darwin, an ba da shafi takwas don a yanka su a matsayin takardar wanka.
Wani rahoto daga ABC Australia a ranar 3 ga Maris ya ce shagunan sun yi matukar rashin amincewa da sanya takunkumi, inda suka ce ba su da wani shiri na sanya takunkumi kan sayayya.
Russell Zimmerman ya ce akwai bukatar wasu kayayyaki, ciki har da abin rufe fuska, kayan tsabtace jiki, kayan bushewa, wanke hannu da gari.
Hakazalika, a waje da Australia, ana sayar da takarda bayan gida biyu a cikin 12-roll pack a kowane yammacin Lahadi a kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kantin sayar da kant
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana annobar COVID-19 mai gudana, cutar da coronavirus SARS-CoV-2 ke haifarwa, a matsayin annoba.
"Duk da cewa kalmar nan "annoba" ba ta nufin yadda wasu cututtuka ke da hatsari ba amma yadda cutar ta yadu, WHO ta yi kira ga gwamnatoci su dauki mataki:"
"Dukkanin kasashe na iya canza yanayin wannan annobar ta duniya".
"Sakatare Janar na WHO Adnan Ghebreasas ya ce idan jihohi za su iya ganowa, "" za su iya gwadawa, su iya magance su, su iya ware su, su iya ganowa, kuma su iya hada kai. ""
"Muna matukar damuwa game da yaduwar cutar da kuma matakan rashin aiki da kuma rashin lafiya".
"Dokar da aka yi a baya ta ci gaba da zama ruwan dare a duniya, a cewar Dr. Tom Friedan, tsohon daraktan Cibiyar Kula da Cututtuka da Rigakafin Amurka, "ba a taɓa ganin irinta ba".
"A cikin wata sanarwa da ya bayar a CNN a watan Fabrairu, ya ce, "Babu wani kwayar cutar numfashi da aka gano a duniya tun lokacin da ta fara ba, sai dai cutar mura".
Gabrussus ya ce, "Ba mu taɓa ganin annobar da ta haifar da kwayar cutar coronavirus ba".
Ya ci gaba da cewa, "Ba mu taɓa ganin wata annoba ta duniya da za a iya sarrafawa ba".
Sabon matsayin na annoba na duniya ya biyo bayan shawarar WHO a watan Janairu na ayyana barkewar cutar a matsayin gaggawa ta lafiyar jama'a ta duniya.
"Darakta Anthony Fauci na Cibiyar Kula da Cututtuka da ke yaduwa ta Amurka ya ce game da barkewar cutar, ""A gaskiya, yanayin zai kara muni"."
Kamfanin dillancin labarai na Associated Press ya ruwaito a ranar Alhamis cewa adadin kamuwa da cutar COVID-19 a duniya ya kai akalla 126,000 wanda ya haifar da mutuwar sama da 4,600.
Cutar cutar korona ta 2019-20 annoba ce ta cutar korona ta 2019 (COVID-19), wadda ke haifar da cutar SARS-CoV-2.
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, wanda aka ayyana a matsayin gaggawa na lafiyar jama'a na damuwa ta duniya a ranar 30 ga Janairu, 2020, kuma an gane shi a matsayin annoba ta duniya a ranar 11 ga Maris, 2020.
Kimanin mutane miliyan 1.61 na COVID-19 sun kamu a kasashe 210 da yankuna a ranar 10 ga Afrilu 2020, wanda ya haifar da mutuwar kusan 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta cewa cutar ta kashe mutane 4% a kasar Sin, yayin da a duniya, adadin ya kai daga 13.04% a Aljeriya zuwa 0.08% a New Zealand.
Alamun da aka saba da su sun hada da zazzabi, tari da kuma numfashi.
Rikicin na iya haɗawa da ciwon huhu da kuma ciwon ƙwayar numfashi mai tsanani.
Lokaci daga haɗuwa zuwa bayyanar cututtuka yawanci kwanaki biyar ne, amma yana iya zama daga kwana biyu zuwa goma sha huɗu.
Babu allurar rigakafi ko takamaiman maganin rigakafin cutar.
Maganin farko shine maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuk
Hukumomi a duniya sun amsa da hana tafiye-tafiye, keɓewa, dokar hana fita, kula da haɗarin aiki da rufe wurare.
Cutar ta haifar da mummunan rikice-rikicen tattalin arziki da zamantakewar duniya, an soke wasanni, addini, siyasa da al'adu, kuma cin kasuwa saboda tsoro ya kara haifar da karancin kayayyaki.
Makarantu da jami'o'i sun rufe ko dai a kasa ko kuma a gida a kasashe 193 da ke fama da cutar, wanda ya shafi kusan kashi 99.4 cikin 100 na yawan daliban duniya.
Rashin gaskiya game da cutar ya bazu a kan layi, kuma akwai wasu al'amuran nuna bambanci da nuna wariya ga mutanen China, da sauran mutanen da ke Gabas da Kudu maso Gabashin Asiya, da kuma wasu daga yankunan da aka gano cewa akwai cutar.
Saboda rufe tafiye-tafiye da masana'antu masu nauyi, an rage yawan gurɓataccen iska da fitar da carbon.
Hukumomin lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton wani gungu na kamuwa da cutar huhu da ba a san dalilin ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin waɗannan cututtuka sun danganta ne da kasuwar sayar da abincin teku ta Hunan, saboda haka ana ganin cewa cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da barkewar cutar, wanda aka sani da SARS-CoV-2, sabon ƙwayar cuta ce da aka gano wacce ke da alaƙa da cutar baturi, cutar Bonrui da SARS-CoV. Mutumin da aka fara gano alamun cutar, an ba da rahoton cewa ya yi rashin lafiya a ranar 1 ga Disamba, 2019; kuma mutumin ba shi da wata alaƙa da wata ƙungiyar kasuwar ruwa.
An gano cewa kasuwar tana da alaƙa da kashi biyu bisa uku na farkon cluster na masu kamuwa da cutar a watan Disamba na 2019.
Wani rahoto da ba a tabbatar da shi ba a cikin Jaridar ta Kudu ta China a ranar 13 ga Maris, 2020 ya nuna cewa wataƙila shari'ar da aka gano tushen ta 17 ga Nuwamba, 2019 ita ce ta farko, wacce ta faru a cikin wani mutum mai shekaru 55 daga lardin Hubei. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa sabon kamuwa da cuta ya ragu a China, amma ya tashi kwatsam a Italiya, Iran da Koriya ta Kudu, kuma sabon adadin da aka samu a wajen China ya mamaye sabon adadin da aka samu a cikin China a karon farko.
Ana iya rage yawan masu kamuwa da cutar, musamman ma waɗanda ke da ƙananan alamun cutar.
A ranar 26 ga watan Fabrairu, an samu karancin cututtuka a cikin matasa, yawancinsu 'yan kasa da shekara 19, da kuma kashi 2.4% na wadanda suka kamu da cutar a duniya. Babban mai ba da shawara kan kimiyya a Burtaniya Patrick Valens ya kiyasta cewa kashi 60% na yawan jama'ar Burtaniya suna bukatar kamuwa da cutar kafin su sami rigakafi.
A cikin yarjejeniyar hukuma, adadin waɗanda suka gwada COVID-19 kuma suka sami sakamako mai kyau.
Babu wata ƙasa da ta gwada sama da kashi 3 cikin ɗari na yawan jama'arta har zuwa 23 ga Maris, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain da Switzerland sun kafa ƙa'idodin hukuma na ƙin gwada waɗanda ke da ƙananan alamun kawai.
Wani bincike da aka fitar a ranar 16 ga Maris ya nuna cewa kusan kashi 86% na kamuwa da cutar COVID-19 a China ba a gano su ba har zuwa ranar 23 ga Janairu, kuma wannan kamuwa da cutar da ba a rubuta ba ta kasance tushen kamuwa da kashi 79% na abubuwan da aka rubuta.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cutar a Italiya ya fi na hukuma yawa.
Hasashen farko na yawan haihuwa (R0) don COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani bincike da Cibiyoyin Kula da Cututtuka da Rigakafin Amurka suka fitar ya kammala da cewa mai yiwuwa 5.7 ne.
Yawancin mutanen da suka kamu da COVID-19 sun warke.
A cikin waɗanda ba su da cutar, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa ya kasance kwanaki 6 zuwa 41, wanda matsakaicin matsakaicin lokaci ya kasance kwanaki 14.
Kimanin mutuwar 97,000 a ranar 10 ga Afrilu, 2020 an danganta su da COVID-19.
A China, kashi 80% na mutanen da suka wuce shekaru 60 sun mutu a ranar 5 ga Fabrairu, kuma kashi 75% na su sun riga sun kamu da cututtukan zuciya da ciwon sukari.
Yawan mutuwar COVID-19 na iya zama mai yawa, saboda ba zai haɗa da mutanen da suka mutu ba tare da an gwada su ba - kamar a gida, gidajen jinya, da sauransu.
Wasu bayanai daga Italiya sun nuna cewa adadin ƙarin mutuwar a lokacin annobar ya ninka na COVID sau 4-5 na adadin mutuwar hukuma.
"Maya magana daga Cibiyoyin Kula da Cututtuka da Rigakafin Amurka (CDC) ya yarda cewa ""Mun san cewa [adadin mutuwar da aka bayar] ƙarancin kimantawa ne fiye da ainihin lambobi"", wanda aka tabbatar da shi ta hanyar rahotanni da ba su dogara da ƙididdigar ƙididdiga a cikin Amurka ba. Irin wannan rashin kimantawa yana faruwa sau da yawa a cikin annobar duniya, kamar cutar sankara ta 2009 H1N1.
Mutuwa ta farko a wajen kasar Sin a Philippines ta faru ne a ranar 1 ga watan Fabrairu, sannan ta farko a wajen Asiya a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, an samu mutuwar mutane fiye da goma sha biyu a kasashen waje, a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga watan Maris, an samu mutuwar mutane a kasashe da yankuna sama da arba'in a duk nahiyoyin duniya, sai dai Antarctica.
Wannan adadi ya bambanta daga yanki zuwa yanki, kuma ya dogara da yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokaci tun farkon barkewar cutar, da kuma halaye na alƙaluma kamar su shekaru, jinsi da lafiyar gaba ɗaya. Adadin mutuwa da kamuwa da cuta yana nuna yawan mutuwar da aka raba da adadin waɗanda aka gano a cikin lokaci.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar da cutar a duniya ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Adadin ya bambanta da yankin.
A China, adadin mutuwar da cutar ya ragu daga 17.3% (waɗanda ke da alamun bayyanar cututtuka daga 1 zuwa 10 ga Janairu 2020) zuwa 0.7% (waɗanda ke da alamun farko tun 1 ga Fabrairu 2020). Sauran matakan rigakafi sun haɗa da - yawan mutuwar (CFR), wanda ke nuna yawan mutanen da suka mutu daga cutar, da kuma yawan mutuwar mai yaduwa (IFR) wanda ke nuna yawan mutanen da suka kamu da cutar (waɗanda aka gano ko ba a gano ba) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyaka a kowane lokaci kuma suna biye da takamaiman yawan mutane daga kamuwa da cuta ta hanyar nazarin shari'ar.
Masana sun yi ƙoƙari su ƙidaya waɗannan adadi don ƙididdigar yawan jama'a.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar cutar a cikin cutar ya kasance tsakanin 0.1% da 0.39%.
Ƙididdigar sama da wannan kewayon ya yi daidai da binciken ƙididdiga na farko na gwajin allopathy na COVID-19 a Jamus da kuma nazarin tasirin gwajin akan ƙididdigar CFR.
WHO ta yi ikirarin cewa za a iya shawo kan annobar.
Matsakaicin iyaka da lokacin ƙarshe na ɓarkewa ba su da tabbas kuma na iya bambanta ta wurin wuri.
"MacKage Bonnie na Penn State University ya ce, "yawanci, cutar ta kan mamaye kuma ta fara lalacewa idan cutar ta rasa mai masaukin".
Amma a yanzu, ba shi yiwuwa a yi tunani a kan lokacin da hakan zai faru.
"Zhang Nanshan, babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin, ya yi jayayya cewa idan aka haɗa dukkan ƙasashe don bin shawarar WHO don hana yaduwar cutar, "za a iya kawo karshen ta a watan Yuni".
"A ranar 17 ga Maris, Adam Kucharsky na Makarantar Kula da Lafiya da Magunguna ta London ya ce SARS-CoV-2 "zai iya ci gaba da yaduwa na tsawon shekara daya ko biyu. ""
"A cewar binciken kwalejin Imperial wanda Neil Ferguson ya jagoranta, ""har sai an samu rigakafin (watakila watanni 18 ko sama da haka) "" ana bukatar kiyaye nisantar jiki da sauran matakan".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar korona, saboda yadda take yaduwa da sauri, za ta iya bacewa gaba daya" kuma "za ta iya zama wata cuta ta yanayi, tana dawowa kowace shekara".
Matsayin dawowar zai dogara ne akan rigakafin dabba da kuma yawan bambance-bambancen.
Alamun COVID-19 na iya zama marasa ma'ana kuma waɗanda ke kamuwa da cutar ba su da alamun.
Alamun da suka fi kowa su ne zazzabi (88%) da kuma tari mai bushe (68%).
Alamun da ba sa yawan faruwa sun hada da rashin nutsuwa, yin hancin numfashi (shag), rashin jin ƙanshi, rashin numfashi, ciwon tsoka da jijiyoyin jiki, kumburi, ciwon kai, sanyi, amai, tsotsa kofi, diarrhea, ko cyanosis. WHO ta bayyana cewa kusan mutum daya cikin shida yana fama da rashin lafiya mai tsanani kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Rigakafi ta Amurka (CDC) ta lissafa numfashi, ciwon kirji ko matsi na yau da kullun, rikicewar kwatsam, farkawa da kuma shuɗi ko lebe a matsayin alamun gaggawa; ana ba da shawarar neman taimakon likita nan da nan idan waɗannan alamun sun bayyana. Ƙarin ci gaba na cutar na iya haifar da ciwon huhu mai tsanani, ciwon ƙwayar cuta, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Wasu daga cikin wadanda suka kamu da cutar na iya zama marasa alamun asibiti, amma sakamakon gwajin ya tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar yin sa ido da gwada duk wanda ya sadu da waɗanda suka kamu da cutar don guje wa kamuwa da cutar.
Kimanin adadin mutanen da ba su da alamun cutar a kasar Sin ya kai kashi 44 cikin dari.
Matsakaicin lokacin hawan (tsarin hawan) (lokacin da kamuwa da cuta da bayyanar cututtuka suka fara) ya kasance daga rana ɗaya zuwa kwanaki 14; matsakaicin kwanaki biyar. Idan aka yi la'akari da misalin rashin tabbas, kashi 30% na waɗanda ke da COVID-19 waɗanda suka fara samun ƙanshi sun kasance kashi 15% na waɗanda suka sami ɓoye.
Ana ci gaba da tantance wasu bayanai kan yadda cutar ke yaduwa.
An yi imanin cewa cutar tana yaduwa ne ta hanyar tuntuɓe da kuma ƙananan ɗigon ruwa da ke fitowa yayin tari, hancin ko magana; kusanci yana nufin kasancewa tsakanin 1 zuwa 2 mita (3 zuwa 6 feet).
Bincike ya nuna cewa ruwa mai yawa daga tari mai budewa zai iya kaiwa mita 4.5 (mita 15) zuwa mita 8.2 (mita 27).
Wasu sun ce ana iya yada kwayar ta hanyar ruwan da ake samu a lokacin magana wanda ke kasancewa a cikin iska na dogon lokaci. Hakanan ana iya samun kwayar cutar ta numfashi a lokacin numfashi, gami da magana, kodayake ba a yawan samun kwayar cutar ta iska.
Ƙwayoyin ruwa na iya shiga cikin hanci ko baki na waɗanda suke kusa ko kuma cikin huhu ta hanyar numfashi.
Wasu hanyoyin kiwon lafiya kamar su intubation da cardiopulmonary resuscitation (CPR) na iya sa aerosol ya zama iska.
Ana iya yada shi idan mutum ya taba duk wani gurɓataccen abu, ciki har da fata, sannan ya taɓa idanunsa, hanci, ko baki.
Duk da cewa akwai damuwa cewa za a iya yada shi ta hanyar fitsari, an yi la'akari da cewa wannan hadarin bai kai ba.
Gwamnatin kasar Sin ta musanta yiwuwar kamuwa da SARS-CoV-2 ta hanyar bakin mutum. Kwayar cutar tana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya kamuwa da cutar kafin bayyanar cututtuka da kuma bayan bayyanar cututtuka.
Yawancin mutane sun yi gwajin gwaji kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya kamuwa da cutar kafin bayyanar cututtuka.
Akwai rahotanni kaɗan na marasa alamun cutar da aka tabbatar da su a cikin dakin gwaje-gwaje, amma wasu ƙasashe sun gano cutar da ba ta da alamun cutar yayin binciken gano alaƙa.
Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ke yaduwa ba amma mutum ɗaya yakan kamu da mutane biyu zuwa uku.
Musamman, ana iya gano kwayar cutar a cikin filastik (polypropylene) na tsawon kwanaki uku, 304 bakin karfe, katako na tsawon kwana ɗaya, da kuma tagulla na tsawon awanni huɗu.
Wannan ya bambanta dangane da zafi da zafin jiki. Dabbobi da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu tabbacin cewa dabbobi na iya yada kwayar cutar zuwa ga mutane, kodayake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan hulɗa da dabbobi, kamar yadda mutane masu kamuwa da cutar ke yi bayan sun taɓa wasu wurare.
Kwayar cutar coronavirus mai saurin numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2), wani sabon kwayar cuta, an fara ware ta ne daga mutane uku da suka kamu da cutar sankarar huhu a Wuhan, wanda ke da alaƙa da rukunin masu fama da cutar numfashi mai saurin kamuwa da cuta.
Dukkanin halayen da ke cikin kwayar cutar SARS-CoV-2 ana samun su a cikin dukkanin kwayar cutar corona da ke faruwa a yanayi. A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida saboda ta karya murfin kariya na kwayar cutar. SARS-CoV-2 yana da alaƙa da ainihin SARS-CoV.
An yi imanin cewa wannan cutar ta samo asali ne daga wani cuta da ke yaduwa a cikin dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar ta corona ta haɗu da kwayar cutar betacoronavirus a cikin subgenus Cerbericovirus (Line B) tare da nau'ikan da aka samo daga wasu bat.
A cikin wani samfurin BatCov RaTG13, kashi 96% na dukkanin kwayoyin sun kasance iri ɗaya.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa bambancin amino acid daya ne kawai a wasu sassan jerin kwayoyin halittar tsakanin kwayar cutar da ke cikin Bonruai da kwayar cutar da ke jikin mutum.
A cikin kwatancen da aka yi na dukkanin kwayoyin halittar, an gano cewa akwai daidaito na kashi 92% tsakanin kwayar cutar coronavirus da SARS-CoV-2 wanda bai isa ya tabbatar da cewa Bonrui ta kasance a matsayin mai watsa shiri ba.
Ana iya gano kamuwa da cutar ta hanyar kwayar cutar ta hanyar alamun bayyanar cututtuka na ɗan lokaci, amma a ƙarshe ta hanyar tabbatar da cutar ta hanyar jujjuyawar layin polymerase chain reaction (rRT-PCR) ko CT imaging.
Wani bincike da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR saukin ganewa, amma ba shi da cikakken bayani, kuma yawancin siffofin da yake nunawa sun yi daidai da na wasu cututtukan huhu da kuma hanyoyin cutar.
"A watan Maris na 2020, Kwalejin Kula da Radiology ta Amurka ta ba da shawarar cewa ""Kada a yi amfani da CT a matsayin gwajin farko don gano COVID-19"."
WHO ta fitar da wasu ka'idojin gwajin RNA don SARS-CoV-2, wanda aka fara bayarwa a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin jujjuyawar jujjuyawar polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin ne ta hanyar numfashi ko kuma jini.
Ana samun sakamako a cikin sa'o'i da yawa zuwa kwanaki.
Ana yin gwajin ne a kan wani sandan nasopharyngeal, amma ana iya amfani da wani sandan makogwaro. Wasu dakunan gwaje-gwaje da kamfanoni suna samar da gwajin serological wanda ke gano antibodies.
Babu ɗayan da ya isa ya zama cikakke don a ba da izinin amfani mai nisa a ranar 6 ga Afrilu, 2020.
An amince da gwajin serological da aka samar da Chelex a Amurka don amfani da shi a cikin gaggawa kawai a cikin dakunan gwaje-gwaje masu izini.
Abubuwan da ke nuna mutane masu bayyanar cututtuka a cikin hoton radiograph da CT sun haɗa da rashin daidaiton gilashin gilashin da babu ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayayay
Kamfanin Radiological na Italiya yana tattara bayanan yanar gizo na duniya na hotunan da aka samo daga gwajin da aka tabbatar da shi.
An hana yin hoto da gano COVID-19 ba tare da tabbaci ta hanyar PCR ba don haɗuwa da sauran kamuwa da cuta kamar adenovirus.
Wani babban bincike a China ya kwatanta PCR da sakamakon CT na kirji kuma ya bayyana cewa, kodayake yanzu ba a nuna ainihin cutar ba, yana da sauri kuma yana da saukin ganewa wanda ya ba da shawarar yin la'akari da shi a matsayin kayan aikin bincike a yankunan da cutar ta barke.
An samar da na'urar haifuwa ta hanyar AI wanda ke ba da damar gano kwayar cutar ta hanyar radiographs da CT.
Hanyoyin da za a iya hana yaduwar cutar sun hada da kiyaye tsabtar mutum, wanke hannu, kada a taba idanu, hanci ko baki da hannu, da kuma yin tari ko tari a cikin nama da jefa shi kai tsaye cikin kwandon shara.
An shawarci waɗanda ke da cutar su sanya abin rufe fuska a cikin jama'a.
An kuma bada shawarar kiyaye nisantar jiki don hana yaduwar cutar. Yawancin gwamnatoci sun ba da shawara ko kuma sun hana duk tafiye-tafiye marasa mahimmanci daga ƙasashe da yankuna da cutar ta shafa.
Amma cutar ta kai matakin yaduwar jama'a a yawancin sassan duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'umma kuma wasu mutane a cikin al'umma ba su san inda ko yadda suka kamu da cutar ba. Ana ba da shawarar cewa masu ba da kiwon lafiya da ke kula da wanda zai iya kamuwa da cutar su yi amfani da matakan tabbatarwa, matakan tuntuɓar mutum da kariya ta ido.
Amfani da bayanan wurin wayar salula ta gwamnati don wannan dalili ya haifar da damuwa game da sirri, kuma Amnesty International da fiye da kungiyoyi 100 sun ba da sanarwar da ke kira ga iyakance irin wannan sa ido.
An aiwatar da aikace-aikacen hannu da yawa ko an ba da shawarar yin amfani da su da son rai, kuma har zuwa 7 ga Afrilu, 2020, sama da ƙwararrun ƙwararrun ƙwararrun suna aiki kan mafita mafi kyau na sirri, kamar kusanci na mai amfani da amfani da Bluetooth don shiga wayar hannu ta wasu.
Masu amfani za su sami saƙo idan sun haɗu da wani mai cutar COVID-19, kuma akwai ra'ayoyi da yawa game da yadda za a hana kamuwa da cutar, kamar yadda wanke hanci da kuma gargling tare da wanke baki ba zai iya taimakawa ba.
Babu allurar rigakafin COVID-19, duk da cewa kungiyoyi da dama na aiki don samar da daya.
An ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na aƙalla sakan ashirin, musamman bayan sun je bayan gida ko kuma idan hannayensu suna da datti; kafin cin abinci; kafin su yi hanci, lokacin da suke yin tari, ko kuma lokacin da suke yin tari.
Domin za a iya kashe kwayar cutar ta hanyar sabulu na gida a waje da jikin mutum, wanda ke lalata kumburin kariya na kwayar cutar.
CDC ta ba da shawarar cewa idan sabulu da ruwa ba su da sauƙi, a yi amfani da sabulu mai maye gurbinsa da ke da aƙalla kashi 60% na barasa.
Hukumar ta WHO ta shawarci mutane da su guji taɓa idanunsu, hanci ko baki da hannuwansu marasa tsabta.
Za'a iya tsabtace farfajiyar da wasu magunguna (a cikin minti daya na hulɗa da maganin kashe ƙwayoyin cuta a cikin farfajiyar bakin karfe), wanda ya haɗa da 62% ethanol, 50% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.2% podividone-iodine.
Sauran hanyoyin kamar benzalkonium chloride da clohexidine gluconate ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko tabbatar da cutar COVID a wani wuri, kamar ofis ko wurin kulawa da rana, to ya kamata a yi amfani da maganin kashe cututtukan ƙwayoyin cuta a ofis, ɗakunan wanka, wuraren jama'a, kayan aikin lantarki da aka raba, kamar su kwamfutar hannu, allon taɓawa, maɓallan rubutu, na'urorin sarrafawa na nesa da na'urorin ATM da marasa lafiya ke amfani da su.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe hanci da baki da takarda da suka yi amfani da shi a lokacin da suke yin tari ko tari kuma su zubar da shi da kyau.
An shawarci wadanda ke da hadarin kamuwa da cutar su sanya abin rufe fuska. Sanye da abin rufe fuska na iya sarrafa adadin ruwa da ke fitowa yayin magana, tari, ko tari.
Hukumar Lafiya ta Duniya ta fitar da jagora kan yadda ake sanya abin rufe fuska da kuma lokacin da ya kamata a yi hakan.
"A cewar Stephen Griffin, masanin ilmin cututtuka na Jami'ar Leeds, ""saka abin rufe fuska na iya rage sha'awar taɓa fuska, wanda shine babban tushen kamuwa da cuta ba tare da tsaftace hannu ba. "" An kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da mutanen da ke da cutar. "
WHO ta shawarci mutanen da ke da lafiya su sanya abin rufe fuska ne kawai idan suna da babban haɗari, kamar waɗanda ke kula da mutumin da ke da COVID-19, kodayake sun yarda cewa sanya abin rufe fuska na iya taimakawa wajen kauce wa taɓa fuska.
Wasu kasashe sun fara karfafawa jama'a gwiwa su sanya abin rufe fuska.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na baki wanda ba na likita ba. China ta ba da shawarar musamman ga mutanen da ke da lafiya su yi amfani da abin rufe fuska na likita, musamman ma lokacin da suke kusa da wasu mutane (mita 1 (ƙasa 3) ko ƙasa da haka).
Hong Kong ta ba da shawarar sanya abin rufe fuska na tiyata yayin tafiya a cikin sufuri na jama'a ko yayin kasancewa a wuraren jama'a.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su sanya abin rufe fuska a gida kuma su wanke su kowace rana.
An haramta sanya abin rufe fuska ko rufe hanci da fuska yayin fita waje a Jamhuriyar Czech da Slovakia.
A ranar 16 ga Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska yayin tafiya zuwa wuraren jama'a don kare kansa da sauran mutane.
Gwamnatin Austria ta ba da umarnin cewa dole ne a sanya abin rufe fuska a duk lokacin da aka shiga kowane kantin sayar da kayayyaki.
Isra'ila ta bukaci dukkan mazaunanta da su sanya abin rufe fuska a duk lokacin da suka fita waje.
Taiwan, wacce ke samar da abin rufe fuska miliyan 10 a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjoji su sanya abin rufe fuska a jiragen kasa da bas a ranar 1 ga Afrilu.
Panama ta sanya sanya abin rufe fuska a duk lokacin da ta fita waje, kuma ta ba da shawarar sanya abin rufe fuska na gida ga waɗanda ba za su iya sayan abin rufe fuska ba.
A Japan, Koriya ta Kudu, Malaysia da Singapore, ana amfani da abin rufe fuska sosai.
Halin nisantar zamantakewa (wanda ake kira nisantar jiki) ya hada da rage yawan hulɗa tsakanin mutane da rage yaduwar cutar ta hanyar rage yaduwar cutar.
Hanyoyin sun hada da: killacewa; ƙuntata tafiye tafiye; rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko kasuwanni.
Mutane na iya aiwatar da hanyoyin nisantar jama'a ta hanyar kasancewa a gida, rage tafiye tafiye, guje wa wuraren da mutane ke zaune, gaishe-gaishe ba tare da taɓawa ba, da kuma nisantar jiki daga juna.
Gwamnatoci da dama yanzu suna yin wa'adi ko kuma ba da shawarar nisantar zamantakewa a yankunan da cutar ta bulla.
Matsakaicin taron da aka ba da shawara ga hukumomin gwamnati na Amurka da cibiyoyin kiwon lafiya ya ragu da sauri daga mutane 250 (idan ba a san cewa COVID-19 yana yaduwa a yankin ba) zuwa mutane 50 sannan zuwa mutane 10.
"A ranar 22 ga Maris, 2020, Jamus ta hana mutane fiye da biyu taruwa a fili. Manya tsofaffi da mutanen da ke da yanayin kiwon lafiya kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma lalacewar rigakafi suna fuskantar haɗarin kamuwa da cuta da rikitarwa, kuma a cikin al'ummomin da ke fama da cutar, CDC ta shawarce su da su zauna a gida kamar yadda ya kamata. A ƙarshen Maris 2020, WHO da sauran kungiyoyin kiwon lafiya sun fara maye gurbin kalmar ""yanke nesa"" da ""yanke nesa"," don bayyana cewa manufar ita ce ta kiyaye hulɗa ta hanyar sadarwa ta hanyar na'ura mai kwakwalwa ko ta nesa".
"Amfani da kalmar "nesa" ya haifar da nisantar mutane gaba ɗaya daga yin hulɗa da wasu ta wasu hanyoyi maimakon ƙarfafa su. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i don amfani a lokacin annobar".
Ya haɗa da shawarar yin jima'i da wanda ba shi da cutar ko kuma wanda ba shi da alamun cutar, wanda ke zaune tare da kai.
An ba da shawarar keɓe kai a gida ga waɗanda ke da COVID-19 da waɗanda ake zargin suna da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun jagororin don keɓancewar kai. Gwamnatoci da yawa sun ba da shawarar ko kuma sun ba da shawarar keɓewa ga duk mazauna yankunan da ke fama da cutar.
An ba da umarnin da aka fi tsauri don keɓewa ga ƙungiyoyin haɗari.
Mutanen da suka sadu da wani mai cutar COVID-19 da kuma waɗanda suka yi tafiya zuwa ƙasashe ko yankuna da ke da yawan kamuwa da cutar a kwanan nan an shawarce su da su keɓe kansu na tsawon kwanaki 14 daga lokacin da suka kasance tare da su.
Hanyoyin sarrafawa na barkewar cutar sune hanawa da kuma hanawa.
An fara aiwatar da matakan hanawa a farkon barkewar cutar, kuma an fara aiwatar da wasu matakan sarrafawa da allurar rigakafi ban da ganowa da keɓe mutanen da ke da cutar don dakatar da yaduwar cutar a cikin sauran al'umma.
Lokacin da babu yadda za a iya hana yaduwar cutar, ana iya sauya matakan zuwa ragewa: ana iya ɗaukar matakan da za su rage saurin yaduwar cutar da kuma tasirinsa ga tsarin kiwon lafiya da al'umma.
Ana iya ɗaukar ma'auni na haɗuwa da ƙuntatawa a lokaci guda.
Ya kamata a yi amfani da ƙarin matakan hanawa don juya zagayen annoba zuwa ƙasa da farkon haifuwa 1. Rage iyakar annoba wani ɓangare ne na magance ɓarkewar cutar, wanda aka sani da daidaita yanayin annoba.
Wannan yana rage haɗarin da ke tattare da samar da kiwon lafiya da kuma ba da lokaci don yin allurar rigakafi da kuma inganta hanyoyin magani.
Sauran hanyoyin da za a iya sarrafa cutar ban da magunguna sun hada da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da kuma keɓe kai; matakan jama'a don kiyaye nisantar jiki, kamar rufe makarantu da taron jama'a; yarda da sauran hanyoyin da za a yi da kuma shigar da jama'a don shiga; da kuma matakan muhalli, kamar tsabtace farfajiyar. Bayan bayyanar cutar ta zama mai tsanani, an ɗauki matakai masu ƙarfi a cikin China don magance cutar, kamar su keɓewar gari gaba ɗaya da kuma sanya takunkumin tafiya.
Sauran ƙasashe ma sun ɗauki ƙa'idodi don iyakance yaduwar cutar.
Koriya ta Kudu ta fara gwajin jama'a da keɓewa a gida, kuma ta ba da gargadi kan motsin mutane masu kamuwa da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda ke da cutar da suka keɓe kansu kuma sun sanya manyan tarar waɗanda suka kasa yin hakan.
Taiwan ta kara samar da takunkumin rufe fuska da kuma sanya takunkumin cin hanci da rashawa a kayayyakin kiwon lafiya. Yunkurin da Burtaniya da Amurka ke yi na nuna cewa akwai babban kalubale na rage (sake rage amma ba a hana yaduwar cutar ba) da kuma hana (ƙara cutar).
Ko da yake ƙa'idodin kawar da ƙwayoyin cuta sun rage yawan buƙatun kiwon lafiya da kashi biyu cikin uku da mutuwar mutane, har yanzu ana ci gaba da lalata tsarin kiwon lafiya, wanda ke haifar da dubban mutuwar.
Dakatar da cutar na iya zama zaɓi amma ya kamata a ci gaba da shi muddin cutar ta ci gaba da yaduwa a cikin al'ummar dan adam (ko kuma har sai an sami rigakafi, idan ya zo da farko), saboda idan ba a sassauta matakan ba, cutar za ta dawo da sauri.
Dagewa a cikin rigakafin cutar na haifar da lalacewar zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19 da aka amince da shi, amma ana ci gaba da ƙoƙarin haɓaka tare da gwajin magungunan da ke akwai.
Shan magungunan sanyi-kishi na kan-kan, shan ruwa, da kuma hutawa na iya rage alamun.
Dangane da yadda rashin lafiyar yake, ana iya bukatar maganin oxygen, ruwan jini, da kuma taimakon numfashi.
Yin amfani da kwayoyin steroid zai iya haifar da sakamako mafi muni.
An riga an amince da wasu abubuwa da aka yi amfani da su don magance wasu cututtukan kwayar cuta, kuma ana ci gaba da bincike a kan su don maganin COVID-19.
WHO ta kuma bayyana cewa wasu magunguna na gargajiya da na gida na iya taimakawa wajen rage alamun cutar SARS-CoV-19.
WHO ta bayyana haɓaka iya aiki da kuma sayen cibiyoyin kiwon lafiya don marasa lafiya na COVID-19 a matsayin matakan rigakafi don hana barkewar cutar.
ECDC da WHO na Yankin Turai sun ba da umarni ga asibitoci da cibiyoyin samar da farko na farko don cire tushen abubuwa da yawa, gami da haɓaka kulawar dakin gwaje-gwaje don gwajin COVID-19, haɓaka yawan kulawa ta musamman ta hanyar warewa da keɓewar marasa lafiya masu cutar COVID-19, da kuma horar da ma'aikata, da kuma yawan iska da gadaje da ke akwai.
Akwai ra'ayoyi da dama game da inda lamarin farko (wanda ake kira Patient Zero) ya samo asali.
An gano farkon cutar coronavirus a ranar 1 ga Disamba, 2019, a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
An yi amfani da su ne a kasuwannin sayar da abincin teku na Hunan, inda ake sayar da dabbobi masu rai, kuma an yi ka'idar cewa cutar ta fito ne daga irin wannan dabba; ko kuma a ce, ta samo asali ne daga dabbobi. An gano tarin cutar huhu na sanadin da ba a sani ba a ranar 26 ga Disamba, kuma likita Zhang Jixian ya yi maganin ta a asibitin lardin Hubei, wanda ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
"A ranar 30 ga watan Disamba, wata tawagar likitoci a asibitin Wuhan ta gargadi abokan aikinsu game da wani "kwayar cutar korona mai kama da SARS".
Likitoci takwas, ciki har da Li Wenliang, sun fuskanci tsawa daga 'yan sanda saboda yada jita-jita, kuma wani likita mai suna Ai Fen ya ci amanar manyan ma'aikatansa saboda faɗakar da barazanar.
Hukumar Lafiya ta Wuhan ta ba da sanarwar a ranar 31 ga Disamba kuma ta sanar da WHO.
A farkon watan Janairu, Wuhan ta samu wasu cututtuka na cutar sankarar bargo da ba a san ko su waye ba, wadanda ake bukatar bincike.
A farkon da tsakiyar shekarar 2020, cutar ta bazu zuwa wasu yankuna na kasar Sin, tare da gudun hijirar Sabuwar Shekarar Sin da Wuhan, cibiyar sufuri da babbar hanyar jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta ce an samu sabbin mutane 140 a cikin kwana daya, wadanda suka hada da mutane biyu daga Beijing da daya daga Shenzhen.
Bayanai na baya-bayan nan sun nuna cewa mutane 6174 sun riga sun nuna alamun cutar a ranar 20 ga Janairu, 2020. Har zuwa 26 ga Maris, Amurka ta ga mafi yawan adadin masu kamuwa da cutar a duniya, ta zarce China da Italiya. Har zuwa 9 ga Afrilu, 2020, an ba da rahoton sama da mutane miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu, kuma sama da mutane 364,000 sun warke.
Kimanin kasashe da yankuna 200 sun sami aƙalla mutum ɗaya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da dama na yankin Schengen sun takaita motsi da kuma sanya takunkumin kan iyakoki.
Amsar kasa ta hada da wasu matakan hana mutane shiga, kamar su keɓewa (a cikin gida ko kuma a wani wuri, ko kuma a san shi da kulle-kulle) da kuma dokar hana fita. A ranar 2 ga Afrilu, kusan mutane miliyan 300 ko kuma kashi 90% na yawan jama'a, suna cikin wani nau'i na kulle-kulle a Amurka, sama da mutane miliyan 50 suna cikin kulle-kulle a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu da mutane biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna karkashin wani irin kulle-kulle, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon tabbataccen yanayin COVID-19 a Wuhan a ranar 1 ga Disamba, 2019; amma, a cewar wani labari da ba a tabbatar da shi ba, an fara gano cutar a ranar 17 ga Nuwamba.
Likita Zhang Jijian ya lura da tarin cutar ciwon huhu na sanadin da ba a sani ba a ranar 26 ga Disamba, bayan haka asibitinsa ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwajin farko na kwayoyin halittar da aka yi a kan 27 ga Disamba, 2019 ya nuna cewa akwai kwayar cutar SARS.
A ranar 31 ga watan Disamba, Hukumar Kiwon Lafiya ta Wuhan ta fitar da sanarwar a fili.
An sanar da WHO a ranar.
"Bayan fitowar wadannan sanarwar, 'yan sanda sun yi gargadin likitocin Wuhan kan "rashin yada jita-jita" game da barkewar cutar".
"A farkon, Hukumar Lafiya ta Kasa ta kasar Sin ta yi ikirarin cewa babu wata "tabbatacciyar hujja" ta kamuwa da cutar daga mutum zuwa mutum".
"A ƙarshen watan Janairu, gwamnatin kasar Sin ta fara wani kamfen na juyin juya hali wanda daga baya Sakatare Janar na Jam'iyyar Kwaminis ta Sin Xi Jinping ya bayyana a matsayin ""yaƙin mutane"" don shawo kan yaduwar cutar".
"An sanar da dakatar da zirga-zirgar balaguro da balaguro a Wuhan a ranar 23 ga Janairu, wanda aka bayyana a matsayin ""mafi girman keɓewa a tarihin ɗan adam", wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi kusan mutane miliyan 57".
An hana amfani da motocin masu zaman kansu a cikin birni.
An soke bikin Sabuwar Shekarar Sin (Janairu 25) a wurare da dama.
Jami'ai sun kuma sanar da gina asibitin wucin gadi, Huoshansan Hospital, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti don kula da ƙarin marasa lafiya bayan asibitin Leishenshan.
Bugu da kari ga sabbin asibitoci, kasar Sin ta maida wasu cibiyoyi 14 na Wuhan, kamar su Cibiyar Taro da Filin wasa zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta dauki wasu matakai don hana barkewar COVID-19, gami da sanarwar kiwon lafiya ga masu yawon bude ido da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a duk fadin kasar.
Yankunan Hong Kong da Macau sun ɗauki matakai daban-daban, musamman a makarantun da jami'o'i.
An kuma kafa hanyoyin aiki daga nesa a yankuna da dama na kasar Sin.
An sanya takunkumi kan tafiye-tafiye zuwa da daga Hubei.
An sauya tsarin sufuri na jama'a a duk fadin kasar Sin, kuma an rufe gidajen tarihi na wucin gadi.
"An sanya takunkumi kan zirga-zirgar jama'a a birane da yawa, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu takunkumin tafiye-tafiye. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin kasar Sin sun dauki matakai masu tsauri don hana cutar daga "" shigowa "" daga wasu ƙasashe. "
Misali, Beijing ta ayyana wa dukkan matafiya na duniya da ke shiga birnin cewa dole ne su keɓe kansu na tsawon kwanaki 14. Kashi daya ne kawai aka samu a cikin gida a cikin babban yankin kasar Sin kwanaki biyar da suka gabata a ranar 23 ga Maris.
A ranar 24 ga Maris, 2020, Firayim Ministan China Li Keqiang ya bayyana cewa an toshe yaduwar cututtukan da ke yaduwa a cikin gida kuma an sarrafa barkewar cutar a China.
Watanni biyu bayan sanya dokar kulle, an sassauta takunkumin tafiye-tafiye zuwa Hubei a ranar da ba Wuhan ba. Ma'aikatar Harkokin Wajen Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da izinin shiga ga mutanen da ke da biza ko izinin zama daga ranar 28 ga Maris, kuma ba a ba da takamaiman bayani kan lokacin da wannan manufar za ta ƙare ba.
Duk wanda ke son shiga kasar Sin dole ne ya nemi takardar izinin shiga ta ofishin jakadancin kasar Sin ko ofishin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa 'yan kasuwa da masana'antu gwiwa su sake budewa a ranar 30 ga watan Maris, kuma ta bayar da kudade ga kamfanoni. Majalisar Jiha ta sanar da ranar makoki wanda ya fara da yin shiru na minti uku a duk fadin kasar a karfe 10:00 na ranar 4 ga watan Afrilu, ranar da ake bikin Qingming, duk da cewa gwamnatin tsakiya ta nemi iyalai su yi ta'aziyya ta yanar gizo tare da nisantar jiki don gujewa sake barkewar COVID-19.
An tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar kiwon lafiya ta kasar ta bayar da rahoton karuwar adadin wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda ya danganta da sabon tsarin addinin Daegu, wanda ya saba da addinin Yahudawa da ake kira Shincheonji Church.
Ana zargin cewa masu zuwa coci na Shinchangi daga Wuhan zuwa Daegu ne suka haddasa cutar.
A ranar 22 ga Fabrairu, 1,261 daga cikin mabiya cocin 9,336, ko kuma kusan kashi 13 cikin 100 na masu bin cocin, sun ba da rahoton alamun. Koriya ta Kudu ta ba da sanarwar matakin gaggawa a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an samu fiye da 2,000 da aka tabbatar da kamuwa da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin soji na Koriya ta Kudu bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
Koriya ta Kudu ta ƙaddamar da wani shiri wanda ake ganin shine mafi girma kuma mafi kyawun tsari a duniya don gwada mutane don cutar da ke ware mutane masu kamuwa da cutar da ganowa da keɓe waɗanda suka sadu da su.
Hanyoyin bincike sun hada da bayar da rahoton alamun cutar ga sabbin masu shigowa daga kasashen waje ta hanyar wayar salula, gwajin gwaji na cutar wanda sakamakon ya kasance a rana ta gaba, da kuma iyawar gwajin mutum 20,000 a kowace rana.
Ko da yake ba a keɓe birane gaba ɗaya ba, an yi la'akari da shirin a Koriya ta Kudu a matsayin nasara wajen hana barkewar cutar.
Yawancin 'yan Koriya sun sanya hannu kan takarda ko dai suna ikirarin an yi amfani da cutar a hukumance, suna kira ga wanke Moon ko kuma suna yaba masa saboda yadda ya amsa.
A ranar 23 ga Maris, an bayar da rahoton cewa Koriya ta Kudu tana da mafi ƙarancin adadin masu kamuwa da cutar a cikin kwana ɗaya a cikin makonni huɗu.
A ranar 29 ga Maris, an sanar da cewa duk sabbin mutane da suka shigo daga kasashen waje za a killace su na tsawon makonni biyu daga ranar 1 ga Afrilu.
A ranar 1 ga Afrilu, kafofin watsa labarai sun ruwaito cewa Koriya ta Kudu ta karbi buƙatun gwajin cutar daga kasashe 121.
Iran ta bayar da rahoton farkon tabbatar da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda ta sami mutuwar mutane biyu a ranar da ta gabata, a cewar Ma'aikatar Lafiya da Ilimin Kiwon Lafiya.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da wake-wake da sauran bukukuwa na al'adu da wasannin motsa jiki, da rufe sallar Juma'a da makarantu, cibiyoyin ilimi da jami'o'i.
Iran ta ware tiriliyan biyar na Riyal don magance cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 cewa babu wani shiri na keɓe wuraren da cutar ta shafa, kuma za a keɓe mutane ne kawai.
An sanar da shirin hana zirga-zirga tsakanin birane a watan Maris, duk da cewa ana ci gaba da yin zirga-zirga tsakanin biranen yayin da Sabuwar Shekarar Farisa ke gabatowa.
Wuraren ibada na Shi'a a Koum sun kasance a bude har zuwa 16 ga Maris, 2020.
A cikin ikirarin da ake yi na cewa Iran ta shawo kan yaduwar cutar, sama da kasashe goma sun gano Iran a matsayin tushen kamuwa da cutar a ranar 28 ga Fabrairu, wanda ke nuna cewa yaduwar cutar ta fi yawan wadanda gwamnatin Iran ta ruwaito sun kamu da cutar 388 a wannan ranar.
A ranar 3 ga watan Maris ne aka rufe majalisar dokokin kasar Iran, inda 23 daga cikin mambobin majalisar su 290 suka kamu da cutar.
A ranar 12 ga watan Maris, Human Rights Watch ta yi kira ga jami'an gidan yarin Iran da su saki masu cin zarafin 'yan Adam da aka tsare saboda rashin amincewarsu ba tare da wani sharadi ba, da kuma 'yanci na wucin gadi ga duk fursunoni da suka cancanta.
An ce akwai babban haɗarin yaduwar kwayar cutar a wuraren da aka rufe kamar gidajen yari, waɗanda kuma ba su da isassun hanyoyin kiwon lafiya.
A ranar 15 ga watan Maris, gwamnatin Iran ta bayar da rahoton mutuwar mutane 100 a rana, wanda shine mafi girma a kasar tun lokacin da cutar ta bulla.
Akalla 'yan siyasa da jami'an gwamnati 12 na yanzu da kuma na baya sun mutu sakamakon cutar a ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, cutar coronavirus ta kai 50 a kowace awa a Iran, kuma ta kai ga mutum daya ya mutu a kowace minti goma.
Wani jami'in WHO ya ce Iran na iya samun adadin kamuwa da cutar da ya ninka na wadanda aka ruwaito sau biyar.
An kuma ba da shawarar cewa takunkumin Amurka kan Iran na iya lalata ikon tattalin arzikin kasar wajen magance cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya bukaci a dage takunkumin tattalin arziki kan kasashen da suka fi fama da annobar, ciki har da Iran.
An tabbatar da cewa annobar ta bazu a Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido biyu na kasar Sin a Rome suka gwada tabbatacciyar cutar SARS-CoV-2.
Lamarin ya fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa daga China kuma ta ba da dokar ta baci a kasar.
A ranar 21 ga Fabrairu, an gano wasu mutane 16 da suka kamu da cutar COVID-19 a Lombardy, bayan an tabbatar da su. A ranar 22 ga Fabrairu, Majalisar Ministocin ta ba da sabuwar doka game da barkewar cutar, inda aka keɓe mutane sama da 50,000 daga gundumomi 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce annobar ta nuna cewa babu hanyoyin shiga da fita a duk wuraren da za a yi.
"An riga an katse ayyukan a waɗannan yankuna kuma an dakatar da wasannin motsa jiki. " "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar saboda mutuwar mutane 100 a Italiya. "
Duk da cewa an tsara a gudanar da manyan wasannin wasanni, ciki har da wasannin kwallon kafa a Siriya, tare da iyakance har zuwa watan Afrilu, a ranar 9 ga Maris, an dakatar da duk wasannin wasanni na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin rufe kusan duk ayyukan kasuwanci, ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Kula da Anesthesia, Analgesia, Resuscitation da Intensive Care (SIAARTI) ta ba da shawarar manufofin likita game da yarjejeniyar gwaji da za a iya ɗauka.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin kasar da ta fi kowacce mutuwa a duniya, inda ta samu mutuwar mutane 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, Rasha ta aika da jiragen yaki guda tara da kayayyakin kiwon lafiya zuwa Italiya.
A ranar 5 ga Afrilu, an samu mutane 128,948 da suka kamu da cutar, 15,887 sun mutu, kuma 21,815 sun warke, mafi yawa a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa, haɗuwa da yawan tsofaffi a Italiya da rashin iya gwadawa don gano ko akwai cutar a yau, na iya haifar da yawan mutuwar.
A farko, Burtaniya ita ce ta fi sassautawa a cikin kasashen da cutar ta shafa, kuma har zuwa ranar 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane nau'in nisantar zamantakewa ko keɓewar jama'a a kan 'yan kasarta ba.
A sakamakon haka, gwamnati ta fuskanci zargi da yawa saboda rashin fahimtar tasirin cutar da za ta iya yi wa mutane. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar cewa an dakatar da duk tafiye-tafiye marasa mahimmanci, zamantakewar jama'a, kuma ya ba da shawarar yin aiki daga gida inda zai yiwu, kuma ya ba da umarnin kauce wa mashaya, gidajen cin abinci da wuraren wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da wuraren motsa jiki za a rufe su da wuri-wuri, kuma ta yi alƙawarin biyan kashi 80% na ma'aikata albashi har zuwa £2,500 a kowane wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar zamantakewar jama'a, ya hana taron mutane sama da biyu, kuma ya iyakance tafiye-tafiye da ayyukan waje ga waɗanda ake ganin suna da mahimmanci.
Ba kamar tsarin da ya gabata ba, ana iya tilasta wa 'yan sanda ta hanyar sanya tarar da kuma kawar da tarurruka.
"An umarci yawancin kasuwancin da suka hada da manyan kantuna, kantunan magani, bankuna, kantunan kayan aiki, tashoshin mai da kuma gidajen ajiye motoci su rufe, ban da kasuwancin da aka ɗauka ""mai mahimmanci"".
A ranar 20 ga Janairu, an tabbatar da sanannen shari'ar COVID-19 a cikin jihar Pacific Northwest ta Washington a cikin mutum ɗaya da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar White House Coronavirus Task Force a ranar 29 ga watan Janairu.
Gwamnatin Trump ta ayyana dokar ta baci ta lafiyar jama'a a ranar 31 ga Janairu kuma ta sanya takunkumi kan shigar masu yawon bude ido daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar cibiyar kiwon lafiyar jama'a ta gwamnatin US, ta sanar da cewa sun shirya kayan gwajin kansu.
Duk da haka, Amurka ta yi gwajin da ya yi jinkiri sosai wanda ya sa a lokacin barkewar cutar, yawan kamuwa da cutar ya wuce na hayaki.
An katse gwajin ne saboda rashin amincewar gwamnatin jihar kan kayan gwajin da gwamnati ta samar a watan Fabrairu da kuma kayan gwajin da ba na gwamnati ba (cibiyoyin ilimi, kamfanoni da asibitoci) a karshen watan Fabrairu, da kuma cancantar da mutane ke da ita (daga nan sai a nemi umarnin likita) don cancanta don gwaji har zuwa farkon Maris.
A ranar 27 ga watan Fabrairu, jaridar The Washington Post ta ruwaito cewa akwai kasa da gwaje-gwaje 4,000 a Amurka.
A ranar 13 ga Maris, The Atlantic ta ruwaito cewa an yi gwaji kasa da 14,000.
A ranar 22 ga Maris, majiyar Associated Press ta ruwaito cewa: "Mutane da yawa da ke da umarnin likita kuma suna da alamun cutar sun jira tsawon sa'o'i ko kwanaki don yin gwaji". Bayan an ba da rahoton mutuwar farko a jihar Washington ta Amurka a ranar 29 ga Fabrairu, Gwamna Joy Insley ya ayyana dokar ta baci a jihar - matakin da sauran jihohi suka bi nan da nan.
Makarantu a yankin Seattle sun rufe aji na uku a watan Maris, kuma a tsakiyar Maris, makarantu a duk faɗin ƙasar suna ta rufewa. A ranar 6 ga Maris, 2020, wasu masana cututtukan cututtuka daga Imperial College London, sun ba da shawara ga Amurka game da tasirin sabon coronavirus a cikin ƙasar da kuma hasashen da za a yi.
A wannan ranar ne Shugaba Trump ya sanya hannu kan Dokar Tallafawa kan Shirye-shiryen Cutar Korona da Amsa, wanda ya samar da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun sanya takunkumin tafiye-tafiyen ma'aikata, sun soke taro, kuma sun karfafa ma'aikata su yi aiki daga gida.
An soke wasanni da kuma kakar wasanni. A ranar 11 ga watan Maris, Trump ya kafa dokar hana zirga-zirga a kusan dukkanin kasashen Turai, sai dai Birtaniya, na tsawon kwanaki 30 daga ranar 13 ga watan Maris.
Kashegari ya ƙara tsawaita takunkumin don ya haɗa da Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci a duk fadin kasar, wanda hakan ya ba da damar samun kudaden tarayya don magance matsalar.
Tun daga ranar 15 ga Maris, yawancin kasuwancin da ke fadin Amurka sun rufe ko kuma sun rage lokacin aiki don kokarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da annobar a jihohi 50 da Gundumar Columbia. A ranar 23 ga Maris, an bayar da rahoton cewa New York City tana da mutane 10,700 da suka kamu da cutar, fiye da adadin da aka samu a Koriya ta Kudu.
A ranar 25 ga Maris, Gwamnan ya ce ya nuna cewa manufofin nisantar jama'a suna aiki yayin da kimar ninkawar cutar ta ragu daga 2.0 zuwa 4.7 a rana.
A ranar 28 ga Maris, New York City ta sami kamuwa da cuta 32,308 da kuma mutuwar mutane 672 da cutar. A ranar 26 ga Maris, Amurka ta sami adadin kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, gami da China da Italiya. A ranar 8 ga Afrilu, Amurka ta sami kamuwa da cuta 400,335 da kuma mutuwar mutane 12,841.
A cewar rahotanni na kafofin watsa labarai na ranar 30 ga Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita umarnin nesa da juna har zuwa ranar 30 ga Afrilu.
A wannan rana ne jirgin asibiti mai dauke da gado 1,000, USNS Comfort, ya sauka a New York.
A ranar 3 ga Afrilu, an samu mutuwar mutane 884 a cikin sa'o'i 24 na cutar coronavirus a Amurka.
An soki Fadar White House saboda yin watsi da wannan siginar ta rashin lafiya da kuma umarnin da ta aikawa jami'an kiwon lafiya da masana kimiyya a ofishin Mataimakin Shugaban Kasa Mike Pence don daidaita maganganun jama'a da wallafe-wallafen da suka shafi cutar.
An kuma yi magana game da amincewar Trump da gudanar da rikicin.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci daga China, ciki har da kayan aikin likitanci.
An yi amfani da nazarin yanayin jirgin sama don tsarawa da kuma hango hasashen yanayin yaduwar cutar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar watan Janairun 2020.
Bangkok, Hong Kong, Tokyo da Taipei sun sami mafi yawan matafiya daga Wuhan bisa ga bayanan 2018 da aka samu daga Transportungiyar Jirgin Sama ta Duniya.
Dubai, Sydney da Melbourne sun kasance manyan wuraren zuwa yawon bude ido daga Wuhan.
Daga cikin biranen da aka fi so 20 a cikin yanayin shiri, Bali ya kasance mafi ƙarancin ƙarfi, inda aka ga cewa biranen Australiya sun fi ƙarfin. Australia ta sanar da shirinta na gaggawa don cutar coronavirus (COVID-19) a ranar 7 ga Fabrairu.
An bayyana cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19 kuma Australia za ta ba da fifiko kan kula da iyakoki da hanyoyin sadarwa a cikin martani ga cutar.
A ranar 21 ga watan Maris, an ayyana dokar ta-baci ta kare lafiyar dan adam a Australia.
Saboda takunkumin keɓewar sufuri na jama'a a Wuhan da Hubei, da farko tare da izinin hukumomin China, ta hanyar jiragen da aka yi izini daga ƙasashensu, ƙasashe da yawa suna shirin fitar da 'yan ƙasa da ma'aikatan diflomasiyya daga yankin.
Kasashen da suka fara shirin dawo da 'yan kasar su ne Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand.
Pakistan ta ce ba za ta mayar da 'yan kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko kuma danginsu, ban da 'yan Poland hudu, da dan kasar Sin daya da kuma dan kasar Indiya daya.
Mazauna Poland, China da Indiya sun sauka a Poland inda jirgin na Brazil ya yi tafiya kafin ya tashi zuwa Brazil.
An killace 'yan Brazil da suka je Wuhan a wani sansanin soja da ke kusa da Brazil.
A wannan rana, an kwashe 215 'yan Kanada (masu 176 daga jirgin farko da 39 daga jirgin na biyu da gwamnatin Amurka ta yi izini) daga Wuhan zuwa CFB Trenton kuma an keɓe su na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin saman Canada mai fasinjoji 185 ya sauka a CFB Trenton daga Wuhan.
Hukumomin Australiya sun kwashe mutane 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake amfani da shi azaman wurin keɓewa, kuma sun kasance a can tsawon kwanaki 14.
Jirgin da ke jigilar 'yan gudun hijira daga New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinsa (ciki har da wasu daga Australia da Pacific) an tsare su a wani sansanin jiragen ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe mutanen Amurka da ke cikin jirgin Diamond Princess Promote.
A ranar 21 ga watan Fabrairu, wani jirgin fasinja dauke da 'yan Kanada 129 ya tashi daga Diamond Princess zuwa Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara dawo da 'yan asalin Indiya daga Iran. A ranar 14 ga watan Maris, wani jirgin saman kamfanin jiragen sama na South Africa Airways wanda gwamnatin Afirka ta Kudu ta karba ya dawo da 'yan Afirka ta Kudu 112.
An yi gwajin likita kafin a tashi, kuma an bar mutanen Afirka ta Kudu huɗu waɗanda ke da alamun cutar coronavirus don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da suka yi gwajin ba su da tabbacin cutar, ne kawai aka mayar da su gida.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, direbobi, ma'aikatan otal,' yan sanda da sojoji, waɗanda ke da hannu a ayyukan jin kai, an cire su daga cikin zargin, kuma an sanya su a cikin keɓewa na kwanaki 14 a wurin shakatawa na Ranch a matsayin matakin tsaro.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iran saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da tallafi ga kasar Sin.
Wasu daliban kasar Sin sun taru a jami'ar Amurka don aika da agaji zuwa wuraren da cutar ta addabi kasar Sin. Tare da su, wata kungiya daga yankin Chicago ta tura takunkumin N95 50,000 zuwa asibitocin yankin Hubei a ranar 30 ga Janairu.
"A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa bincike kan allurar rigakafi da kuma maganin cutar, tare da manufar kare "'yan adam masu hadari a Afirka da Kudancin Asiya".
Interaction ya bayyana cewa gwamnatin China ta ba da gudummawar masks 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya kai Wuhan da masks miliyan 3.16.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 na agaji zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan ɗaya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayan aikin likita sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da tallafin safofin hannu na likita miliyan 18 ga China, Jamus ta ba da kayan aikin likita daban-daban ciki har da kayan aikin 10,000 na Hazmat, kuma Amurka ta ba da kayayyakin kiwon lafiya tan 17.8 ga China, tare da yin alkawarin ƙarin dala miliyan 100 na tallafin kuɗi ga ƙasashen da abin ya shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da masana don taimakawa Italiya wajen magance barkewar cutar coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1 zuwa Addis Ababa, Habasha, da abin rufe fuska miliyan 6, da kuma kayan kariya 60,000 don rarraba zuwa Tarayyar Afirka.
Daga baya ya aika da kayan gwajin 5,000, masks 100,000 da na'urorin motsa jiki guda biyar zuwa Panama.
Ma ta kuma kawo kayayyakin kiwon lafiya a Kanada, inda ta nuna shakku kan abin da ake kira masks da kayan gwajin da aka yi a Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech.
Misali, Spain ta janye kayan gwajin coronavirus da aka yi da kasar Sin 58,000 tare da daidaito na kashi 30 cikin dari, yayin da Netherlands ta mayar da takunkumin fuska na kasar Sin 600,000, wadanda suka kasance marasa inganci.
Belgium ta dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba, wanda ake tsammanin ya fito ne daga China, amma a zahiri daga Colombia.
A wani bangare kuma, an yi maraba da cinikin kasar Sin a sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya amince da shirin agaji na gaggawa ga kasashe masu tasowa.
WHO ta yaba wa kokarin da jami'an kasar Sin ke yi wajen shawo kan cutar.
WHO ta nuna bambanci tsakanin barkewar cutar SARS a shekarar 2002-2004, inda aka zargi hukumomin kasar Sin da tsare sirri wanda ya kawo cikas ga kokarin hanawa da kuma sarrafawa, da kuma rikicin na yanzu, inda gwamnatin tarayya ke ba da sabuntawa akai-akai don kauce wa fargaba kafin hutun sabuwar shekara.
"A ranar 23 ga Janairu, a martanin da aka ba hukumomin tsakiya na aiwatar da takunkumin hana zirga-zirga a Wuhan, wakilin WHO, Goden Galley ya yi sharhi cewa ""WHO ba ta bayar da shawarar hakan ba", kuma wannan ""wani muhimmin alama ne na jajircewa wajen shawo kan annobar a duniya a inda ta fi yawa,"" kuma ya kira shi ""wanda ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan tabbatar da kamuwa da mutane daga waje da China da kuma karuwar adadin masu kamuwa da cutar a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin Matsalar Lafiya ta Duniya (PHEIC), ta shida tun lokacin da aka ayyana annobar cutar sankara ta Sinau a duniya a shekarar 2009. "
"Darakta Janar na WHO ya ce PHEIC na da "haɗarin yaɗuwa a duniya a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi waɗanda ba su da ingantaccen tsarin kiwon lafiya".
"A mayar da martani ga aiwatar da takunkumin tafiye -tafiye, Tedros ya ce ""babu wani dalili na matakan da ke tsoma baki ba dole ba a cikin tafiye -tafiye na duniya da kasuwanci"" kuma ya kara da cewa ""WHO ba ta ba da shawarar rage kasuwanci da motsi ba"."
A ranar 5 ga watan Fabrairu, WHO ta nemi al'umma ta duniya da ta ba da dala miliyan 675 domin shirya matakan yaki a ƙasashe masu karancin kuɗi, kuma ta ba da taimakon gaggawa ga ƙasashen da ba su da hanyar gano ko su waye ke da cutar a yankin, ko kuma idan an kashe ta.
"Tedros ya kara da cewa ""mu masu karfi ne kamar yadda mafi rauni yake"" kuma ya bukaci al'ummar duniya da ""su zuba jari a yanzu ko kuma su biya daga baya"". A wani taron manema labarai da WHO ta gudanar a ranar 11 ga watan Fabrairu, ta gabatar da sunan cutar a matsayin COVID-19".
"A wannan rana, Tedros ya sanar da cewa Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince ya ba da iko ga dukkan tsarin Majalisar Dinkin Duniya a matsayin martani ga wannan".
"A sakamakon haka, an kunna ƙungiyar gudanar da rikice-rikicen Majalisar Dinkin Duniya, wanda ya ba da damar daidaitawa a duk faɗin amsawar Majalisar Dinkin Duniya, wanda a cewar WHO zai ba su damar ""mai da hankali kan amsawar kiwon lafiya, da sauran hukumomi don amfani da ƙwarewarsu don magance tasirin zamantakewar jama'a, tattalin arziki da ci gaban barkewar cutar. ""
A ranar 14 ga Fabrairu, tawagar hadin gwiwa da WHO ke jagoranta ta haɗu tare da China don kawo ƙwararrun ƙwararrun WHO da na duniya zuwa ƙasar Sin don taimakawa wajen gudanar da ayyukan gida da kuma kimantawa game da cutar da yaduwar cutar ta hanyar tarurruka tare da manyan ƙungiyoyi na ƙasa da kuma tafiya zuwa wurare masu dacewa don tantance tasirin da kuma martani ga ayyukan a larduna da larduna, gami da birane da ƙauyuka. A ranar 25 ga Fabrairu, WHO ta sanar da cewa duniya ya kamata ta kasance cikin shiri don wannan yiwuwar barkewar cutar coronavirus kuma ta ce, kodayake ba a bayyana cutar a matsayin annoba ba, ƙasashe su kasance cikin shiri.
"A cikin martani ga karuwar barkewar cutar a Iran, WHO ta aika da wata hadin gwiwa don kimanta yanayin a can. A ranar 28 ga Fabrairu, WHO ta bayyana cewa za a ƙara kimanta cutar ta coronavirus a duniya daga ""mai tsanani"" zuwa ""mai tsanani"" wanda shine matakin mafi girma na faɗakarwa da kimanta hadarin.
"Mike Ryan, darektan gudanarwa na shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa, "Wannan gwaji ne na gaske ga kowace gwamnati a duniya: tashi".
"Wannan cuta na iya kasancewa a kusa kuma ya kamata ku kasance a shirye", "da kuma amsa mai kyau zai iya taimakawa duniya ta guje wa "mafi munin yanayin".
"Ryan ya ci gaba da cewa bayanan da ake da su yanzu ba su ba da hujja da ya dace da jami'an kiwon lafiya su ayyana cutar a matsayin annoba ta duniya ba, yana mai cewa irin wannan sanarwar za ta nuna cewa ""mun amince da cewa kowane mutum a duniya zai iya kamuwa da cutar"."
A ranar 11 ga watan Maris, WHO ta ayyana barkewar cutar ta coronavirus a matsayin annoba.
"Manajan Daraktan ya ce WHO tana da matukar damuwa game da "tsananin yaduwar cutar da kuma matakin rashin saukin kamuwa da ita. WHO ta fuskanci zargi da yawa saboda rashin isasshen matakan da ta dauka wajen shawo kan annobar, ciki har da jinkirin sanar da gaggawa na kiwon lafiya da kuma rarraba cutar a matsayin annoba".
Amsar da ba ta dace ba ta hada da takardar neman a yi murabus daga mukamin darakta-janar na WHO Tedros Adhanom, wanda mutane 733,000 suka sanya hannu a kai har zuwa ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, wasu ƙwararrun masanan haƙƙin ɗan adam na Majalisar Dinkin Duniya sun bayyana girmama haƙƙin kowane mutum yayin COVID-19.
Kungiyar ta ce kowa na da hakkin yin aikin ceton rai kuma gwamnati ce ke da alhakin yin hakan.
Kungiyar ta jaddada cewa rashin albarkatu ko rashin inshorar lafiya ba zai iya zama hujja don nuna bambanci ga wani rukuni ba.
Masana sun jaddada cewa masu nakasa, membobin ƙabilu, tsofaffi, marasa gidaje, marasa gidaje, waɗanda ke rayuwa cikin matsanancin talauci, waɗanda ke cikin kurkuku, waɗanda ke cikin 'yan gudun hijira da sauran ƙungiyoyi marasa iyaka waɗanda ke buƙatar taimakon gwamnati suna da haƙƙin kiwon lafiya.
Hukumomin duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar Tattalin Arziki da Ci Gaban (OECD) ta kaddamar da wani dandamali don samar da bayanai masu dacewa da cikakkun bayanai kan martani na manufofi a cikin ƙasashe a duniya, da kuma samar da ra'ayoyi da shawarwari.
Tattalin arzikin duniya ya haɗa da mai bin diddigin manufofin ƙasa, daga ƙa'idodin ƙarfafa tsarin kiwon lafiya zuwa tafiye-tafiye, ƙuntatawa na cibiyoyin dijital da magance tasirin kulle-kulle, da kuma taimakawa ƙasashe su koya daga juna da sauƙaƙe haɗin kai na duniya a cikin martani ga ƙalubalen coronavirus.
Gwamnatin Amurka, Ministan Burtaniya na ofishin majalisar ministoci Michael Gove da ɗan shugaban Brazil Zayyar Bolsonaro, Eduardo Bolsonaro sun soki gwamnatin China kan yadda ta magance annobar, wacce ta fara ne daga yankin Hubei na kasar Sin.
An kori wasu jami'an jam'iyyar kwaminis ta kasar Sin (CPC) a matakin lardin saboda kokarin da suka yi na ware mutane a yankin tsakiyar kasar Sin, wanda ke nuna rashin jin daɗin da ake yi wa kungiyoyin siyasa kan yadda cutar ta bulla a wadannan yankuna.
Wasu masu sukar sun ce an dauki matakin ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping daga fushin jama'a kan barkewar cutar.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun musanta ka'idodin da suka nuna cewa Amurka ko Italiya ne suka fara shirya COVID-19, sun kuma musanta abin da suka ce game da farkon barkewar cutar a Wuhan.
"Gwamnatin Donald Trump ta Amurka ta ambaci cutar coronavirus a matsayin ""kwayar cutar Sin"" ko ""kwayar Wuhan"" inda ta ce "tsabtacewar da China ke yi ta haifar da cutar da ta zama annoba a duniya", wanda wasu masu sukar suka ce wariyar launin fata ce, kuma "ƙoƙarin karkatar da hankali daga gazawar gwamnatinsa wajen hana cutar".
"The Daily Beast ta samu jawabi game da ayyukan gwamnatin Amurka wanda ya bayyana dabarun sadarwa tare da majiyoyin da suka bayyana a Majalisar Tsaro ta Kasa, inda aka ambata dabarar a matsayin "duk abin da ya shafi China".
"An umurce mu da mu yi kokarin yada wannan sakon ta kowace hanya, ciki har da taron manema labarai da kuma fitowar talabijin. " "Kasuwanci kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na aika da agaji ga kasashen da cutar ta addabi wani bangare ne na yunkurin yada tasirin duniya. "
"Joseph Borel, shugaban manufofin kasashen waje na Tarayyar Turai ya yi gargadin cewa akwai wani bangare na siyasa da ya shafi "halayyar kirkirar labarai da kuma gwagwarmayar samun rinjaye ta hanyar 'siyasa ta' yanci.'"
"Borrell ya kara da cewa, ""China tana tura saƙo da cewa, ba kamar Amurka ba, ita ce abokiyar tarayya mai hakki da aminci"."
China ta sha roƙon Amurka da ta dakatar da tallafinta ga Syria, Venezuela da Iran, yayin da aka samu rahoton cewa ita kanta tana tura tallafi zuwa kasashen biyu na baya.
A ranar 3 ga Afrilu, an dakatar da tallafin Jack Ma na kayan rufe fuska 100,000 ga Cuba.
An zargi hukumomin Amurka da amfani da tallafin da aka bayar ga wasu kasashe don amfanar kasarsu.
An yi jayayya game da abin rufe fuska a Jamus, Austria da Switzerland, da sauran ƙasashe kamar Czech Republic da Italiya.
Turkiyya ta kuma kwace daruruwan na'urorin sanyaya numfashi da aka yi niyya ga Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Tarayyar Turai kan rashin hadin kai ga Italiya da ke fama da cutar coronavirus.
Jakadan Italiya a Tarayyar Turai Maurizio Massari ya ce, "China ce kadai ta mayar da martani a bangarorin biyu".
"Tabbas wannan ba alama ce mai kyau ga haɗin kan Turai ba".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaba Vladimir Putin ya shirya sojojin Rasha su aika da likitocin soja, motocin kashe-kashe na musamman da sauran kayan aikin kiwon lafiya zuwa Italiya.
"A cikin jaridar La Stampa ta Italiya, wani "babban jami'in siyasa" wanda ba a san sunansa ba ya bayyana cewa kashi 80 cikin 100 na taimakon Rasha "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
"Wadannan majiyoyin sun zargi Rasha da sauka a kan wani yunkuri na faranta wa al'ummar kasar rai rai ""a fannin siyasa da kuma diflomasiyya"".
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi De Maio sun yi watsi da rahoton da kafofin watsa labarai suka fitar, suna mai nuna godiyarsu.
Rasha ta kuma aika da jirgin jigilar kayayyaki da kayayyakin kiwon lafiya zuwa Amurka.
"Dimitry Peskov, mai magana da yawun Kremlin ya ce, "Lokacin da ya zo ga taimakon abokan aikin Amurka, [Putin] ya yi tunanin cewa idan masana'antun na'urorin kiwon lafiya na Amurka suka sami ɗan ci gaba, za su iya biya".
"Ma'aikatar Soji ta NATO ""Defender 2020"" da aka shirya a Jamus, Poland da kuma ƙasashen Baltic, wanda shi ne babban aikin soja na NATO tun ƙarshen Cold War, za a gudanar da shi a raguwa".
"Sakatare Janar na Kamfen don Rashin Makaman Nukiliya Kate Hudson ta soki atisayen Defender 2020: ""A cikin rikicin kiwon lafiya na yanzu, ba wai kawai zai sanya rayuwar dakarun Amurka da sauran kasashen Turai masu halarta cikin haɗari ba, har ma da rayuwar mazauna ƙasashen da suke iko da su. " Gwamnatin Iran ta yi mummunan rauni ta hanyar cutar, wanda ya haɗa da 'yan majalisa goma sha biyu da suka kamu da cutar, da kuma wasu sha biyar ko wasu tsoffin jami'an siyasa na yanzu. "
Shugaban Iran Hassan Rouhani ya rubuta wata wasika a bude ga shugabannin duniya don neman taimako a ranar 14 ga Maris, 2020, inda ya ce Amurka ta sanya takunkumi kan Iran, wanda hakan ya sa ya zama da wahala a kasar ta yaki da barkewar cutar saboda karancin damar shiga kasuwannin duniya.
Masu sharhi na siyasa sun yi hasashen cewa hakan na iya shafar yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020. Dangantakar diflomasiyya tsakanin Japan da Koriya ta Kudu ta yi sanyi a lokacin annobar duniya.
"Bayan sanarwar da Japan ta yi na keɓe duk wanda ya zo daga Koriya ta Kudu a wuraren da gwamnati ta keɓe na tsawon makonni biyu, Koriya ta Kudu ta soki Japan kan "ƙoƙarin keɓewa da ba a bayyana ba".
Koriya ta Kudu ta fara samun ra'ayoyi biyu game da yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a kori Moon, suna zargin gwamnati ta yi rashin kula da annobar, yayin da wasu kuma suka yi maraba da martani. Cutar ta duniya ta ba da dama ga ƙasashe da yawa don aiwatar da dokar ta gaggawa a cikin martani.
Wasu masu sharhi sun nuna damuwa cewa hakan na iya bai wa gwamnati damar kara karfafa matsayinta na iko.
A Hungary, majalisar dokoki ta bai wa firaminista Viktor Orban ikon yin mulki har abada, dakatar da majalisar ko gudanar da zaben, da kuma hukunta mutanen da ke yada labaran karya game da yadda cutar ta kamu da kuma yadda gwamnati ke magance matsalar.
An danganta barkewar cutar ga karancin kayan aiki, karuwar amfani da kayan aikin da ake bukata a duniya don yaƙar cutar, haifar da fargaba, da kuma katsewar masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar masu sayayya da kuma katsewar masu samar da kayayyaki.
An kuma ga yawan cin kasuwa a yankuna da dama saboda fargaba, wanda ya sa mutane suka sayi kayan masarufi kamar kayan abinci, takardar wanka da ruwan kwalba, wanda ya haifar da karancin kayayyaki a Gahogan.
Masana fasahar zamani musamman sun yi gargadin jinkirin jigilar kayayyakin lantarki.
A cewar Daraktan-Janar na WHO Tedros Adhanam, bukatar kayan kariya ta mutum ya ninka sau 100.
Wannan bukatar ta haifar da ninka farashin sau 20 da kuma jinkirin watanni shida na isar da kayayyakin kiwon lafiya.
Wannan ya haifar da karancin kayan kariya na mutum a duniya, kuma WHO ta yi gargadin cewa hakan zai sanya ma'aikatan kiwon lafiya cikin hadari.
Cutar ta Australia ta ba da sabuwar dama ga dillalan daigowa don sayar da kayayyakin Australiya a China.
Wannan aikin ya haifar da rashin wadatar jariri a wasu manyan kantuna kuma daga baya gwamnatin Australia ta dakatar da shi. Duk da yawan yaduwar COVID-19 a arewacin Italiya da yankin Wuhan, wanda ke tabbatar da tsananin bukatar abinci, duka yankunan sun sami kansu daga tsananin karancin abinci.
Matakan da China da Italiya suka dauka kan adana kayayyakin more rayuwa da kuma cinikin haram sun yi nasara, wanda ya kawar da karancin abinci da aka yi hasashen zai yi a Turai da kuma Arewacin Amurka.
Ko da yake ba a ga raguwar kayayyakin gona a arewacin Italiya ba, masana'antu na iya ganin farashin ya karu.
Lokacin da jami'an gwamnatin kasar Sin suka saki naman alade da aka tanada don ciyar da jama'a, har ma a birnin Wuhan, sun fara fuskantar shingen abinci marasa amfani.
A Italiya, akwai irin wannan dokar kasa da ke buƙatar masu samar da abinci su ajiye abinci don irin wannan gaggawa.
An kuma ji rauni a cikin tattalin arzikin duniya a China: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi matukar rauni a farkon watanni biyu na shekarar 2020 saboda matakan da gwamnati ta dauka na dakile yaduwar cutar, kuma tallace-tallace na sayar da kayayyaki sun ragu da kashi 20.5%.
Tunda babban yankin kasar Sin yana taka muhimmiyar rawa a matsayin cibiyar tattalin arziki da masana'antu, barkewar cutar ta yi barazanar haifar da gagarumin tashin hankali a tattalin arzikin duniya.
Agathe Demarais na sashen bincike na masana tattalin arziki ya yi hasashen cewa kasuwannin za su ci gaba da kasancewa masu saurin canzawa har sai an bayyana wani kyakkyawan hoto game da sakamakon da ake tsammani.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa matsalar tattalin arziki da cutar ta haifar a duniya na iya wuce barkewar cutar SARS a 2002-2004.
Wani masani a Jami'ar Washington da ke St. Louis ya kiyasta cewa hasarar da aka yi wa sarkar samar da kayayyaki a duniya ta kai dala biliyan 300, wanda zai iya wucewa har tsawon shekaru biyu.
"Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta ce ta "yi kasala" bayan da farashin mai ya fadi sosai saboda karancin bukatar da ake samu daga kasar Sin".
Kasuwannin hannun jari na duniya sun faɗi saboda ƙaruwar ƙaruwar COVID-19 a waje da babban yankin China a ranar 24 ga Fabrairu.
A ranar 27 ga Fabrairu, saboda karuwar damuwa game da barkewar cutar coronavirus, yawancin alamun jari na Amurka, gami da NASDAQ-100, S&P 500 da Dow Jones Industrial Average sun buga mafi ƙarancin faɗuwarsu tun 2008, tare da Dow Dow ta faɗi da maki 1,191, babbar faɗuwar kwana ɗaya tun lokacin rikicin kuɗi na 2007-08.
Dukkanin alamomin uku sun haura kashi 10 cikin 100 a karshen makon.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da darajar bashi na kasar Sin, amma ya ci gaba da kasancewa mara kyau.
Kasuwancin hannun jari sun sake faɗuwa saboda tsoron cutar coronavirus, mafi girma a ranar 16 ga Maris.
Mutane da yawa suna tunanin yiwuwar koma bayan tattalin arziki.
Masanin tattalin arziki Muhammad El-Arian ya yaba wa babban bankin kasar da kuma jihar kan yadda suka dauki matakin gaggawa.
Babban bankuna na fama da sauri fiye da yadda suka yi a lokacin rikicin kuɗi na 2008.
Yawon shakatawa na ɗaya daga cikin manyan sassan da aka fi shafa, tare da hana tafiye-tafiye, duk wuraren da ake da jama'a, da kuma duk wata tafiya a duk duniya.
Sakamakon haka, kamfanonin jiragen sama da dama, ciki har da British Airways, China Eastern Airlines da Qantas sun soke zirga-zirgar jiragen sama saboda karancin bukatar da ake samu, bayan da kamfanin jirgin sama na yankin na Burtaniya Flybe ya rushe.
Ba a taɓa ganin irin wannan mummunan tasirin a masana'antar tafiye-tafiye ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa.
A lokacin hutun Sabuwar Shekarar Sin, lokacin da babban lokacin tafiye-tafiye ya fara a China, ana kiransa da suna Chunlun, lokacin da annobar ta barke a kasar Sin.
Yawancin abubuwan da ke iya haifar da taro mai yawa kamar bikin Sabuwar Shekara na shekara-shekara, an rufe su ta hanyar gwamnatocin ƙasa da na yanki. Kamfanoni masu zaman kansu suna rufe shagonsu da kansu, kuma sun rufe wuraren shakatawa da yawa kamar su Disneyland a Hong Kong da Shanghai Disneyland.
An dakatar da bukukuwan Sabuwar Shekara da yawa na Lunar, gami da birnin da aka hana shi da kuma bikin haikalin gargajiya, da kuma taron masu yawon bude ido a Beijing don hana taron jama'a.
A cikin larduna 24 daga cikin larduna 31, jami'ai a larduna, garuruwa da yankuna sun tsawaita hutun sabuwar shekara har zuwa 10 ga Fabrairu, kuma sun ba da umarnin cewa ba za a sake buɗe wuraren aiki ba har zuwa wannan kwanan wata.
Waɗannan yankuna suna wakiltar kashi 80% na GDP na ƙasar da 90% na fitarwa.
Hong Kong ta kara yawan maganin cutar ta hanyar kara yawan cutar, kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta soke bikin bikin Sabuwar Shekara.
Ziyarar shago a Turai da Latin Amurka sun ragu da kashi 40 cikin dari.
Masu sayar da kayayyaki a Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar kashi 50-60 cikin dari.
Sakamakon haka, adadin masu siyayya a cibiyoyin cin kasuwa ya ragu da kashi 33 cikin 43 a watan Maris idan aka kwatanta da Fabrairu.
Manajojin shagunan duniya sun sanya ƙarin matakan, kamar haɓaka tsarin kiwon lafiya, sanya masu binciken zafin jiki don bincika yanayin yanayin masu siye, da soke abubuwan da suka faru. A cewar ƙididdigar Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da aka fara saboda annobar duniya na iya jefa mutane miliyan 14 zuwa 22 cikin matsanancin talauci a Latin Amurka fiye da yadda yanayin zai kasance idan ba tare da annobar duniya ba.
A watan Janairu da Fabrairu na shekarar 2020, kusan mutane miliyan 5 a kasar Sin sun rasa ayyukansu a Wuhan a lokacin da annobar ta kai ƙarshenta.
Da yawa daga cikin kimanin ma'aikatan hijira na karkara miliyan 300 na kasar Sin sun yi zaman talala a gidajensu a cikin gidaje ko kuma sun makale a lardin Hubei. Sama da Amurkawa miliyan 10 sun rasa ayyukansu a watan Maris na 2020 kuma sun nemi taimakon gwamnati.
A cewar ƙididdigar da Bankin Tsaro na St. Louis ya yi, annobar coronavirus na iya sa mutane miliyan 47 su rasa ayyukansu a Amurka, kuma rashin aikin yi ya kai kashi 32%. A Indiya, kulle-kulle ya sa miliyoyin ma'aikatan baƙi na Indiya (waɗanda ake biyan su albashi/kuɗin aiki kowace rana) ba su da aiki. Binciken da Cibiyar Angus Red ta gudanar ya nuna cewa kashi 44% na iyalai na Kanada suna fama da rashin aikin yi.
A rabi na biyu na watan Maris, ma'aikata miliyan 4 na Faransa sun nemi fa'idodin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan rabin a Jamus sun tura ma'aikatansu zuwa tsarin aikin ɗan gajeren lokaci wanda aka ba da tallafi na gwamnati wanda aka sani da Kurtzarbeits.
Faransa da Birtaniya sun amince da shirin biyan diyya na ɗan lokaci na Jamus.
Yankin fasaha da al'adun al'adu sun sami mummunan rauni ta hanyar annobar, wanda ya haifar da lalacewar ayyukan kamfanoni da kuma mutane - masu aiki da masu zaman kansu - a duniya.
Cibiyoyin fasaha da al'adu sun yi ƙoƙari su ci gaba da aikinsu (galibi na gwamnati) na ba da damar al'adun al'adu a cikin al'umma, kiyaye lafiyar ma'aikatansu da jama'a, da kuma tallafa wa masu fasaha a duk inda zai yiwu.
A watan Maris na 2020, a duk faɗin duniya da kuma a matakai daban-daban, gidajen tarihi, ɗakunan karatu, gidajen kallo, da sauran cibiyoyin al'adu sun rufe har abada ta hanyar soke ko jinkirta nune-nunen su, abubuwan da suka faru, da kuma wasan kwaikwayon su.
Wani sabon abu kuma mai saurin tasowa na cutar shine soke ayyukan addini, manyan abubuwan wasanni da sauran abubuwan zamantakewa kamar bukukuwa da kide kide, taron fasaha da nunin kayan kwalliya.
An kuma yi watsi da fim din. Vatican ta ce za a soke bikin mako mai tsarki a Roma a makon karshe na azumin azumin Krista.
Da yawa daga cikin diocese sun shawarci tsofaffi su zauna a gida maimakon su zo a ranar Lahadi; wasu majami'u suna ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kan layi ko talabijin, wasu kuma suna gudanar da ibada ba tare da sauka daga mota ba.
Yayin da Diocese na Roman Katolika na Rome ya rufe majami'unsa da kuma wuraren ibada, kuma ya kwashe masu yawon shakatawa daga St. Peter's Square, sauran hukumomin addini sun soke ayyuka kuma sun rage tarurrukan jama'a a majami'u, masallatai, majami'u, gidajen ibada da gurudubar.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa, kuma an rufe wuraren ibada, kuma Saudi Arabiya ta hana baƙi masu yawon shakatawa da mazauna ƙasar shiga wuraren ibada na Makka da Madina.
Cutar ta haifar da babbar matsala a kalandar wasanni ta duniya tun bayan yakin duniya na biyu.
An soke ko kuma dakatar da yawancin manyan wasannin wasanni, ciki har da 2019-20 UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, 2019-20 kakar NBA da kuma 2019-20 kakar NHL.
"Wannan barkewar cutar ta lalata shirin 2020 Summer Olympics, wanda aka shirya fara shi a ƙarshen Yuli; Kwamitin Olympic na International Olympic Committee ya sanar a ranar 24 ga Maris cewa taron zai "bace ranar 2020 amma ba bayan bazara 2021 ba".
Rahotanni na karuwar sabbin sa hannu a shafukan caca sun nuna cewa wannan ya haifar da yawan masu caca zuwa kan layi.
Wasu manyan gidajen wasan kwaikwayo, kamar su Broadway, sun dakatar da duk wani wasan kwaikwayo.
"Wasu masu fasaha sun ci gaba da yin rubutu da kuma raba zane-zane ta hanyar Intanet a matsayin madadin al'adun gargajiya na rayuwa, kamar su watsa shirye-shiryen raye-raye na kide-kide ko ƙirƙirar "bikin" na yanar gizo, inda masu fasaha za su iya yin, rarrabawa da inganta ayyukansu".
A kan layi, ana ta yada wutar ta hanyar yin amfani da yanar gizo mai taken coronavirus wanda ke da ban dariya kuma yana jan hankali daga wannan lokacin rashin tabbas.
Tun bayan barkewar COVID-19, akwai ƙiyayya, tsoratar da baƙi, da wariyar launin fata da ke ƙaruwa ga mutanen asalin Sinawa da na Gabashin Asiya, da kuma waɗanda ke cikin wuraren da ake so a Turai, Amurka da sauran ƙasashe.
A kasashe da dama, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya da Fasifik, akwai tsoron, shakku da kuma ƙiyayya.
Rahotanni na masu kamuwa da cutar tun daga watan Fabrairu sun nuna cewa akwai nuna wariya ga wasu kungiyoyin mutanen kasar Sin a duniya, inda suka ce sun cancanci kamuwa da cutar ko kuma abin da ake yi musu a matsayin fansa.
Wasu kasashen Afirka ma sun ga karuwar adawa da kasar Sin.
Mutane da yawa a Wuhan da Hubei sun ce an nuna musu wariya bisa ga asalin yankin.
Akwai goyon baya ga Sinawa a kan layi da wajen layi, da kuma goyon baya ga mutanen da ke cikin yankunan da cutar ta shafa.
Italiya, wanda ya fara fuskantar mummunan barkewar COVID-19 a cikin Turai, zai iya zama mai saurin shakku da kuma baƙon abu yayin da yake ci gaba da yaduwar cutar a cikin sabbin ƙasashe masu zafi. 'Yan ƙasa daga ƙasashe ciki har da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takarda don neman hana mutanen Sin shiga ƙasarsu a cikin ƙoƙarin hana cutar.
A Japan, hashtag #ChineseRajaJapan, wanda ake kira "Kada Ka Yi Shi" ya shahara sosai.
An samu karuwar cin zarafin 'yan kasar Sin da sauran 'yan Asiya a Birtaniya da Amurka, da kuma hare-haren nuna wariyar launin fata.
"Shugaban Amurka Donald Trump ya fuskanci suka saboda kiran coronavirus a matsayin ""kwayar cutar Sin"", saboda masu sukar suna ganin wannan furucin na nuna wariyar launin fata da kuma adawa da Sin".
Masu zanga-zangar Ukraine sun kai hari kan motocin bas da ke dauke da 'yan kasar Ukraine da kuma fasinjojin da ke dawowa daga Wuhan zuwa Nabi Sanjahari.
Dalibai daga arewa maso gabashin Indiya, wanda ke da iyaka da China, waɗanda ke karatu a manyan biranen Indiya, an ba da rahoton cewa sun sha wahala daga hargitsi dangane da barkewar cutar coronavirus.
"Dilip Ghosh, shugaban jam'iyyar Bharatiya Janata Party na jihar Bengal ta yamma, ya ce Sinawa sun lalata yanayi kuma "saboda haka Allah ya rama musu".
Ofishin jakadancin kasar Sin a Kolkata ya soki wannan kalami a Kolkata, inda ya ce "ba daidai ba ne". A cikin kasar Sin, xenophobia da nuna wariya ga mazauna yankin da ba 'yan asalin kasar Sin ba sun kara karuwa a lokacin annobar.
Akwai wasu jaridu da suka hada da Paywall da suka cire su daga cikakken ko sashi na ɗaukar hoto na cutar ta coronavirus.
Yawancin takardun sun samar da takardun kimiyya game da annobar da ke samuwa a cikin budewa.
Wasu masana kimiyya sun fi son su fitar da sakamakon su cikin sauri a wasu sabbin sabobin kamar Biorex.
Cutar cuta mai tasowa Cutar cuta mai tasowa, wanda sau da yawa ba shi da kyau a cikin yanayin yaduwar sa ko kuma hanyar watsawa
Duniya da Cututtuka - Bayani a kan Duniya da Cutar da ke Tafiya
Jerin annoba da annoba  Jerin mutuwar cututtukan da ke haddasa cututtuka
Kasuwancin namun daji da haɗarin kiwon lafiya da ke tattare da cinikin namun daji na ƙasashen waje
Gwajin dakin gwaje-gwaje don cutar coronavirus na numfashi na 2019 (COVID-19) da kuma cutar SARS-CoV-2 sun haɗa da hanyoyin da ke gano kasancewar kwayar cutar da kuma gano ƙwayoyin cuta da ke haifar da amsawar kamuwa da cuta.
Ana tabbatar da kasancewar kwayar cutar a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Gwajin yana da ƙayyadaddun kuma an tsara shi ne don gano RNA na cutar SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cewa akwai kamuwa da cuta a kwanan nan ko kuma a halin yanzu.
Ana iya amfani da maganin rigakafi (serology) don ganewar asali da kuma lura da jama'a.
Gwajin rigakafin ya nuna yawan mutanen da suka kamu da cutar, har da mutanen da ke da alamun cutar da ba su da yawa ko kuma waɗanda ba su da alamun cutar.
Sakamakon gwajin zai iya ba da cikakken bayani game da mutuwar cutar da kuma yadda ake samun garkuwar jiki a cikin jama'a.
Saboda iyakancewar gwaji, babu wata ƙasa da ke da ingantaccen bayani game da barkewar cutar a cikin al'ummarta har zuwa Maris 2020.
Babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta a ranar 23 ga Maris, kuma akwai bambancin da yawa a cikin adadin gwajin da aka yi a ƙasashe daban-daban.
Wannan bambancin na iya yin tasiri sosai a kan yawan mutuwar da ake bayar da rahoto, wanda a wasu ƙasashe ana iya yin karin la'akari da shi.
Ana iya bincika samfuran numfashi da aka samu ta hanyoyi daban-daban, gami da samfurin nasopharyngeal swab ko sneezing, ta hanyar amfani da halayen sarkar polymerase chain reaction (rRT-PCR) na lokaci-lokaci.
Ana samun sakamako a cikin 'yan sa'o'i zuwa kwana biyu.
Gwajin RT-PCR da aka yi tare da ƙwayar hanci yana da inganci a cikin makon farko na cutar.
Bayan haka, kwayar cutar na iya ɓacewa daga cikin hanci, amma tana iya ci gaba da ƙaruwa a cikin huhu.
A cikin mutane masu kamuwa da cutar da aka gwada a mako na biyu, ana iya ɗaukar samfurin abubuwa daga zurfin numfashi ta hanyar catheter na tsotsa, ko kuma amfani da kayan da aka fitar tare da tari (sneezing).
An shirya daya daga cikin gwajin PCR na farko a cikin Janairu 2020 a Charité na Berlin, ta amfani da ainihin lokacin jujjuyawar jujjuyawar polymerase chain reaction (rRT-PCR), kuma ya kafa tushen kayan aikin 250,000 da Hukumar Lafiya ta Duniya (WHO) za ta rarraba.
Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da kayan aikin gano SARS-CoV-2 na PCR na asibiti (PowerChek Coronavirus) a ranar 28 ga Janairu, 2020.
"Ya gano asalin ""E"" na kowa a cikin dukkan kwayar cutar beta da kuma kwayar cutar SARS-CoV-2. A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami izinin gaggawa na PCR-based SARS-CoV-2 na gano kayan aiki daga Hukumar Kula da Kayan Kiwon Lafiya ta China. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafi (CDC) suna rarraba sabbin kwayar cutar 2019-novel coronavirus (2019-nCoV) zuwa ga masana'antar kiwon lafiyar jama'a ta hanyar albarkatun masu amfani da duniya".
Wani daga cikin gwajin kwayoyin halitta guda uku na tsofaffin sigar kayan gwajin ya haifar da sakamakon da ba a warware ba saboda abubuwan da ke da lahani da kuma katse gwajin a CDC a Atlanta; wanda ya haifar da nasarar sarrafa samfura ƙasa da 100 a kowace rana a cikin watan Fabrairu na 2020.
Gwaje-gwajen da aka yi amfani da kayan haɗin biyu ba a ƙaddara su amintacce ba har zuwa 28 ga Fabrairu, 2020, kuma har zuwa lokacin, ba a ba da izinin fara gwajin ga dakunan gwaje-gwaje na jihar da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin amincewar gaggawa. Labs na kasuwanci na Amurka sun fara gwajin a farkon Maris 2020.
LabCorp ya sanar da cewa za a iya samun gwajin COVID-19 a duk fadin kasar bisa tsarin RT-PCR a ranar 5 ga Maris, 2020.
Quest Diagnostics ta kuma samar da gwajin COVID-19 a duk fadin kasar a ranar 9 ga Maris, 2020.
Babu wani iyaka na adadi da aka sanar; dole ne a aiwatar da tarin samfuran da sarrafawa kamar yadda CDC ke buƙata.
A Rasha, gwajin COVID-19 an tsara shi kuma an samar da shi ta Cibiyar Nazarin Jiha ta Virology da Biotechnology, VECTOR.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin ta Federal Service for Surveillance in Healthcare. A ranar 12 ga Maris, 2020, an sami rahoton cewa Mayo Clinic ta shirya gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya aiwatarwa a cikin awanni 3.5, ta haka ne ta ba da damar yin gwaji 4,128 a cikin na'urar a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba Abbott Laboratories izinin gaggawa ( EUA) don gwaji a kan tsarin Abbott na m2000; FDA ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermo Fisher Scientific.
Hakazalika a ranar 21 ga Maris, 2020, Cepheid ta sami EUA daga FDA don gwaji, wanda ya ɗauki kimanin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Tun da ba a buƙatar sake zagayowar zafin jiki, wannan hanyar na iya ba da sakamako mai kyau a cikin ƙasa da minti biyar kuma yana iya ba da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka, kuma Abbott na fatan kara samarwa don samar da gwaje-gwaje 50,000 a kowace rana. Ana shirya gwajin a Taiwan wanda ke amfani da kwayar cutar monoclonal, wacce ke da alaƙa da kwayar cutar nucleocapsid (N-protein) ta sabon kwayar cutar, kuma yana fatan zai iya samar da sakamako a cikin mintuna 15 zuwa 20 kamar yadda yake a gwajin hanzari na mura.
"Binciken wallafe-wallafen na Maris 2020 ya kammala cewa ""Radiography na kirji a farkon matakai ba shi da mahimmanci a cikin ganewar asali, amma bayanan CT [computed tomography] na iya kasancewa har ma kafin bayyanar cututtuka"."
Abubuwan da CT ke da su sun haɗa da wani nau'i na biyu, mai yawa na gilashin gilashi tare da rarrabawar gefe, ba tare da haɗuwa ba kuma baya baya.
A lokacin da cutar ta fara, ana samun ciwon subplural dominance, da kuma ciwon da ke saurin tashi da kuma karfafawa.
Wani bincike da ya kwatanta PCR da CT a Wuhan, cibiyar cutar ta yanzu, ya nuna cewa CT tana da matukar damuwa, amma ba ta da cikakkiyar bayani, kuma yawancin siffofin da take nunawa sun yi daidai da na wasu cututtukan huhu da kuma hanyoyin cutar.
"A watan Maris na 2020, Kwalejin Kula da Radiology ta Amurka ta ba da shawarar cewa ""ba za a yi amfani da CT ba a matsayin gwajin farko don tantancewa ko a matsayin gwajin farko don gano cutar COVID-19". "A watan Maris na 2020, CDC ta ba da shawarar PCR don gwajin farko na farko.
Sashin amsawar rigakafi ga kamuwa da cuta shine samar da kwayoyin cuta, gami da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutane, don tantance rigakafi, da kuma don lura da jama'a daga kwanaki 7 na bayyanar cututtuka. Ana iya yin kimantawa ta hanyar gwaji a cikin cibiyar bincike (Central Laboratories, CLT) da kuma a wurin kulawa (PoCT).
A yawancin dakunan gwaje-gwaje masu mahimmanci, tsarin sarrafa kansa mai inganci zai iya yin wannan aikin, amma wadatar su zai dogara ne akan yawan samarwa ga kowane tsarin.
Ana amfani da samfurin jini guda ɗaya don CLT, ko da yake ana iya amfani da samfuran jerin don bin diddigin amsawar rigakafi.
Ana yin PoCT ne ta hanyar zubar da jini a cikin fata.
Ba a buƙatar matakin tattarawa kafin gwaji kamar yadda ake yi a hanyar PCR. A ranar 26 ga Maris, 2020, FDA ta sanar da sunayen cibiyoyi 29 waɗanda suka ba da sanarwar ga hukumar kamar yadda ake buƙata kuma yanzu suna iya isar da gwajin rigakafin su.
A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don kayan gwajin su, waɗanda zasu iya gano IgG da IgA antibodies a cikin samfurin jini akan kwayar cutar.
Wannan gwajin yana iya ɗaukar ɗaruruwan samfurori a cikin sa'o'i kaɗan, kuma saboda haka yana da sauri fiye da kimantawar PCR na gargajiya na RNA na kwayar cuta.
Antibodies yawanci ana iya gano su kwanaki 14 bayan fara kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta gano cewa babu wani kayan gwajin antibody da suka saya da ya isa amfani.
"Hong Kong ta kafa wani shiri inda marasa lafiya masu shakku za su iya zama a gida, ""sashen gaggawa zai ba mai haƙuri samfurin tube"", zai yi tsotsa a ciki, ya mayar da shi, kuma ya sami sakamakon gwaji kaɗan. NHS ta Burtaniya ta sanar da cewa suna ƙaddamar da wani shiri na gwaji don bincika abubuwan da ake zargi a gida, wanda ke kawar da haɗarin kamuwa da mutane daga mai haƙuri idan ya je asibiti, ko kuma idan ya yi amfani da motar asibiti don kashe shi.
Cibiyoyin tafi-da-gidanka sun taimaka wa Koriya ta Kudu ta yi saurin, mafi yawan gwaji a kowace ƙasa. Ƙungiyar Ƙungiyar Kula da Kiwon Lafiya ta Ƙasa a Jamus ta ce a ranar 2 ga Maris suna da damar yin gwaji kusan 12,000 a kowace rana a cikin yanayin tafiya, kuma an gwada mutane 10,700 a makon da ya gabata.
Idan likita ne ya umurce shi, inshorar lafiya tana biyan kuɗin.
Shugaban Cibiyar Robert Koch ya ce Jamus na da damar yin gwajin 160,000 a kowane mako.
An gudanar da gwajin tuki a manyan birane da yawa a ranar 19 ga Maris.
Ba a san adadin gwajin da aka yi a Jamus ba a ranar 26 ga Maris, 2020, saboda an ba da rahoton masu cutar kawai.
"Binciken farko na lab ya bayyana cewa an gwada aƙalla samfuran 483,295 har zuwa makon kalanda na 12/2020 har zuwa 12/2020, kuma 33,491 daga cikin samfuran (6.9%) sun sami tabbatacce ga SARS-CoV-2. Masu bincike a asibitin Technion da Rambam a Isra'ila sun haɓaka da gwada hanyar da za su tattara samfuran tare daga marasa lafiya 64, kuma idan an sami samfurin haɗin gwiwa, za a ƙara gwada su kawai. A ranar 5 ga Fabrairu, 2020, BGI ya buɗe wani asibitin gano gaggawa na zamani mai murabba'in murabba'in 2000 mai suna ""Huo-Yan"" (Hasha: 火眼, ko "hasken wuta"" a Turanci), wanda zai iya aiwatar da samfuran sama da 10,000 a rana ɗaya".
Wang Jian, wanda ya kafa BGI, ya kula da aikin kuma ya tsara yadda za a kammala shi a cikin kwanaki biyar, kuma ya nuna cewa idan ba a ƙara ƙarfin gwajin a kan lokaci ba, za a sami ƙarin 47% na ƙwayoyin cuta a cikin Hubei kuma farashin haɗin keɓewa zai ninka.
A cikin birane 12 a duk faɗin ƙasar Sin, kamar Shenzhen, Tianjin, Beijing da Shanghai, dakunan gwaje-gwaje na Huo-Yan sun bi Wuhan Laboratory da sauri.
A ranar 4 ga Maris, 2020, ana iya yin gwaji a kan 50,000 a kowace rana. An fitar da zane-zane masu buɗewa, masu yawa waɗanda za su iya gwada samfurori na marasa lafiya 1122 don COVID19 ta amfani da gwaje-gwaje 93 kawai.
Rashin isasshen kayan aiki da rashin isasshen su sun zama abin ƙyama ga gwajin taro a cikin Tarayyar Turai da Burtaniya da Amurka a watan Maris.
Wannan ya sa wasu masu bincike suka binciki tsarin shirya samfurin inda aka dumama samfuran na tsawon minti 5 a 98 °C (208 °F) don sakin kwayoyin RNA don gwaji na gaba. A ranar 31 ga Maris, an sanar da cewa UAE yanzu tana gwada mutane da yawa don cutar coronavirus fiye da kowace ƙasa kuma tana kan hanyar haɓaka matakin gwaji don isa ga yawancin jama'a.
"An yi hakan ne ta hanyar tara damar fitar da kayayyaki da kuma sayen dakin gwaje-gwaje na samar da kayayyaki a kan sikelin al'umma daga Group 42 da BGI (bisa ga "Huo-Yan" dakunan gwaje-gwajen gano gaggawa a China)".
An gina wannan dakin gwaje-gwaje a cikin kwanaki 14 kuma yana iya yin gwajin RT-PCR sau dubu goma a rana, kuma shine na farko a duniya da ke aiki a waje da China.
An tsara tsarin gwaji daban-daban don gano ɓangarorin daban-daban na tsarin kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta ɗauki tsarin Jamus na samar da kayan aikin da aka aika wa ƙasashe masu ƙarancin kuɗi waɗanda ba su da albarkatun samar da kayan aikin kansu.
An fitar da tsarin Jamusanci a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka shirya ba ta kasance ba har zuwa 28 ga Janairu, wanda ya jinkirta gwajin da ke Amurka. Akwai matsaloli tsakanin China da Amurka game da amincin kayan gwajin a farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aikin da suka dace da buƙatu da shawarwarin gwaji na masana kiwon lafiya ba.
Akasin haka, masana sun ce yawan gwajin da aka yi a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar.
Gwamnatin Koriya ta Kudu ta yi shekaru tana gina kayan aikin gwaji a cikin manyan dakunan gwaje-gwaje na kamfanoni masu zaman kansu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta bukaci a kara shirin gwaji a matsayin hanya mafi kyau ta rage ci gaban cutar ta COVID-19. Karin bukatar gwaji saboda yaduwar kwayar cutar ya haifar da dubban dubban dubban gwaje-gwaje a cikin dakunan gwaje-gwaje na Amurka masu zaman kansu, da matsin lamba kan wadatar swabs da sinadarai masu yaduwa.
A watan Maris na shekarar 2020, kasar Sin ta bayyana matsalar daidaito a kayan gwajin ta.
"A cikin Amurka akwai ""kuskure"" a cikin kayan gwajin da CDC ta shirya; sannan gwamnati ta kawar da shingen da ke hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta ga cewa sakamakon ba daidai ba ne".
Hukumar ta bayyana cewa sakamakon da bai dace ba na iya haifar da gazawar tattara samfura ko amfani da kayan aikin yadda ya kamata.
Ma'aikatar Mutanen Espanya ta ce za ta janye kayan aikin da suka ba da sakamako mara kyau, kuma za ta maye gurbin su da wani kayan aikin da Shenzhen Bioeasy ta bayar. Jamhuriyar Czech ta sayi kashi 80% na kayan aikin gwajin da suka samo daga China. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China waɗanda aka gano ba daidai ba.
"Firai minista Matovič ya ba da shawarar a jefa su a cikin Kogin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da ""iyakar kurakurai"" kuma ba su "yi amfani da su ba"." Birtaniya ta sayi kayan gwajin miliyan 3.5 daga China amma ta sanar a farkon Afrilu 2020 cewa ba za su iya amfani ba".
Ana iya samun sakamako mai kyau ta hanyar gwadawa da kuma keɓe waɗanda suka sami sakamako mai kyau, da kuma gano waɗanda suka yi hulɗa da mutanen da ke da SARS-CoV-2.
Masu bincike a garin Vo, Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaji sau biyu a kan mutane 3,400 a cikin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma an killace duk waɗanda aka gano.
An kuma yi amfani da hanyoyin da aka tsara don kawar da sabon kamuwa da cuta.
Ta hanyar gano mutane da suka sadu da su, ta hanyar hana tafiye-tafiye, gwaji da keɓewa, amma ba tare da wani iko mai ƙarfi kamar rufe gidajen cin abinci da shagunan sayar da kayayyaki ba, cutar coronavirus ta 2020 a Singapore ta ci gaba da jinkirin fiye da sauran ƙasashe masu tasowa.
An soke bukukuwa da yawa, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutun ranar 23 ga Maris.
Wasu ƙasashe sun yi ƙoƙari su bi mutane da suka haɗu da su ta hanyar bincike mai ƙarfi, ƙuntatawa na tafiya, gwaji da keɓewa, amma tare da ƙuntatawa na ƙasa, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya nuna cewa kasashen da suka yi gwajin cutar fiye da adadin mutuwar, suna da ƙananan mutuwar, saboda wataƙila waɗannan ƙasashe sun iya gano marasa lafiya masu ƙarancin ko babu alamun cutar.
WHO ta ba da shawarar cewa ƙasashe waɗanda ba su da ƙarfin gwaji kuma waɗanda ke da ƙarancin ƙwarewar COVID-19 a cikin dakunan gwaje-gwaje na ƙasa, ya kamata a aika da samfuran COVID-19 na farko masu inganci biyar da na farko 10 zuwa ɗaya daga cikin dakunan gwaje-gwaje na 16 na WHO don tabbatar da gwajin.
A cikin dakunan gwaje-gwaje 16, akwai bakwai a Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amurka, ɗaya kuma a Ostiraliya.
"A cikin ginshiƙi na gaba, "kashi nawa na gwaji masu kyau" shafi ne na dokokin gwaji na ƙasar".
Kasashen da ke gwada marasa lafiya kawai a asibiti suna da kashi mafi girma na gwajin fiye da ƙasashen da duk abin da ya kasance daidai, ko da kuwa akwai alamun cutar ko babu.
Wanke hannu (ko wanke hannu), wanda kuma aka sani da tsabtace hannu yana nufin aikin wanke hannuwan mutum don kawar da ƙura, grease, microorganisms, ko wasu abubuwa marasa so.
"Tsaftace hannuwanka a kai a kai da sabulu a wasu ""mafi muhimmanci a lokacin"" na rana yana hana yaduwar cututtuka da dama, misali, zawo da kuma cutar kwalara, wanda ke faruwa ta hanyar fitsari da kuma bakin jini".
Mutane na iya kamuwa da cututtukan numfashi kamar mura ko kuma sanyi, alal misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko kuma baki (watau, mucous membranes).
Abubuwa biyar da suka fi muhimmanci a wanke hannuwanmu da sabulu a rana su ne: kafin da kuma bayan yin fitsari, bayan wankewa da wankewa ko canza wanki, kafin ciyar da yaro, kafin cin abinci, da kuma kafin da kuma bayan wankewa da nama, kifi, ko kaji.
Idan ba a sami ruwa da sabulu ba, ana iya wanke hannu da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin a dafa abinci, a lokacin da ake dafa abinci, da kuma bayan an gama.
Kafin ka kula da marar lafiya da kuma bayan ka yi hakan.
Bayan an canja diaper ko bayan an tsabtace gidan wanka da yaron ya yi amfani da shi.
Bayan ka yi hanci, ka yi tari ko kuma ka yi tari.
Bayan ka taɓa dabba, abincin dabba, ko kuma sharar dabba.
Tsabtace hannu na likita yana nufin ayyukan kiwon lafiya da suka shafi hanyoyin kiwon lafiya.
Wanke hannu kafin a ba da magani ko kula da lafiya na iya hana ko rage yaduwar cuta.
Babban manufar wanke hannu shine a kiyaye hannayenmu daga ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda ke haifar da cuta) da kuma sunadarai masu cutarwa ko waɗanda ke haifar da cuta.
Wannan yana da mahimmanci ga mutanen da ke kula da abinci ko aiki a fannin kiwon lafiya, amma kuma yana da mahimmanci ga jama'a.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, ciki har da rage yaduwar mura, coronavirus da sauran cututtukan da ke yaduwa; hana cututtukan da ke haifar da zawo; rage kamuwa da cututtukan numfashi;
Kuma rage yawan mutuwar jarirai a lokacin haihuwa a gida.
Wani bincike na 2013 ya nuna cewa ingantaccen al'adar wanke hannu na iya haifar da ƙarancin ci gaba a cikin tsayin yara a ƙarƙashin shekaru biyar.
A ƙasashe masu tasowa, ana iya rage mutuwar yara daga cututtukan numfashi da cututtukan da ke tattare da zawo ta hanyar gabatar da sauye-sauye na dabi'a kamar wanke hannu da sabulu.
Wannan tsari na iya rage yawan mutuwar cutar da kusan kashi 50%.
Matakan da aka ɗauka na ƙarfafa wanke hannu na iya rage yawan zawo da kashi ɗaya bisa uku, kuma yana da kwatankwacin samun ruwa mai tsafta a yankunan masu karamin arziki.
Wanke hannu da sabulu yana da alaƙa da raguwar 48% na yawan cututtukan ciki. Wanke hannu da sabulu shine hanya mafi inganci da araha don hana fitsari da cututtukan numfashi (ARI) a duniya ana aiwatar da shi azaman al'ada a cikin gidaje, makarantu da al'ummomi.
Cutar sankarar bargo, wadda babbar ARI ce, ita ce sanadin mutuwar yara 'yan kasa da shekara biyar. Tana kashe yara kimanin miliyan 1.8 a kowace shekara.
Cutar amai da ciwon huhu suna kashe yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, sauyawa zuwa al'adar wanke hannu da sabulu kafin cin abinci da bayan amfani da bayan gida zai iya ceton rayuka fiye da na rigakafi ko kuma na likita, rage mutuwar zawo da kusan rabi, da kuma mutuwar cututtukan numfashi na yau da kullun da kashi ɗaya cikin huɗu.
Ana haɗa wanke hannu tare da sauran tsarin tsabtace jiki a matsayin wani ɓangare na shirye-shiryen Ruwa, Tsabtace Tsabtace Tsabtace (WASH).
Wanke hannu yana karewa daga cututtukan fata (impetigo) waɗanda ke yaduwa ta hanyar hulɗa ta jiki.
Wani sakamako mai illa na wanke hannu shine cewa yawan wanke hannu yana iya haifar da lalacewar fata saboda bushewar fata.
Wani binciken Danish na 2012 ya nuna cewa yawan wanke hannu na iya haifar da itching, fata-fitar da fata wanda ake kira hand eczema ko kuma dermatitis na hannu, wanda ya zama ruwan dare musamman tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa yana iya zama alamar cutar OCD.
Hanyoyi guda biyar na yau da kullum da ya kamata a wanke hannuwanku da sabulu don rage kamuwa da cututtukan hanji da na ciki sune: bayan amfani da gidan wanka (gajiya, fitsari), bayan wankewa ko canza wanki, kafin ciyar da yaro, kafin cin abinci, da kuma kafin / bayan dafa abinci ko taɓa naman alade, kifi, ko kaji.
Sauran lokutan da ya kamata a yi amfani da dabarun wanke hannu da suka dace don hana kamuwa da cuta sun haɗa da kafin da kuma bayan jiyya na ciwo ko rauni; bayan yin tari, tari, ko hanci; bayan taɓa ɓarnar dabba ko motsa dabba; da bayan taɓa shara.
A ƙasashe da yawa, ba a wanke hannaye da sabulu sosai ba.
Wani binciken da aka yi a shekarar 2015 ya nuna cewa a kasashe 54 ne ake wanke hannu, a kan matsakaita, kashi 38.7% na iyalai suna wanke hannu da sabulu. Wani bincike da aka yi a shekarar 2014 ya nuna cewa Saudi Arabiya ce ke da kashi 97 cikin dari, inda ta fi kowacce a duniya; Amurka tana da kashi 77 cikin dari; kuma China ce ke da kashi 23 cikin dari.
"Shirin kula da lafiya na musamman da sashen ilimi na Philippines ke gudanarwa misali ne na yadda ake samun isasshen matakan inganta kiwon lafiya da ilimi ga yara".
Babban abin da wannan shirin ya kunsa shi ne a yi musu maganin kashe ƙwayoyin cuta sau biyu a shekara, tare da wanke hannayensu da sabulu a kowace rana, da kuma wanke haƙoransu da fluoride a kowace rana.
An yi nasara a Indonesia.
Safa da ruwa suna sa mu kawar da kwayoyin cuta daga fata.
Babban aikin sabulu da na'urar wankewa shine rage shingen maganin da kuma kara narkewa.
Ruwa kawai ba shi da amfani wajen tsabtace fata domin kitse da furotin, waɗanda su ne abubuwan da ke cikin ƙasa, ba sa narkewa cikin ruwa.
Ana yin wanka ne ta hanyar ruwa mai yawa.
Sabulu mai narkewa, saboda yanayin sake amfani da shi, na iya riƙe kwayoyin cuta daga amfani da suka gabata.
Ƙananan nazarin da suka yi niyya ga ƙwayar cuta daga sabulu mai ƙazanta sun kammala cewa ba za a iya samun sauyi ba saboda ana wanke kwayoyin tare da kumfa.
"Har yanzu CDC ta ce ""ana bada shawarar yin amfani da sabulu mai ruwa wanda za a iya sarrafawa ba tare da amfani da hannu ba"."
An yi wa jama'a da ke da masaniya game da maganin rigakafi sabulu.
Babu wata hujja da ta nuna cewa ana amfani da maganin kashe ƙwayoyin cuta ko kuma maganin kashe ƙwayoyin cuta ga kwayoyin da suka saba da maganin rigakafi.
Amma sabulu na rigakafi yana da kayan rigakafi na yau da kullun kamar Trichlosan, wanda ke da ƙarfin hana kwayoyin cutar a cikin babban adadin.
Saboda haka, ko da yake ba a zaɓi ƙwayoyin cuta masu ƙin maganin rigakafi don sabulu na rigakafi ba, ƙila ba su da tasiri kamar yadda ake tallatawa.
Baya ga abubuwan da ke tattare da kayan shafawa da kuma kare fata, shirye-shiryen da aka ƙera na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid), antibacterially active benzoic acid, da ƙarin masu sanyaya fata (alovera, bitamin, methanol, tsire-tsire na shuka) a matsayin masu daidaita pH. Wani cikakken bincike na Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun kamar su Trakhlovan sun hada da sabulun anti-bacterial don hana cututtuka da cire kwayoyin cuta daga hannu.
Ruwa mai zafi mai sanyaya don wanke hannu ba ya da isasshen zafi don kashe kwayoyin cuta.
Kwayar cuta tana girma da sauri a zafin jiki (37 °C).
Amma ruwan zafi da sabulu sun fi ruwan sanyi da sabulu tasiri wajen kawar da man da ke riƙe ƙasa da ƙwayoyin cuta.
Amma, akasin abin da ake tsammani, binciken kimiyya ya nuna cewa ruwan dumi ba shi da tasiri a kan rage nauyin kwayoyin halittar hannu.
Wani kayan aikin wanke hannu wanda ba shi da ruwa ko kuma maganin kashe wuka wanda ba shi da ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, kayan aikin tsabtace hannu na giya (wanda aka fi sani da tushen giya, antiseptic hand rub, ko kuma hand sanitizer) sun fara samun shahara.
Don sauƙin amfani da rage tasirin busar da giya, an yi galibi ne bisa isopropyl alcohol ko ethanol wanda aka shirya tare da carbomer (polymer na acrylic acid) ko humicant kamar su ruwa ko kuma a cikin kumfa tare da kayan kauri kamar glycerin.
Haɗa hydrogen-peroxide mai haɗuwa yana ƙara haɓaka ayyukan antimicrobial. Hannun tsabtace hannu yana da ƙarancin 60 zuwa 95% na giya wanda ke da tasiri wajen kashe ƙwayoyin cuta.
Maganin tsabtace giya yana kashe kwayoyin cuta, kwayoyin cuta masu tsayayyar magani (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccina, influenza da hepatitis) da fungi.
Maganin tsabtace giya yana da kashi 70% na giya wanda ke kashe kashi 99.97% (3.5 log raguwa, daidai da rage 35 decibels) bayan aikace-aikacen hannu na dakika 30, kuma yana kashe kashi 99.99% zuwa 99.999% (4 zuwa 5 log raguwa) na kwayoyin cuta bayan aikace-aikacen minti 1 a hannu.
Maganin tsabtace hannu na barasa ba shi da tasiri sosai a kan cutar Norovirus (ko Norvac) - wanda shine mafi yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut
Rub da ruwa, kumfa ko gel a gaban da baya na hannaye biyu da tsakanin yatsun hannu da ƙarshen yatsun hannu na kimanin dakika 30 har sai ya bushe.
Cibiyar Kula da Cututtuka da Rigakafin Amurka ta ba da shawarar wanke hannu sosai tare da takunkumin tsabtace hannu, musamman idan hannu ya kasance datti.
Amfani da waɗannan abubuwa yana ƙaruwa ne saboda sauƙin amfani da su da kuma saurin kashe kwayoyin cuta; kodayake bai kamata a yi amfani da su a matsayin maye gurbin wanke hannu ba idan sabulu da ruwa ba su da wadata.
Idan ba a haɗa emollient da / ko moisturizer na fata a cikin tsari ba, yawan amfani da magungunan tsabtace hannu na tushen giya na iya haifar da bushewar fata.
Ana iya rage ko kawar da tasirin busar da giya ta hanyar ƙara glycerin da / ko wasu lotions a cikin tsari.
A cikin gwaji na asibiti, masu tsabtace hannu na tushen giya tare da kayan shafawa sun haifar da ƙarancin damuwa da bushewa fiye da sabulu ko kayan tsabtace ƙwayoyin cuta.
Rashin jin daɗi ga giya ko abubuwan da ke cikin giya ba safai ake samun su a hannun giya.
An gano cewa rashin saurin kamuwa da cutar ta farfajiyar taɓawa ya zama abin jan hankali idan aka kwatanta da wanke hannu da sabulu da ruwa.
Duk da ingancin su, kayan da ba su da ruwa ba sa tsabtace kwayoyin hannu, amma suna kashe ƙwayoyin cuta ne kawai.
Saboda ƙwayoyin cuta suna nan a hannu, sabulu da ruwa ba su da tasiri sosai wajen hana yaduwar ƙwayoyin cuta.
Ingancin sinadarin tsabtace hannu na ba da barasa ya dogara da kayan aiki da kuma shirye-shirye, kuma ya yi aiki sosai fiye da na giya da na giya a baya.
Kwanan nan, an gano cewa shirye-shiryen da ke amfani da benzalkonium chloride suna riƙe da aiki mai ƙarfi da ƙwayoyin cuta mai ƙarfi ba kamar na giya ba, wanda ke iya rage tasiri bayan maimaita amfani saboda yanayin cutar fata mai ci gaba.
A cikin al'ummomin da ke da karancin albashi, mutane da yawa ba su da kuɗin sabulu, kuma suna amfani da toka ko ƙasa.
Ash ko ƙasa na iya zama mafi inganci fiye da ruwa kawai amma ba su da tasiri fiye da sabulu.
Wani abin damuwa shi ne, idan aka gurɓata ƙasa ko toka da ƙwayoyin cuta, hakan zai iya ƙara yaduwar cuta maimakon ragewa.
Ash, kamar sabulu, yana da ƙwayoyin cuta domin yana samar da ruwan alkaline idan ya shiga ruwa.
Idan sabulu bai samu ba, WHO ta bada shawarar ash ko yashi a matsayin madadin sabulu.
Daidai hanyoyin wanke hannu da Cibiyoyin Kula da Cututtuka na Amurka suka ba da shawarar don hana kamuwa da cuta sun haɗa da waɗannan matakan:
Ka yi wanka a cikin ruwan zafi ko ruwan sanyi.
Ana ba da shawarar ruwa saboda ƙazantar da tafkin na iya zama, amma yanayin ruwan ba ya nuna bambanci.
Ka shafa sabulu mai yawa a bayan hannunka, tsakanin yatsanka da kuma ƙarƙashin ƙusa.
Sabulu yana cire kwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu da kyau idan suka yi amfani da sabulu maimakon ruwa kawai.
Ka shafe akalla dakika 20.
Ana samun karkacewa a lokacin da ake gogewa, wanda ke kawar da kwayoyin cuta daga fata, kuma idan aka shafe tsawon lokaci ana cire ƙarin kwayoyin cuta.
Ka wanke shi sosai a cikin ruwa.
Idan mutum ya wanke wanka a cikin kwandon, zai iya sake gurɓata hannunsa.
Ka bushe da tawul mai tsabta ko kuma ka bar shi ya bushe.
Hannun da suka yi sanyi da kuma rigar suna da sauƙin sake gurɓata. Wuraren da aka fi watsi da su sune yatsun hannu, wuyan hannu, tsakanin yatsun hannu da kuma ƙusa.
Na'urar safa da kuma goge ƙusa na iya kare ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da man shafawa don hana hannaye bushewa; bushewar fata na iya cutar da fata wanda zai iya kara hadarin yaduwar kamuwa da cuta.
"A cikin ƙasashe masu tasowa inda babu ruwan famfo da / ko sabulu, za a iya samar da wasu zaɓuɓɓuka masu arha don sauƙaƙe wanke hannu, misali ta hanyar zuba ruwa daga rataye mai rataye ko layin da ke da rami mai dacewa da / ko amfani da toka idan ya cancanta. A cikin yanayin da ke da iyakancewar samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin adana ruwa kamar ""TP-tap"" da sauran zaɓuɓɓuka masu arha".
Tippi-tap wani fasaha ne mai sauki wanda ke amfani da juji da aka ɗora ta igiya da hanci mai motsa jiki da kuma sabulu don zuba ruwa a hannunka.
Goge hannu da kyau wani muhimmin bangare ne na aikin tsabtace hannu, amma akwai takaddama game da yadda za a bushe hannu a cikin gidan wanka.
Karin bincike ya nuna cewa tawul din takarda ya fi na lantarki da ake amfani da shi a wanka da yawa.
Wani bincike da aka gudanar a 2008 wanda masana'antar masana'antar takarda ta Turai ta samar da shi kuma Jami'ar Westminster ta gudanar da shi, don kwatanta matakan tsabtace jiki da takarda ta samar, mai bushewar iska mai zafi da kuma na zamani na jet-air.
Bayan wanke hannu da bushewa da na'urar busar iska, adadin kwayoyin sun karu da kashi 194 cikin dari a yatsun hannu da 254 cikin dari a tafin hannu.
Drying tare da jet-air dryer yana ƙara yawan kwayoyin cuta a yatsun hannu da kashi 42% da 15% a kan hannu.
Bayan wanke hannu tare da tawul ɗin takarda, an sami raguwar kwayoyin cuta a yatsun hannu har zuwa 76% kuma a kan tawul din hannu har zuwa 77% na duka. Masana kimiyya sun kuma gwada don tabbatar da yiwuwar yaduwar gurɓataccen gurɓataccen wuri daga sauran masu amfani da gidan wanka da yanayin gidan wanka sakamakon kowane irin bushewa.
Jirgin jirgi-jirgin da ke fitar da iska a cikin saurin 180 m / s (650 km / h; 400 mph) ya iya hura kwayoyin cuta daga hannu da na'urar da kuma kawar da gurbataccen gurbatawa na masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2.
Yin amfani da na'urar bushe hannu mai iska mai zafi yana watsa kwayoyin halitta har zuwa nisan mita 0.25 daga na'urar bushewa.
Takarda tawul bai nuna wani gagarumin yaduwar micro-kwakwalwa ba. A cikin 2005 wani bincike da aka gudanar da TÜV Produkt und Umwelt (TÜV Produkt und Umwelt) ya tantance hanyoyin bushe hannu daban-daban.
An lura da canje-canje masu zuwa a yawan kwayoyin bayan bushe hannu:
Akwai masana'antun bushe-bushe da yawa, kuma an kwatanta bushe-bushe da bushewa da tawul.
Yin amfani da wanke hannu a matsayin madadin wanke hannu ne saboda rashin sabulu da ruwa yayin tafiya.
Alcohol-based hand sanitizer yana da aƙalla kashi 60% na giya.
Wanke hannu a asibiti ya zama wajibi ne bayan da likitan Hungary Ignaz Semmelweis ya gano tasirin wanke hannu a cikin asibiti (a 1846).
Akwai na'urorin lantarki da ke ba da amsa don tunatar da ma'aikatan asibiti idan sun manta da wanke hannayensu.
Wani bincike ya nuna cewa amfani da su ya rage yawan kamuwa da cuta.
Wanke hannu na likita yana da kyau a yi shi na aƙalla dakika 15 kuma a shafa kowane ɓangaren hannu da isasshen sabulu da ruwa ko gel.
Ya kamata a haɗa yatsunsu tare kuma a shafa hannayensu tare.
Idan akwai datti a ƙarƙashin ƙusa, ana iya amfani da goga na bristle don cire shi.
Tun da yake ƙwayoyin cuta suna iya zama a cikin ruwan hannu, yana da muhimmanci a wanke kumfa sosai kuma a bushe shi da tawul mai tsabta.
Bayan bushewa, ya kamata a rufe bututun ruwa da tawul na takarda (kuma a buɗe wata ƙofa don fita idan ya cancanta).
Wannan zai hana hannayenku daga sake gurɓata su.
"Manufar wanke hannu a cikin yanayin kiwon lafiya ita ce kawar da kwayoyin cuta ("kwayoyin cuta") da kuma guje wa yaduwarsu".
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu ya zama abin ƙyama a yawancin yanayin kiwon lafiya, tare da yawancin likitoci da ma'aikatan jinya da ke manta da wanke hannu a kai a kai kafin su taɓa marasa lafiya, wanda ke haifar da kamuwa da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu hanyoyin da za a bi don rage yawan kamuwa da cutar catheter, zai iya rage yawan kamuwa da cutar ta kashi 66 cikin dari. Hukumar Lafiya ta Duniya ta fitar da takarda da ke nuna yadda ake wanke hannu da kuma shafa hannu a bangaren kiwon lafiya.
Za a iya samun shawarwari daga jama'a a kan tsarin kula da tsabtace hannu na kungiyar a shafin yanar gizon ta.
Wani bita mai dacewa da Whitby da sauransu suka gudanar.
Na'urorin kasuwanci na iya auna da kuma tabbatar da tsabtace hannu idan ana buƙatar tabbatar da bin ƙa'idodi.
"Kungiyar Lafiya ta Duniya tana da ""lokaci biyar"" don wanke hannu:
Bayan sun shiga jini ko ruwa na jiki
Kafin a yi aikin kawar da ƙwayoyin cuta, kuma
"Bayan kulawar mai haƙuri. Ƙara sinadarai masu maganin antiseptic a cikin sabulu ("sabulu mai "magani" ko ""antimicrobial"") yana ba da ikon lalata kayan wanke hannu".
Ana iya yin wannan aikin kafin tiyata ko kuma a wuraren da ke da kwayar cutar. Don yin tiyata, yana da mahimmanci a sami maɓallin 'scrub' wanda za'a iya kunnawa da kashewa ba tare da taɓa hannu ba, wanke wasu chlorhexidine ko iodine, wanke hannu bayan wanka, da kuma wankewa da sauran kayan aikin tsabtace ƙwayoyin cuta.
Dole ne a buɗe dukan kayan ado.
Wannan tsari yakan bukaci wanke hannu da kuma gwiwoyi na tsawon minti 2-6.
Ba a buƙatar shafa hannu na dogon lokaci (minti 10).
A lokacin wanka, dole ne a hana ruwa daga hannun hannu zuwa kwatangwalo daga sake zubewa zuwa tafin hannu.
Bayan wanke hannu, ana bushe hannu da kayan tsabta kuma ana sanya rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan kula da mai cutar.
Don sarrafa kamuwa da Staphylococcus a asibiti, an gano cewa mafi yawan amfanin wanke hannu ya kasance daga farkon 20% na wankewa, kuma an sami ƙarin fa'ida kaɗan lokacin da aka ƙara maimaita wanke hannu sama da 35%.
Yin wanka da sabulu na yau da kullun ya haifar da kamuwa da cuta ta hanyar abinci sau uku fiye da wankewa da sabulu mai hana ƙwayoyin cuta. Idan aka kwatanta wanke hannu da sabulu mai hana ƙwayoyin cuta na matsakaiciyar tsawon dakika 30, tare da wanke hannu tare da maganin tushen giya, kowannensu ya nuna cewa shafa hannu a cikin giya ya rage gurɓataccen ƙwayoyin cuta da kashi 26% fiye da sabulu mai hana ƙwayoyin cuta.
Duk da haka, sabulu da ruwa sun fi tasiri fiye da safa hannu na barasa don rage kwayar cutar H1N1 Influenza A da Clostridium difficile daga hannaye. Abubuwan da zasu iya haɗawa da tsabtace hannu a cikin yanayin kiwon lafiya na iya haɗawa da ilmantarwa ga ma'aikata, da kuma rubuce-rubuce da tunatarwa na ma'aikata game da sauƙin samun safa hannu na barasa.
Ana bukatar ƙarin bincike kan waɗanne daga cikin waɗannan hanyoyin ne suka fi dacewa a yanayin kiwon lafiya daban-daban.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu a matsayin hanya mai amfani da kuma muhimmiyar hanya ta samun lafiya, har ma da abinci mai gina jiki.
Duk da haka, rashin ingantaccen ruwa, sabulu ko kayan wanke hannu a gida, makaranta da wurin aiki na haifar da ƙalubale ga samun daidaitaccen wanke hannu.
Misali, yawancin yankunan karkara na Afirka suna da hanyoyin da ba su da tsada don samar da wuraren wanke hannu, amma babu ruwan wanke hannu kusa da kowane gidan wanka na sirri ko na jama'a.
Amma rashin wanke hannu na iya zama saboda yawan yin wanka da yawa maimakon rashin sabulu ko ruwa.
Tallafawa da shawarwari game da wanke hannu da sabulu na iya tasiri kan yanke shawara na manufofi, haɓaka wayar da kan jama'a game da fa'idodin wanke hannu, da kuma haifar da sauya halaye na dogon lokaci.
Don ya yi aiki yadda ya kamata, ana bukatar a kula da shi kuma a kimanta shi.
"Binciken da aka yi a kan nazarin 70 ya nuna cewa hanyoyin da ake bi a cikin al'umma suna da tasiri wajen wanke hannu a LMIC, yayin da kamfen ɗin tallatawa na zamantakewa ba shi da tasiri. Misali na tallata wanke hannu a makarantu shine "tauraron taurari uku" na UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi, masu tsada don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu a tsakanin sauran bukatun kiwon lafiya".
Idan aka cimma matsakaicin matsakaicin, makarantu za su iya kaiwa taurari uku daga ɗaya zuwa ƙarshe.
Kafa tashoshin wanke hannu na iya zama wani ɓangare na tallafin wanke hannu da aka yi don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a wanda ke ƙoƙarin canza halaye. A sakamakon annobar cutar coronavirus ta 2019-20, UNICEF ta inganta fahimtar emojis na wanke hannu.
DALYs sun yi la'akari da yawan binciken da aka yi game da rage farashin wanke hannu a ƙasashe masu tasowa.
Amma wani bita ya nuna cewa wanke hannu da sabulu ya fi sauran hanyoyin ruwa da tsaftacewa tsada.
"Mahimmancin wanke hannu ga lafiyar ɗan adam - musamman ga mutanen da ke cikin yanayi mai rauni, kamar uwaye a asibiti waɗanda suka haifi jarirai ko sojoji da suka ji rauni - an gane shi a tsakiyar karni na 19 da farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon farkon
Har zuwa wannan lokacin, yawancin mutane sun yi imanin cewa cutar ta samo asali ne daga wani ƙanshi mai ƙanshi da ake kira miyasmos.
A cikin shekarun 1980, barkewar cututtukan abinci da kuma kamuwa da cuta da ke da alaƙa da kiwon lafiya ya sa Cibiyoyin Kula da Cututtuka da Cututtuka da Cibiyoyin Kula da Cututtuka su inganta ingantaccen tsabtace hannu a matsayin hanya mai mahimmanci don hana yaduwar kamuwa da cuta.
Barkewar mura a shekarar 2009 da kuma annobar COVID-19 a shekarar 2020, ya sa kasashen da dama suka kara fahimtar muhimmancin wanke hannu da sabulu wajen kare kansu daga irin wannan cuta.
"A Jamus, alal misali, an saka takardu da ke nuna ""daidaitaccen hanyoyin wanke hannu"" a bayan gidajen bayan gida na jama'a da kuma kusa da bututun wanke hannu a gine-ginen ofis da kuma a wuraren wanka na filin jirgin sama".
"Wannan furcin "ɓoye hannu" yana nufin ƙin yarda da alhakin abin da ya faru ko kuma kasancewa da hannu cikin mugunta".
Ya samo asali ne daga nassi na Littafi Mai-Tsarki na Matiyu inda Pontius Pilate ya dakatar da hukuncin gicciye Yesu Kristi, amma ya zama sanannen magana ta hanyar amfani da shi a cikin wasu al'ummomin Ingilishi.
A Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta don kawar da ɓarna na ƙage ta hanyar nuna laifinta da kuma sa mijinta ya aikata laifi.
An kuma gano cewa mutane, idan suna tunanin ko kuma tunanin yin lalata, suna da sha'awar wanke hannu fiye da sauran mutane kuma suna da sha'awar sanya kayan wanke hannu sama da kima.
"Bugu da kari, waɗanda aka wanke hannayensu bayan irin wannan niyya ba su da saurin shiga cikin wasu ayyukan "tsabtace" na biyan diyya kamar yadda masu sa kai suke yi".
Addinai suna ba da umarnin wanke hannu don dalilai na kiwon lafiya da na alama. Wanke hannu na alama, amfani da ruwa / ruwa don wanke hannu amma ba sabulu ba, wani ɓangare ne na al'adun addini na wanke hannu wanda ke nuna yawancin addinai, gami da Baha'i, Hindu, Tewilah da Netilat Yadaim a addinin Yahudanci, Lavobo a cikin Kristanci da Ozu a cikin Musulunci. Addinai suna ba da umarnin wanke hannu mai kyau bayan yin wasu ayyuka.
A addinin Hindu, Yahudanci da Musulunci wanke hannu bayan amfani da bayan gida yana da muhimmanci.
Kuma, wanke hannu kafin da kuma bayan kowane abinci wajibi ne a addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci.
Gudanar da haɗarin aiki don COVID-19
Kula da haɗarin aiki don COVID-19 shine aiwatar da hanyoyin lafiya da kiwon lafiya na aiki don sarrafa haɗarin don hana cutar coronavirus na 2019 (COVID-19).
Kulawa mai kyau na haɗari a wurin aiki ya dogara da wurin aiki da aikin da ake yi, da kimanta haɗarin tushen haɗari, tsananin cutar a cikin al'umma, da kuma abubuwan haɗarin ma'aikata na musamman waɗanda ke da haɗarin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da ƙananan haɗari suna ɗaukar mafi ƙarancin aiki tare da jama'a da sauran abokan aiki, wanda ke ba da shawarar matakan hana kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ladabi na numfashi, da tsabtace aiki na yau da kullun da kuma tsabtace yanayin aiki.
Ayyukan da ke da matsakaicin haɗarin haɗari sun haɗa da ayyukan da ba a san ko ana zargin cewa akwai COVID-19 ba, amma wuraren kasuwancin suna buƙatar haɗuwa sosai ko kusanci da mutanen da ke iya kamuwa da cutar saboda cutar da ke yaduwa a cikin jama'a ko kuma tafiya ta duniya.
Wannan ya haɗa da ma'aikata da suke da alaƙa da jama'a, kamar su makarantu, wuraren aiki masu yawan jama'a, da kuma wuraren sayar da kayayyaki masu yawan jama'a.
Baya ga matakan rigakafin farko, tsarin kula da haɗari ga wannan rukunin ya haɗa da samun iska mai ƙarfi ta amfani da matattarar iska, masu tsaron sneez, da kuma samar da kayan kariya na mutum lokacin da suka fuskanci mutumin da ke da cutar COVID-19.
OSHA ta ce ma'aikatan kiwon lafiya da ma'aikatan jana'iza suna da haɗarin haɗuwa da waɗanda ke da tabbacin ko kuma waɗanda ake zargi da cutar COVID-19. Wannan haɗarin ya ƙaru idan ma'aikatan sun yi amfani da hanyoyin samar da aerosol ko kuma sun tattara ko kuma sarrafa samfuran waɗanda ke da tabbacin ko kuma waɗanda ake zargi da cutar COVID-19.
Hanyoyin da za a iya amfani da su wajen hana haɗari ga ma'aikata sun haɗa da sarrafa injiniya kamar su ɗakunan iska masu matsin lamba, da kuma kayan kariya na mutum da suka dace da aikin.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya yin rashin aiki saboda rashin lafiya, don kula da wasu, ko kuma don tsoron haɗuwa.
Abubuwan da ake buƙata da kuma hanyar da ake sayen waɗannan kayayyakin (kamar sayayya a lokacin da ba a cika aiki ba ko ta hanyar isarwa ko sabis na tuki-ta hanyar (saya ba tare da sauka daga mota ba), duka suna iya canza yanayin kasuwanci.
A ƙarshe, jigilar kaya daga yankuna masu tasirin COVID-19 na iya zama mai rikitarwa. Za'a iya amfani da shirin shiri da amsa cutar mai yaduwa don jagorantar matakan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da wuraren aiki da ayyuka daban-daban, gami da tushen haɗari, abubuwan haɗari daga gida da kuma al'umma, da abubuwan haɗarin mutum na ma'aikata kamar tsufa ko cututtukan likita na yau da kullun.
Sun kuma bayyana matakan da ake buƙata don magance waɗannan haɗarin da kuma shirye-shiryen da za a iya yi don yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye-shiryen cututtukan cututtuka da shirye-shiryen amsawa na iya zama batun shawarwarin ƙasa ko na ƙasa.
Manufofin amsawa ga barkewar cutar sun haɗa da rage kamuwa da cuta a cikin ma'aikata, kare mutanen da ke cikin haɗarin haɗarin haɗarin rashin lafiya, kiyaye ayyukan kasuwanci, da rage tasirin tasirin su ga sauran ƙungiyoyi a cikin sarkar samar da su.
Matsayin cutar a cikin al'umma inda kasuwancin yake yana shafar yadda ake amsawa.
Tsarin tsari na kula da haɗari tsari ne da aka yi amfani da shi sosai wajen kula da lafiyar sana'a da lafiya.
Inda ba za a iya kawar da haɗarin COVID-19 ba, mafi ingantattun matakan sarrafawa sune sarrafa injiniya, sannan sarrafawa, kuma a ƙarshe kayan kariya na mutum.
Gudanarwa na injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikata ba, kuma yana iya zama mafi kyawun mafita don aiwatarwa.
Dokokin gudanarwa su ne canje-canje a manufofin aiki ko hanyoyin da ke bukatar aiki daga ma'aikaci ko mai aiki.
Kayan kariya na mutum (PPE) ana ganin ba su da tasiri fiye da na injiniya da na gudanarwa, amma yana iya taimakawa wajen hana wasu fallasa.
Za a zaɓi duk PPE bisa ga haɗarin ma'aikaci, a dace da shi yadda ya dace (kamar masu numfashi), a ci gaba da sawa yadda ya kamata, a bincika, a kula da kuma maye gurbinsa a kai a kai, kuma a buɗe shi, a tsabtace shi, kuma a adana shi ko a watsar da shi don kauce wa gurɓata.
Aikin da ke da ƙananan haɗari na haɗari yana da iyakancewar haɗuwa da jama'a da sauran abokan aiki, in ji Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA).
Matakan rigakafin kamuwa da cuta da aka ba da shawarar ga duk wuraren aiki sun haɗa da wanke hannu da kyau da kuma sau da yawa, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, samar da ladabi na numfashi, gami da rufe fuska yayin tari da tari, samar da kayan aiki da kwandon shara, kasancewa a shirye don sadarwa ta waya ko sauyawa a wasu lokuta na rana idan ya cancanta, hana ma'aikata amfani da kayan aikin wasu, da kiyaye tsabtace yanayi da tsabtace yanayi.
Mataki na farko da ya kamata a ɗauka don kiyaye ma'aikata, abokan ciniki, masu neman aiki da sauran mutane a wuraren aiki shine ganowa da ware mutanen da ke da cutar.
Ma'aikatan da ke da alamun cututtukan numfashi na yau da kullun, Cibiyoyin Kula da Cututtuka da Rigakafi na Amurka suna ba da shawarar su zauna a gida har sai sun sami nutsuwa daga zazzabi, alamun zazzabi, da sauran alamun cutar aƙalla awanni 24 ba tare da amfani da magungunan rage zazzabi ko wasu magungunan canza alamun ba, kuma ya kamata a sassauta manufofin hutun rashin lafiya, wanda ke ba ma'aikata damar zama a gida don kula da wani dangin da ke rashin lafiya, kuma ma'aikata su san waɗannan manufofin.
A cewar OSHA, ayyukan da ke da matsakaicin haɗarin haɗari sun haɗa da ayyukan da ba a san ko ana zargin cewa akwai COVID-19 ba, amma yana buƙatar haɗuwa ta kai tsaye ko kusa da mutane waɗanda ke da cutar SARS-CoV-2 a tsakanin ƙafa shida (1.8 m) saboda cutar da ke yaduwa a cikin jama'a a wuraren kasuwanci ko kuma tafiya ta duniya kwanan nan zuwa wani wuri inda COVID-19 ya yadu.
Ayyukan sarrafawa na ma'aikata da ke da alaƙa da jama'a sun haɗa da ƙarfafa marasa lafiya su kasance a gida, maye gurbin hulɗa ta fuska da fuska ta hanyar na'urori na kama-da-wane, gabatar da sauye-sauye na musamman don COVID-19, samar da matakan kiyayewa na yau da kullun a wuraren aiki, ba da horo ga ma'aikata game da yanayin da ke tattare da COVID-19, hana su yin amfani da kayan aiki na yau da kullun, ba da horo ga ma'aikata da kuma masu amfani da wuraren aiki, ba da horo ga masu amfani da wuraren aiki game da yadda za su iya dogara da yanayin da ke tattare da COVID-19, da kuma yadda za a magance matsalolin COVID-19, da kuma samar da wasu hanyoyin kiyayewa na yau da kullun ga ma'aikata da kuma ma'aikatan da ke amfani da kayan aikin kiyayewa na yau da kullun, da kuma samar da horo ga masu amfani da wuraren aiki game da yadda za su iya magance COVID-19.
A wasu lokuta, ma'aikatan da ke cikin wannan rukunin haɗarin suna buƙatar yin amfani da na'urar numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da ware mutum mai rashin lafiya daga sauran mutane a nisan ƙafa 6, sanya wani memba na ma'aikata don kula da mutumin da ke fama da rashin lafiya, da kuma ba wa mutumin da ke fama da rashin lafiya abin rufe fuska ko kuma ya nemi mutumin da ke fama da rashin lafiya ya rufe bakinsa da hanci da nama yayin hancinsa ko tari.
Ya kamata ma'aikatan jirgin su sanya safofin hannu na likita lokacin amsa kiran matafiyi mara lafiya ko kuma lokacin da suka taɓa ruwan jiki ko ɓangarorin da ke iya gurɓata su, kuma ya kamata su yi amfani da ƙarin kayan kariya na sirri idan matafiyin mara lafiya yana da zazzabi, ciwon tari ko numfashi.
Ya kamata a zubar da safofin hannu da sauran abubuwan zubarwa a cikin jakar haɗarin halittu, sannan a tsabtace da kuma tsabtace wuraren da ke da gurɓataccen abu. Don jiragen ruwa na kasuwanci, ciki har da jiragen ruwa da sauran jiragen ruwa, matakan haɗari sun haɗa da jinkirta tafiya mara lafiya, ware kanka, da kuma sanar da cibiyar kiwon lafiya ta jirgin idan wani ya nuna zazzabi ko wasu alamun bayyanar cututtuka yayin da yake cikin jirgin.
A matsayin manufa, ya kamata a bi da lafiyar a cikin ɗakin da aka keɓe. A cikin makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace ko kuma kashe ƙwayoyin cuta idan wani mai cutar ya shiga cikin ginin makaranta, ba tare da la'akari da yadda cutar ke yaduwa a cikin jama'a ba.
Lokacin da cutar ta yi kadan zuwa matsakaici a cikin al'umma, ana iya aiwatar da dabarun nisantar zamantakewa, kamar soke tafiye-tafiye na filin, tarurruka da sauran manyan tarurruka, kamar karatun motsa jiki ko cin abinci a cikin cafeteria; ƙara tazarar tsakanin tebur, raba lokutan zuwa ofis da hutu, iyakance baƙi marasa mahimmanci, da amfani da keɓaɓɓiyar ofishin kiwon lafiya don yara masu alamun cutar mura.
Lokacin da cutar ta yadu a cikin al'ummomin gida, ana iya yin la'akari da ƙarin ɓarna a cikin makarantu don dabarun nisantar zamantakewa. CDC ta ɗauki haɗarin rashin lafiyar ma'aikatan tilasta bin doka waɗanda ke gudanar da ayyukan yau da kullun a matsayin ƙasa.
Jami'an tilasta bin doka waɗanda ke da alaƙa da mutanen da ke da tabbataccen ko ake zargin suna da COVID-19 ana ba da shawara su bi ƙa'idodin da ake ba da su ga masu fasahar likita na gaggawa, gami da kayan kariya na sirri.
Idan ma'aikata sun yi hulɗa ta kusa a lokacin da ake da damuwa, ya kamata a tsabtace su da kuma kashe kayan aikin su ta hanyar amfani da mai tsabtace gida ko shafawa kafin a sake amfani da su, kuma a bi hanyoyin sarrafa shaida don sarrafawa da kuma kawar da PPE da aka yi amfani da su.
OSHA ta sanya wasu ma'aikatan kiwon lafiya da na mutuwa a cikin manyan ko kuma masu haɗarin haɗari.
Ayyukan haɗarin haɗari sun haɗa da samar da kiwon lafiya, tallafi, ma'aikatan dakin gwaje-gwaje da ma'aikatan jigilar likita waɗanda suka haɗu da marasa lafiya waɗanda aka sani ko ake zargin suna da COVID-19.
Idan ma'aikata suna aiwatar da hanyoyin samar da aerosol, ko tattara ko motsa samfuran daga marasa lafiya da aka sani ko ake zargi da COVID-19, suna da babban haɗarin haɗuwa.
Hanyoyin samar da aerosol sun hada da shigar da bututu, hanyoyin fara coughing, bronchoscopy, wasu hanyoyin hakori da kuma daukar samfur ta hanyar shigar da gwaji ko kayan aiki.
Ayyukan haɗarin haɗari, haɗarin mutuwa sun haɗa da ma'aikatan da ke aiki a kan shirya gawawwakin mutanen da aka san ko ake zargin suna da COVID-19 a lokacin mutuwar; wannan ya zama haɗarin haɗari sosai idan sun yi autopsy. Ƙarin sarrafawar injiniya ga mutanen da ke cikin wannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don waɗanda aka san ko ake zargin suna da COVID-19, gami da lokacin da ake aiwatar da hanyoyin samar da aerosol.
Ana iya amfani da iska mai matsi mai matsi mai matsi a wasu wuraren kiwon lafiya da kuma wuraren shakatawa.
Ya kamata a kula da samfurori bisa matakin tsaro na 3 na biosafety.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar ware masu zuwa a cikin yankunan jira na musamman bisa la'akari da ko ana zargin suna da COVID-19. OSHA ta ba da shawarar respirators ban da sauran PPE ga mutanen da aka sani ko ake zargin suna da SARS-CoV-2 a cikin ƙafa 6 na aiki da kuma mutanen da ke aiwatar da hanyoyin samar da aerosol.
A cikin Amurka, N95 ko ingantaccen mai numfashi na numfashi na NOSH dole ne a yi amfani da shi a cikin tsarin ingantaccen tsarin kiyaye numfashi, wanda ya haɗa da gwajin lafiya, horo da gwaji na likita.
Sauran nau'ikan masu numfashi na iya samar da ƙarin kariya da haɓaka kwanciyar hankali ga ma'aikata. WHO ba ta ba da shawarar ɗaukar hoto ba, saboda COVID-19 ba ya yaduwa ta hanyar ruwan jiki, amma cutar ne ta numfashi.
WHO ta ba da shawarar sanya abin rufe fuska na tiyata ga ma'aikatan tantancewa a ƙofar shiga kawai.
WHO ta ba da shawarar sanya abin rufe fuska, tabarau, ko garkuwa, tufafi da safar hannu ga waɗanda ke tattara, kula ko jigilar samfuran numfashi daga marasa lafiya na COVID-19 ba tare da wata hanyar samar da aerosol ba.
Idan an yi aikin samar da aerosol, ana maye gurbin abin rufe fuska tare da N95 ko FFP2 respirator.
Ganin cewa samar da PPE bai isa ba a duniya, WHO ta ba da shawarar yin amfani da tazarar jiki kamar telemedicine, windows masu haske, da kuma barin waɗanda ke cikin kulawa kai tsaye su shiga ɗakin da ke da mai cutar COVID-19, amfani da PPE kawai don takamaiman aiki, ci gaba da amfani da shi ba tare da cire mai numfashi ba yayin kula da marasa lafiya da yawa da ke da cutar iri ɗaya, ba da izinin saka idanu da daidaita sarkar samar da PPE, da kuma hana sanya abin rufe fuska ga mutanen da ba su da alamun cutar.
Mawallafin: Katherine Maher, Shugaba na Gidauniyar Wikimedia
Ga: Dukan ma'aikatan Wikimedia Foundation
Jigon: [Covid-19] Rage nauyi da kuma shirya don nan gaba
Ranar da aka aika: 14 ga Maris, 2020, 00:24 UTC
An bayar da lasisi: CC0: Babu haƙƙoƙi
Mun sami kanmu a cikin yanayi na musamman a wannan watan.
Cutar COVID-19 ta duniya wani lamari ne da ya nuna alakar dan Adam da kuma nauyin da muke da shi ga juna.
Ba mu da misali a kan ƙalubalen da muke fuskanta, amma mun san cewa amsarmu mafi kyau ta dogara ne da tausayi, haɗin kai da kuma gina al'umma a duniya, waɗanda suke a zuciyar wannan kungiya.
Dangantaka, amana da kulawa da muka gani a tsakanin dukkan abokan aikinmu ta hanyar imel, kira da hira, wata alama ce ta ban mamaki ga mutanen ban mamaki da muke da sa'a mu yi aiki tare.
Ina matuƙar godiya da alfahari da samun ku a matsayin abokan aiki.
A makon da ya gabata, wani ya yaba mini game da aikinmu.
Sun tunatar da ni yadda yake da muhimmanci a wannan lokacin ga duniya ta iya ganin Wikipedia, kuma yadda yake da alama mai ƙarfi cewa wannan muhimmin abu yana kan layi kuma yana samuwa ga kowa.
Aikinku ne ya sa hakan ya yiwu, ko kun ci gaba da ci gaba da shafukan yanar gizonku ko ku biya abokan aikinmu ko ku kiyaye al'ummominmu lafiya.
Duniya na bukatar bayanai da Wikipedia ke bayarwa, a yanzu fiye da kowane lokaci.
Wannan lokaci ne da ba wai kawai abin da muke yi ba, amma yadda muke yi zai yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan manufa da kuma matsayinku a cikinta, za mu yi wasu muhimman canje-canje a yadda muke aiki tare daga wannan makon.
Ka yi la'akari da waɗannan misalan da suka nuna cewa muna bukatar mu kasance da daidaita a tsarinmu.
Kamar yadda Robin ya ambata a baya, ƙungiyar c-team ta haɗu a daren jiya don tattauna tsarinmu da kuma tsara jadawalin kwanaki da watanni masu zuwa.
A wannan tattaunawar mun yi tunani a kan yadda za mu bi da yanayin da muke ciki, kuma yadda za mu ci gaba da gudanar da ayyukanmu a wannan lokaci.
Yawancinmu muna son mu kawar da matsin lamba kuma mu tallafa wa manufarmu na dogon lokaci.
Idan kana bukatar ka sake kira, babu matsala.
Ga dukkan ma'aikata, 'yan kwangila, da ma'aikatan kwangila:
Har sai an sanar da mu, za mu yi aiki na awa 4 a rana, ko kuma awa 20 a mako.
Ba mu sanar da hutu ba - idan za ku iya yin aiki a lokacin da ya fi dacewa, aikin zai iya amfani da ku.
Amma a yanzu duniya ba ta da tabbas, kuma ko kuna bukatar kula da ƙaunatattunku ko ku kawo kayan masarufi ko ku je wurin likita, lafiyarku ita ce fifiko.
Ba ma lura da lokacinku.
Kada ku yi aiki idan kuna rashin lafiya.
Ba ma bukatar mu faɗi hakan, amma muna faɗin haka.
Babu bukatar hutu na rashin lafiya ko PTO - kawai gaya wa manajanka kuma ka taimaki tawagarka ta gyara kalandar da kuma jadawalin don tabbatar da cewa an rufe muhimman fannonin aikin.
(Idan ka yi tabbatacce ga COVID-19, don Allah ka sanar da Brian na T&C Ops domin T&C su taimaka kuma su tabbatar da cewa an kula da yanayinka daga hukumomi.)
Za a biya ma'aikatan da ke aiki na sa'o'i a cikakken albashi.
Mun riga mun faɗi haka, kuma mun sake yin alkawarin cewa za mu cika alkawarin da muka yi wa 'yan'uwanmu da suka yi mana aikin gyaran agogo.
Za a biya dukansu daidai da lokutan da suka yi aiki a cikin yanayi na al'ada.
Wannan ya haɗa da idan ka yi rashin lafiya kuma ba za ka iya yin aiki ba.
Idan kana son aiki, za mu taimake ka.
Mutane da yawa suna amfani da aiki a matsayin hanyar kawar da damuwarsu daga duniya.
Abin da muke yi zai iya kawo sakamako mai ban mamaki, musamman a irin wannan lokaci.
Har ila yau, yana da game da kula da kanka.
Muna so ku tuntuɓi manajanku domin mu san abin da za mu yi tsammani kuma mu daidaita yadda muke so.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da dole ne mu yi.
SRE, HR Ops, Trust & Safety, da kuma ƙungiyoyin tara kuɗi (a tsakanin wasu) suna yin ayyuka masu muhimmanci waɗanda za su buƙaci ƙarin taimako.
Za mu fara aiki tare da dukkan sassanmu don kimanta manufofinmu na yanzu da kuma mayar da hankalinmu ga yin aiki tare da abin da muke bukata don aikinmu.
Akwai ayyuka da yawa da za mu yi, amma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan ka yi jinkiri, ba za ka ji rauni ba.
Ba mu da shirin yin aiki sau biyu don ciyar da kanmu bayan annobar ta ƙare.
Ba za a sa ran cewa za ka yi awoyi da yawa ba don ka gama aikinka a kan lokaci, wanda ba zai yiwu ba.
Mun yarda cewa yanayi ya canza, kuma za mu yi aiki don kafa sababbin manufofi da kuma lokaci inda ya dace.
Menene ya faru da APP?
Don daidaitawa da sabon gaskiyarmu da tsammanin lokutan aiki na yau da kullun, muna kuma son daidaita lokacin isar da shirinmu na shekara-shekara na 2020-2021.
Manufarmu ita ce ta ba da shawarar faɗaɗa shirinmu na 2019-2020, wanda zai ba ma'aikata damar fifita ayyukan da suka wajaba, ba su ƙarin lokaci don shirya kasafin kuɗi don ba su damar kula da kansu da ƙaunatattun su, tare da biyan duk bukatun mutanen da suke so ko suke buƙatar yin aiki a cikin sa'o'i masu zuwa.
Wannan tsawaitawar lokaci yana rage nauyin aikin da ake yi a yanzu da kuma matsin lamba a kan kamfanin.
Za mu gabatar da shawarwarinmu ga hukumar a mako mai zuwa kuma za mu sanar da wakilai da kungiyoyi game da matakai na gaba da wuri-wuri da zarar mun sami tabbaci.
Ina godiya ga tawagar APP don jagorancinku a wannan.
Yanayin ofishi, yin magana, da kuma tsabtace shi
A makon da ya gabata mun gano cewa ɗaya daga cikin abokan aikinmu na SF na iya kasancewa cikin haɗuwa da cutar COVID-19.
Amma saboda mu na da hankali, mun tura wani rukunin masu tsabtace abubuwa da ke San Francisco don su tsabtace dukkan wuraren da ake amfani da su.
Sun yi amfani da maganin rigakafin cutar da ya dace da asibiti don kashe kowace farfajiya da kuma lobby da kuma bankuna na lif da ke shiga bene.
Ginin yana amfani da samfuran da ke amfani da tsarin kula da sabis na kansa wanda ke taimakawa cikin lafiyar masu haya.
Mun gamsu da cewa ofishin zai kasance a shirye lokacin da muka yanke shawarar komawa.
Ofishinmu na DC yana cikin WeWork, wanda ya raba yarjejeniyar COVID-19 tare da mu da kuma dukkan ma'aikatan da ke DC.
A makon da ya gabata, ofishinmu na DC ya koma wani wuri mai nisa, daidai da umarnin da aka bayar a San Francisco.
Wasu daga cikin abokan aikinmu a birnin New York sun san cewa muna magana ne game da yin hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawa amma ana iya jinkirta.
Wasu abokan aikinmu suna aiki ne daga nesa a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa wannan zai iya zama daidaitawa, kuma suna so su ba ku wasu shawarwari:
Idan taron ya yi tsawo, ka rage zuwa awa ɗaya ko biyu.
Idan ana bukatar ƙarin lokatai, ka yi la'akari da yadda za ka raba su zuwa ƙananan lokatai na kwanaki da yawa.
Ka bayyana taron a fili, ka rubuta jadawalin, kuma ka aika da littattafan da aka rubuta a gaba.
Tare da kayan aiki kamar Google Docs da Zoom, saita bidiyo ta tsohuwa don sauƙaƙa haɗin kai da haɗin kai.
Ka sa wani ya yi magana a kowane taro, ka sa wani ya lura da tambayoyin da ake yi a taɗi, ya lura da jerin masu magana, kuma ka sa wani ya rubuta (ko kuma ya yi rubutu tare da wani).
Idan kana bukatar wani na'urar sauraren sauti mai dadi, ka aika imel zuwa ga goyon bayan fasaha.
Ku yi amfani da kayan jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin.
Shiga tashar #remoties a Slack don tattaunawa da abokan aikinka game da aikin da aka raba.
HR Management Team yana mai da hankali kan koyarwar ergonomics ta yanar gizo don taimakawa haɓaka aikin da aka rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi masu bayar da gudummawa daga cikin al'umma su dakatar da taron jama'a kamar su Editathon da Wikimedia ke tallafawa har sai WHO ta ayyana ƙarshen cutar.
Muna sanar da su cewa mun fahimci cewa buƙatarmu ta sokewa da sauran ƙuntatawa na iya sa ba zai yiwu su kammala ayyukan ba da gudummawar da suka amince da su ba, kuma ba za a hukunta kowa ba saboda jinkiri ko gyara waɗannan manufofin.
A wannan makon da ke zuwa za mu gabatar da ƙarin jagorori ga Wikimania da sauran taron yanki da na al'umma.
Akwai baƙin ciki da rashin jin daɗi ga jama'a na duniya, amma a lokaci guda, Wikimedia da sauran wurare, suna da ikon da kuma 'yanci daga rashin fahimta game da al'ummarsu.
A cikin kwanaki masu zuwa CRT tana aiki don ƙirƙirar shafi a kan Meta-Wiki, don samar da wuri ga jama'a don lura da tasirin da kuma bin hanyoyinmu tare da su.
Kasancewa cikin hulɗa da abubuwan da suka shafi COVID-19
Za mu aika muku da gayyatar zuwa kalandarku don taron ma'aikata na musamman a ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa da amsa tambayoyinku da kuma ciyar da lokaci don haɗi tare da juna.
A wannan yanayin, muna tare kuma za mu taimaka yadda za mu iya.
A halin yanzu, za ka iya ci gaba da bincika wannan imel ɗin, da kuma samun wasu muhimman bayanai game da COVID-19 a kan Office Wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka kuma ta sanya duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da tuntuɓar ma'aikatan da ke zaune a ƙasashe masu tasiri.
Idan kana da tambayoyi game da tafiye-tafiye, abubuwan da suka faru, babban aiki ko ƙalubalen ɗaukar hoto, ko kuma idan kana bukatar taimako game da wani abu, don Allah kada ka yi jinkirin sanar da CRT kuma ka yi aiki tare da ita.
Muna nan don taimakawa da kuma daidaitawa a duk lokacin da ake bukata.
Idan kana da wani abu mai muhimmanci ko kuma mai sirri, ka aika imel zuwa Brian Judan, darektan ayyukan HR International na duniya.
Babu wani daga cikin waɗannan canje-canjen da ya kamata a ɗauka a matsayin watsi da aikinmu da kuma alhakinmu.
Maimakon haka, ya nuna cewa a yanzu, muna bukatar mu daidaita ayyukanmu da kuma hakkokinmu a hanyoyi da ba mu taɓa yi ba a dā.
Mun yi imanin cewa waɗannan matakan suna da mahimmanci don tallafawa juna, don mu ci gaba da aiki, don samar da tallafin da muke buƙata don motsinmu, da kuma samar da sabis ɗin da duniya ta dogara da shi.
A lokacin da lokaci ya yi, aikin da muka shirya zai jira mu.
Yanzu ne lokacin da za mu taimaki juna da kuma samar da sarari ga muhimman ayyuka da za su zo a cikin makonni masu zuwa, watakila ma watanni masu zuwa.
Don yin hakan, muna bukatar taimakonku, kuma muna so ku kula da kanku da kuma iyalanku domin ku kasance cikin koshin lafiya idan bukata ta taso.
Yanzu, don Allah -- ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Catherine, ƙungiyar CRT (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Hime V, Joel L, Lynette L, Ryan M, da Tony S) da sauran ƙungiyar jagoranci (Grant I, Heather W, Hime V, Janine U, Lisa S, Robin A, Ryan M, da Toby N).
B2angiotensin-converting enzyme 2 (ACE2) shine mai karfafawa wanda ke haɗuwa da ƙwayoyin cuta na huhu, jijiyoyi, zuciya, koda da kuma ƙwayoyin cuta.
ACE2 yana hana aikin enzyme mai canza angiotensin (ACE) ta hanyar rage adadin angiotensin-II da kuma kara Ang ((1-7) yana mai sanya shi a matsayin mai bada magani don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin hanyar shiga cikin kwayoyin halitta don wasu coronaviruses.
An kira fasalin ɗan adam na enzyme hACE2.
Angiotensin-converting enzyme 2 shine zinc-containing meta-enzyme wanda yake a cikin endothelial da sauran kwayoyin halitta.
Kwayar ACE2 tana da yankin N-terminal peptidase M2 da kuma yankin C-terminal colectrin renal amino acid transporter.
ACE2 shine mai wucewa guda ɗaya na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Wani enzyme mai suna ShadDase yana raba yankin waje na ACE2 daga yankin membrane kuma sakamakon haka ya saki furotin mai narkewa a cikin jini kuma daga ƙarshe ya fita ta hanyar fitsari.
ACE2 yana cikin yawancin gabobin jiki: ACE2 yana haɗuwa da ƙwayoyin alveolus na nau'in II na huhu, ƙwayoyin enterocytes na ƙananan hanji, ƙwayoyin jijiyoyin jiki da ƙwayoyin endothelial na jijiyoyi da ƙwayoyin tsokoki na jijiyoyi.
Hakanan ana samun bayyanar ACE2 mRNA a cikin cerebral cortex, streat, hypothalamus, da brainstorm.
Aikin farko na ACE2 shine ya zama mai daidaitawa na ACE.
ACE yana raba kwayar angiotensin I zuwa angiotensin II mai saurin rage jini.
ACE2 yana ware carboxyl-terminal amino acid phenylalanine (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) daga angiotensin II kuma yana hydrolysing shi zuwa vasodilator angiotensin (1-7) (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya ware wasu peptides, ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dinorphine A, da ghrelin.
ACE2 yana sarrafa musayar membrane na mai ɗaukar amino acid mai tsaka tsaki SLC6A19 kuma yana da alaƙa da cutar zuciya.
ACE2 a matsayin furotin mai wucewa yana aiki a matsayin babban wurin shigar ƙwayoyin cuta ga wasu ƙwayoyin cuta, ciki har da HCoV-NL63; SARS-CoV (wanda ke haifar da SARS); da SARS-CoV-2 (wanda ke haifar da COVID-19).
A takaice dai, ƙulla kwayar SARS-CoV da kuma SARS-CoV2 Spike S1 a cikin enzymatic domain na ACE2 a farfajiyar ƙwayoyin halitta yana haifar da endocytosis da kuma sauya wuri a cikin endosomes da ke tsakanin ƙwayoyin cuta da enzymes.
Wannan tsarin shigarwa yana buƙatar priming na S protein ta mai masaukin baki serine protease TMPRSS2, wanda hana shi a halin yanzu yana ƙarƙashin bincike a matsayin mai warkarwa mai yuwuwa. Wannan ya taimaka wa wasu suyi tunanin cewa rage matakan ACE2 a cikin ƙwayoyin zai iya taimakawa wajen yaƙar kamuwa da cuta.
Duk da haka, ƙungiyoyi da hukumomi da dama sun ba da shawarar ci gaba da maganin ACE inhibitors da ARB.
"A cikin wani bita na tsarin da meta-analysis da aka buga a ranar 11 ga Yuli, 2012, an gano cewa ""idan aka kwatanta da masu kula, an sami raguwar 34% na haɗarin kamuwa da cutar huhu tare da amfani da masu hana ACE"."
"Bugu da ƙari, ""yanayin cutar pneumonia ya ragu a cikin marasa lafiya da aka yi wa maganin ACE, musamman a cikin waɗanda ke da babban haɗarin kamuwa da cutar huhu, musamman waɗanda ke da ciwon bugun jini da kuma cututtukan zuciya".
"Amfani da ACE inhibitors an kuma danganta shi da rage yawan mutuwar da ke da nasaba da ciwon huhu, ko da yake sakamakon ya yi kasa da yadda yake da iko a kan hadarin kamuwa da ciwon huhu baki ɗaya"."
Ana ɗaukar ACE2 na mutum mai haɗawa (rhACE2) a matsayin sabon magani don lalacewar huhu mai tsanani kuma ya bayyana don inganta hawan jini da kuma iskar oxygen na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na lipopolysaccharide.
A cikin mutane, rabin rayuwar rhACE2 kusan awanni 10 ne kuma farawa aiki a cikin mintuna 30, kuma tsawon lokacin tasiri (tsayawa) awa 24 ne.
Bayanai sun nuna cewa rhACE2 na iya nuna bege ga mutanen da ba sa iya jurewa ga masu hana tsarin rennin-angiotensin na farko (RAS inhibitors) ko kuma waɗanda ke da cututtuka inda ake samun karuwar maganin angiotensin II. An kimanta rhACE2 a cikin kwayoyin halitta don alamun cututtukan cututtukan numfashi (Acute Respiratory Distress Syndrome).
"B'COVID-19 Apps aikace-aikacen software ne na wayar hannu waɗanda aka tsara don gano lambobin sadarwa, wato, hanyar gano mutanen da suka kasance tare da mutumin da ke da cutar ("saduwa"") a cikin martani ga annobar cutar coronavirus ta 2019-20".
An kuma samar da aikace-aikace da yawa a wasu yankuna da yankuna tare da taimakon gwamnati.
An gina wasu kayan aikin don samar da aikace-aikacen ganowa.
An nuna damuwa game da sirrin, musamman game da tsarin da ke aiki bisa ga gano wurin da masu amfani da aikace-aikacen suke.
Zaɓuɓɓukan shiga ba tare da izini ba sun haɗa da amfani da siginar Bluetooth don yin rajistar taɓawar mai amfani da wasu wayoyin salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan tallafawa irin waɗannan aikace-aikacen masu amfani da Bluetooth kai tsaye tsakanin tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin tare da Alipay sun ƙaddamar da wani aikace-aikace wanda zai ba wa 'yan ƙasa damar bincika ko sun taɓa hulɗa da mutanen da ke da COVID-19.
Ana amfani da shi a birane fiye da 200 na kasar Sin, kuma ana amfani da shi a Singapore ta hanyar wani app mai suna TraceTogether.
Kungiyar IT ta yankin ce ta kirkiro manhajar, kuma an fitar da ita a matsayin mai budewa, kuma za a mika ta ga gwamnati. Arewacin Macedonia ta kaddamar da "Stop Corona!", wani manhajar Bluetooth da ke da manufar gano bayyanar cututtukan mutane da ke da cutar da kuma samar da saurin amsawa ga hukumomin kiwon lafiya.
An kirkiro wannan app ne daga Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya.
A ranar 14 ga Afrilu, 2020, ana jiran amincewar app ɗin a cikin Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnati ta sanar da cewa aikace-aikacen neman haɗin yanar gizo yana cikin ci gaba kuma zai kasance cikin makonni kaɗan. Ana shirin irin wannan aikace-aikacen ("StopCovid") a Ireland da Faransa".
Australia da New Zealand suna la'akari da aikace-aikacen da suka dogara da TraceTogether na Singapore da kuma yarjejeniyar BlueTrace. Rasha tana shirin ƙaddamar da aikace-aikacen geofencing don marasa lafiya masu cutar COVID-19 da ke zaune a Moscow don tabbatar da cewa ba za su bar gida ba.
Ross Anderson, Farfesa a fannin aikin kare lafiya a Jami'ar Cambridge, ya lissafa wasu matsaloli masu yuwuwa na amfani da tsarin tushen aikace-aikace, gami da rashin inganci idan karɓar aikace-aikacen ta iyakance ga ƙananan ɓangaren jama'a.
"Yin magana game da damuwa game da yaduwar ɓatarwa ko cutarwa ""coronavirus"" apps, Apple ya sanya takunkumi kan irin kamfanonin da za su iya ƙara aikace-aikacen da suka shafi coronavirus a cikin shagon yanar gizon ta ta hanyar iyakance su ga ""gwamnati"" ko kuma wasu kamfanoni masu daraja".
Google da Amazon sun yi irin wannan takunkumin.
Masu fafutukar tsare sirri sun nuna damuwarsu game da mahimmancin sa ido kan jama'a ta amfani da aikace-aikacen coronavirus, musamman, ko za a iya kawo ƙarshen tsarin sa ido da aka gina don magance cutar ta coronavirus a duniya bayan barazanar ta tafi.
Kungiyar Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a rage irin wannan sa ido.
Kungiyar ta bayyana sharudda takwas game da ayyukan gwamnati:
"Dole ne a yi tsaro ""daidai, dole, da kuma daidaitacce".
Za a sami hanyar faɗuwar rana don ƙara saka idanu da sa ido;
Za a iyakance amfani da bayanai don dalilai na COVID-19.
Tsaron bayanai da rashin sani za a kiyaye su kuma za a nuna tsaro bisa hujja;
Za a yi sa ido ta hanyar dijital don hana nuna bambanci da kuma rarrabuwa;
Sharuɗɗan kowane irin bayanai tare da ɓangare na uku dole ne a bayyana a cikin doka;
Dole ne a kare 'yan ƙasa daga cin zarafi kuma dole ne su sami 'yancin yin zanga-zanga.
"Za a bukaci muhimmiyar sa hannu daga dukkan "'masu ruwa da tsaki"" ciki har da masana kiwon lafiyar jama'a da kungiyoyin da ke kan iyaka. Kungiyar Kwamfuta ta Jamus (CCC) da kuma Reporters Without Borders (RSF) sun fitar da jerin abubuwan bincike".
Manufar shirin Google/Apple da aka gabatar shine magance matsalar sa ido ta hanyar cire tsarin ganowa daga tsarin aiki na na'urorin su idan ba a buƙatar su ba.
Wasu ƙasashe sun yi amfani da sa ido kan wurin da ke kan hanyar sadarwa maimakon aikace-aikace, wanda ya kawar da buƙatar saukar da aikace-aikace da kuma damar guje wa sa ido.
A Isra'ila, an amince da gano hanyar sadarwa.
Hanyoyin sadarwa da ke da damar shiga bayanan da ba a gyara ba suna da mahimman matsalolin sirri.
Duk da haka, ba duk tsarin da ke cikin cibiyar sadarwar ke buƙatar samun damar yin amfani da bayanan wuri na sirri ba; an gina tsarin tsare sirri da yawa wanda ke amfani da uwar garken tsakiya don sadarwa kawai (duba sashe na ƙasa).
An yi amfani da tsarin da ba shi da aikace-aikace a Koriya ta Kudu don saka idanu kan hulɗa.
Maimakon amfani da aikace-aikacen da aka tura, tsarin ya tattara bayanan bin diddigin daga tushe daban-daban, gami da bayanan bin diddigin na'urar wayar hannu da bayanan ma'amala a katin, kuma ya haɗa su don aika sanarwar ta hanyar saƙon rubutu ga waɗanda ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da yiwuwar haɗuwa, gwamnati ta samar da bayanan wuri ga jama'a, wasu abubuwan da aka ba da izini saboda canje-canje masu yawa a cikin dokokin sirri na bayanai bayan barkewar cutar MERS a ƙasar.
Wasu ƙasashe, ciki har da Jamus, sun yi la'akari da amfani da tsarin da aka mayar da hankali da kuma tsare sirri.
Har zuwa 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba.
Gano sadarwa mai zaman kanta yana da kyakkyawan ra'ayi, tare da wani ɓangare na ilimin bincike wanda ya fara aƙalla a 2013. Har zuwa 7 ga Afrilu, 2020, fiye da gungun masana dozin suna aiki kan mafita mai aminci, kamar yin rikodin kusanci da wani mai amfani da wayar salula ta amfani da Bluetooth Low Energy (BLE).
Duk da haka, PEPP-PT wani shiri ne na haɗin kai wanda ke da tsarin da aka mayar da hankali da kuma rarraba, kuma ba tsarin aiki guda ɗaya ba. Tsarin aiki na rarraba ya haɗa da ƙididdigar kusanci na tsare sirri (DP-PPT/DP-3T), lambobin tuntuɓar wucin gadi (TCN, lambobin tuntuɓar fka, CEN), tsarin sirri da kuma hanyoyin da za a iya ganowa don sadarwa ta wayar hannu (PACT), da sauransu.
A cikin waɗannan ladabi, bayanan da za a iya gano su da kansu ba sa barin na'urar kuma suna faruwa a cikin duk na'urorin da aka haɗa.
Kungiyar tsare sirri a MIT Media Lab tana haɓaka SafePaths, wani dandamali don amfani da dabarun kiyaye sirri yayin tattarawa da amfani da bayanan wurin ko hanyar haɗuwa don sa ido kan yaduwar COVID-19.
Wannan ya dogara ne akan takarda mai suna Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic, wanda aka fitar a watan Maris na 2020. Wani irin wannan yunƙuri shine Enigma MPC ta SafeTrace Platform, kamfanin da ke kera fasahar tsare sirri wanda kuma aka kafa a MIT Media Lab.
SafeTrace yana amfani da fasahohin kayan aiki masu aminci don ba da damar musayar wuri mai mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da jami'ai ba tare da yin sulhu da sirrin bayanan masu amfani ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Alliance na Duniya ta wasu ƙungiyoyi waɗanda ke da niyyar rage rarrabuwa da kuma ba da damar hulɗa ta duniya don ganowa da faɗakar da aikace-aikace, wanda shine babban mahimmancin tallafi wanda ya haɗa da hanyoyin da suka dace da kuma ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa tana da yarjejeniyar BlueTrace mai buɗewa wacce ake amfani da ita ta hanyar aikace-aikacen gwamnati.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun sanar da wani shiri don gano mutanen da suka yi hulɗa da su, wanda za su kare sirrin da suka ce, wanda ke aiki bisa haɗin fasahar Bluetooth mai ƙarancin makamashi da kuma ɓoye-ɓoye na sirri.
Sun kuma bayyana cikakkun bayanai game da fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, tsarin yana shirin samuwa a matakai uku:
Rarraba kayan aiki don bawa gwamnatoci damar ƙirƙirar aikace-aikacen hukuma masu kiyaye sirri don gano kwayar cutar coronavirus
Haɗa wannan aikin kai tsaye zuwa iOS da Android: Google da Apple suna shirin magance matsalar ɗaukar hoto da kuma saurin sa ido ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki da farko sannan kuma cire shi a cikin hanyar da ta dace idan bala'i ya faru.
Sake sanya magani (wanda kuma ake kira sake amfani da shi, sake fasalinsa, sabon aiki ko maye gurbin magani) magani ne da aka amince da shi wanda ake amfani da shi don magance wata cuta ko cuta daban da wacce aka fara tsarawa.
Wannan hanya ce ta bincike na kimiyya wanda a halin yanzu ake bi don haɓaka ingantaccen magani na COVID-19.
Sauran hanyoyin bincike sun hada da samar da allurar rigakafin COVID-19 da kuma cutar cutar ta plasma. SARS-CoV-2 yana da takamaiman sunadarai 66 na takamaiman magani, kowannensu yana da shafuka masu ɗaure ligand da yawa.
Binciken waɗannan rukunin yanar gizon yana ba da kyakkyawan tsari don ƙirƙirar magungunan antiviral masu tasiri akan furotin COVID-19.
Abubuwan da suka fi muhimmanci na SARS-CoV-2 sune sunadaran papine national protease, RNA-dependent RNA polymerase, helix, S protein, da kuma ADP ribophosphatease.
Hussain A.A., da sauransu sun yi nazarin wasu magungunan da aka yi wa takara waɗanda aka inganta da kuma bincika a cikin binciken sa na farko don kamanceceniya da ƙashin ƙashin ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallon ƙwallo.
Chloroquine magani ne na rigakafin zazzabin cizon sauro wanda kuma ake amfani da shi wajen magance wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da kuma hydroxychloroquine mai alaƙa yana ɗaya daga cikin magunguna huɗu da za a yi nazari a kansu a matsayin ɓangare na gwajin gwaji na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin chloroquine da hydroxychloroquine a jihar New York zai fara ne a ranar 24 ga Maris. A ranar 28 ga Maris FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin amfani da gaggawa (EUA).
Ba a amince da maganin ta hanyar tsarin gwajin asibiti na FDA ba kuma an amince da shi ne kawai a matsayin magani na gwaji don amfani da gaggawa a cikin EU ga marasa lafiya da ke asibiti amma ba su iya shiga gwajin asibiti ba.
"CDC ta ce ""amfani, sashi ko kwanciyar hankali na hydroxychloroquine don rigakafi da magani na cutar SARS-CoV-2"" ba a tabbatar da su ba tukuna".
"Likita ya ce ba su da wani zaɓi kuma suna shan maganin".
A Istanbul, wata ƙungiyar bincike ta Turkiyya tana gudanar da karamin bincike kan amfani da chlorokine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a jami'o'in Duke da Oxford.
NYU Langone Medical School tana gudanar da gwaji kan aminci da ingancin amfani da hydroxychloroquine a matsayin rigakafi.
"Gwaji na asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa Favipiravir ya nuna ""a bayyane yake yana da tasiri"."
A tsakanin kwanaki 4 a Shenzhen, marasa lafiya 35 sun sami sakamako mara kyau, yayin da marasa lafiya 45 da ba su samu ba sun yi kwanaki 11 da rashin lafiya.
A cikin wani binciken da aka gudanar a Wuhan na marasa lafiya 240 da ke fama da cutar sankarar bargo, rabin an ba su Favipirar da kuma rabin Umyfenov.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke goyon bayan maganin ba ta da isasshen tushe kuma ba ta da tushe.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don adanawa da kuma amfani da sojoji don isar da magunguna zuwa asibitocin jami'a, inda za a yi amfani da magunguna don kula da marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya ba da shawarar sayan magungunan ga gwamnatin Trump, wanda zai iya zama mai tasiri a yanayin rashin lafiya inda cutar ta riga ta ninka.
Ba zai zama lafiya ba ga mata masu juna biyu ko waɗanda ke ƙoƙarin yin ciki.
"Bincike na lopinavir/ritonavir (Kaletra), wani magani mai hana kwayar cuta da aka hada da lopinavir da ritonavir, ya kammala cewa ""ba a ga amfanin ba"."
An tsara magungunan ne don hana kwayar cutar HIV yin kwafi ta hanyar ɗaure shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin canza magunguna don nemo mahaɗan da za su iya haɗuwa da protease na SARS-CoV-2. Akwai sukar a cikin ƙungiyar kimiyya game da amfani da albarkatu don canza manufar magungunan da aka haɓaka musamman don HIV/AIDS.
WHO ta haɗa lopinavir/ritonavir cikin gwajin tallafi na duniya.
Gilead Sciences ta kirkiro Remdesivir kuma ta bunkasa shi a matsayin magani don cutar Ebola da kuma kamuwa da cutar Marburg. Gilead Sciences daga baya ta gano cewa Remdesivir yana da aikin rigakafi a cikin vitro akan yawancin filayo-, pneumonia-, paramyxoma-, da coronaviruses.
Wata matsala da maganin rigakafin cutar ke fuskanta ita ce, yana iya haifar da kamuwa da cuta ta hanyar maye gurbi wanda zai iya haifar da cututtuka da kuma kamuwa da cuta.
Wasu binciken farko na farko sun nuna cewa Remdesivir na iya samun babban takunkumi na kwayoyin cuta don rigakafi. Ana gudanar da gwaje-gwaje da yawa na bincike, gami da gwaje-gwaje biyu da asibitin Jami'ar Cleveland ke gudanarwa; daya ga mutanen da ke da rashin lafiya mai matsakaici, da kuma wani ga mutanen da ke da rashin lafiya mai tsanani.
Akwai gwaje-gwaje uku na ci gaba na asibiti na Vitamin C don bayarwa a cikin jini ga waɗanda ke da mummunan rashin lafiya tare da COVID-19; biyu placebo-sarrafawa (China, Kanada) da ɗaya wanda ba a sarrafa shi ba (Italiya).
Jihar New York ta fara gwaji don maganin rigakafi Azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Magunguna ta Japan (NCGM) tana shirin gudanar da gwajin gwaji don Alvesco (Cyclosonide) na Teigen, corticosteroid na numfashi don asma, don magance marasa lafiya da ke da alamun cutar coronavirus.
Ana gudanar da gwaji na nau'in enzyme mai canza angiotensin 2 a cikin marasa lafiya 200 da ke cikin asibiti a Denmark, Jamus da Austria don tantance tasirin maganin.
Masu bincike a Cibiyar Zuciya ta Montreal a Kanada suna nazarin rawar da colchicine ke takawa wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke fama da ƙananan alamun COVID-19.
Wannan binciken mai suna COLCORONA yana tattare da manya 6000 masu shekaru 40 zuwa sama waɗanda suka kamu da COVID-19 kuma suka sami ƙananan alamun da ba sa buƙatar asibiti.
Mata masu juna biyu ko masu shayarwa, ko kuma waɗanda ba su da ingantacciyar hanyar hana haihuwa ba, ba za su iya shiga ba.
Ana gwada wasu maganin rigakafi a Italiya.
Ana amfani da heparin mai nauyin kwayoyin ƙasa don kula da marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta ba da umarni game da amfani da shi.
An sanar da wani bincike mai yawa a Italiya a ranar 14 ga Afrilu, wanda ya yi nazari kan amfani da maganin Enoxaparin sodium a cikin rigakafi da kuma maganin rigakafi a kan marasa lafiya 300.
Tun da SARS-CoV-2 kwayar cuta ce, an mai da hankali kan tsarin kimiyya wajen sake fasalin maganin rigakafin cutar da aka amince da shi wanda aka yi don bullar da ta gabata kamar su MERS, SARS da West Nile virus.
Ribevirin: An ba da shawarar Ribevirin don maganin COVID-19 bisa ga jagorar China na 7th.
Umyfenvir: Umyfenvir an bada shawarar don maganin COVID-19 bisa ga jagorar 7th na kasar Sin.
Wasu kwayoyin rigakafi da aka gano suna da sabon amfani a matsayin maganin COVID-19:
Tselisumab (Anti-IL-6 receptor): an amince da shi daga China.
Ana kuma gudanar da gwaji a Italiya da China.
B'A COVID-19 rigakafin rigakafi ne da ake shirin yi kan cutar Coronavirus Disease 2019 (COVID-19).
Ko da yake babu wani allurar rigakafin da ta kammala gwajin gwaji, ana ci gaba da yin ƙoƙari don samar da irin wannan rigakafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a sami allurar rigakafin cutar SARS-CoV-2 mai tasiri a cikin ƙasa da watanni 18.
A watan Afrilu, akwai 'yan takarar allurar rigakafi guda biyar a cikin gwajin tsaro na farko.
An gano COVID-19 a watan Disamba na 2019.
A shekarar 2020, wata babbar annoba ta barke a duniya, wanda ya haifar da babban jari da ayyukan bincike don samar da rigakafi.
Kungiyoyi da yawa suna amfani da kwayoyin halittar da aka bayyana don haɓaka yiwuwar allurar rigakafin SARS-CoV-2.
A watan Afrilu, an ce, tsarin CEPI na samar da allurar rigakafi ya dogara ne da saurin, iya samarwa, yaduwar amfani da kuma samun damar duniya.
A watan Afrilu, masana kimiyyar CEPI sun ba da rahoton cewa suna aiki a kan dandamali daban-daban na fasaha guda 10 a farkon 2020 don haɓaka ingantaccen rigakafin COVID-19.
Manyan manufofin dandalin da suka ci gaba a cikin nazarin tsaro na Phase I sun hada da:
Nucleic acid (DNA da RNA) (mai haɓaka lokaci na I da kuma ɗan takarar allurar rigakafi: Moderna, mRNA-1273)
Mai ɗaukar kwayar cutar (mai haɓaka Phase I da ɗan takarar allurar rigakafi: Cancino Biologics, adenovirus type 5 vector)
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa mutane 115 ne ke cikin farkon ci gaba, 78 daga cikinsu an tabbatar da su a matsayin masu aiki (milken institute ya ce 79) da kuma wasu 37, amma duk wannan ya samo asali ne daga bayanan da ba a bayyana su ba a fili (wanda ake tsammani ana shirin yi).
Gwajin Phase I-II yana gudanar da gwajin farko na aminci da rigakafi kuma ana yin sa ne a wurare da yawa, wanda ba a daidaita shi ba, mai sarrafa placebo, yayin da ake tantance takamaiman, ingantaccen sashi.
Gwaje-gwaje na Phase III, tare da gwajin rigakafi don rigakafin cutar da rukunin kulawa, yawanci suna da alaƙa da ƙarin mahalarta, yayin da ake lura da tasirin cutarwa a cikin magungunan magunguna masu kyau.
"Daga cikin masu neman allurar rigakafi 79 da ke cikin ci gaba (kamar yadda aka tabbatar a farkon Afrilu 2020), 74 ba a yi kimantawa a cikin mutane ba tukuna (har yanzu suna cikin binciken ""preclinical"")".
A ranar 24 ga Janairu, 2020, Jami'ar Queensland a Ostiraliya ta sanar da cewa tana binciken yiwuwar samar da rigakafin da ke ɗaure kwayar halitta wanda zai iya canza kwayar cutar ta kwayar halitta don haifar da amsawar rigakafi.
A Kanada, a ranar 24 ga Janairu, 2020, Cibiyar Alurar riga kafi ta Duniya a Jami'ar Saskatchewan (VIDO-Intervac) ta sanar da fara aikin kan allurar rigakafi tare da burin fara gwajin mutum a 2021.
An sanar da ayyukan ci gaba da allurar rigakafi a Cibiyar Kula da Cututtuka ta Sin a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu, 2020.
A ranar 29 ga Janairu, 2020, Kamfanonin Magunguna na Janssen karkashin Hanneke Schuitemaker sun sanar da cewa sun fara aikin samar da rigakafi.
Janssen tana aiki tare da Vaxart, wani kamfanin samar da maganin maganin sauro.
A ranar 18 ga Maris, 2020, Emergent Bio Solutions ta sanar da haɗin gwiwa tare da Vaxart don samar da allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na Oncogene a Romania ya buga wani ɗan gajeren rubutu kan ƙirar allurar rigakafi na irin wannan fasahar da ake amfani da ita don maganin rigakafin cutar kansa.
A ranar 25 ga Maris, shugaban cibiyar binciken ya sanar da cewa sun kammala hada allurar rigakafin kuma suna fara gwaji.
A ranar 27 ga Fabrairu, 2020, kamfanin Generex na kamfanin NuGenerex Immuno-Oncology ya sanar da cewa suna fara aikin rigakafin don haɓaka rigakafin peptide mai mahimmanci na LI-K a kan COVID-19.
Suna son samar da wani rigakafi wanda za a iya gwadawa a cikin mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirin samar da allurar rigakafin.
A ranar 5 ga Maris, 2020, Rundunar Binciken Likitocin Amurka da kuma Hukumar Kula da Kayan Aikin Soja a Fort Detroit da Cibiyar Nazarin Soja ta Walter Reed a Silver Spring, duka biyu na Yammacin Maryland, sun sanar da cewa suna aiki kan rigakafi.
A kusa da ranar 10 ga Maris, 2020, Emergent Biosolutions ya sanar da cewa ya haɗu da Novavax Inc.
A cikin samar da rigakafi.
Abokan hulɗa sun kuma sanar da shirin gudanar da gwajin farko da na farko a watan Yuli na 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki a kan keɓewa 11 kuma zai ɗauki aƙalla shekara ɗaya da rabi zuwa biyu don samar da allurar rigakafi, kodayake a cikin sauri.
A ranar 12 ga Maris, 2020, wani kamfanin kimiyyar kere-kere a Quebec City, Quebec, ya ba da rahoton ci gaban kwayar cutar coronavirus, wanda Cibiyoyin Kiwon Lafiya na Kanada ke tallafawa.
Ana gudanar da gwajin gwaji na takardar rigakafin a cikin dakin gwaje-gwaje tare da shirin gwajin ɗan adam a watan Yuli ko Agusta 2020.
A farkon wannan makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba da 'babban kuɗi' ga Kurivac don samun 'yancin yin rigakafin COVID-19, wanda gwamnatin Jamus ta yi adawa da shi.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin Biotech na Jamus don haɓaka allurar rigakafin mRNA.
BNT162, dan takarar rigakafin mRNA, wanda a halin yanzu yana cikin gwajin farko, kuma ana sa ran fara gwajin gwaji a watan Afrilu na 2020.
A Italiya a ranar 17 ga Maris, 2020, wani kamfanin kimiyyar kere-kere na Italiya mai suna Takis Biotech ya sanar da cewa za su sami sakamakon gwajin farko a watan Afrilu, kuma za a iya gwada takardar rigakafin su na ƙarshe a jikin mutum a cikin kaka.
A ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) a Faransa ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike don allurar COVID-19, wanda ya haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburg, wanda ya kai CEPI ga saka hannun jari na dala miliyan 29 a cikin haɓaka allurar COVID-19.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin takaddun rigakafi daban-daban guda shida a kan dabbobi.
Masu bincike a Imperial College London sun sanar a ranar 20 ga Maris, 2020 cewa suna samar da rigakafin RNA mai saurin faɗaɗa kansa don COVID-19.
An samar da takardar rigakafin ne cikin kwanaki 14 da samun umarni daga China.
A ƙarshen Maris, gwamnatin Kanada ta ba da sanarwar dala miliyan 275 don ayyukan bincike 96 kan kariya ta likita a kan COVID-19, gami da ƙwararrun masu neman allurar rigakafi a cibiyoyin bincike da jami'o'i na Kanada, kamar su Medicigo da Jami'ar Saskatchewan.
"A lokaci guda, Gwamnatin Kanada ta sanar da dala miliyan C$192 musamman don samar da allurar rigakafin COVID-19, kuma akwai wasu sabbin alluran rigakafi da ke shirin kafa wani bankin allurar rigakafi na kasa wanda za a iya amfani da shi idan akwai wani annobar cutar coronavirus".
"A watan Afrilu na 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin yiwuwar allurar rigakafin COVID-19 a kan beraye, PittCoVacc, suna cewa ""SARS-CoV-2 S1 subunit vaccines da MNA ta gano sun nuna karfi antigen-takamaiman maganin rigakafi [a cikin beraye] wanda ya bayyana a farkon mako na 2 bayan allurar"."
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da shirin samar da dan takarar rigakafin DNA a matsayin mai yuwuwar maganin hanci.
Za a tsara DNA ta amfani da bacteriophages don yin kwafi a cikin kwayoyin halittar ɗan adam don samar da ƙwayoyin cuta masu kama da ƙwayoyin cuta, wanda zai iya motsa tsarin rigakafi don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na 2020, Hewlett Packard Enterprise, haɗin gwiwar Amazon, Microsoft da kamfanin sarrafa kwamfuta na Google, sun kirkiro haɗin gwiwar gwamnati, masana'antu da jami'o'i uku na Amurka don samun damar shiga manyan kwamfutoci daga IBM.
Wasu alluran rigakafi suna da tasirin heterologous, wanda ake kira da tasirin da ba na musamman ba.
Wannan yana nufin cewa suna da amfani fiye da yadda suke hana cutar.
Ana kokarin yin rajistar ma'aikatan kiwon lafiya 4,170 a Australia don ƙarin gwaji na bazuwar.
Akwai yiwuwar cewa alluran rigakafin da ake ci gaba ba za su kasance masu lafiya ko tasiri ba.
Bincike na farko na kimanta tasirin allurar rigakafi a cikin ƙirar dabbobi na COVID-19 kamar ACE2-transgenic mice, sauran dabbobi masu bincike, da dabbobi masu shayarwa waɗanda ba mutane ba, ya nuna buƙatar matakan kula da lafiyar 3 da haɗin kai na duniya don gudanar da kwayar cutar mai rai don tabbatar da ingantattun matakan kariya.
An gwada allurar rigakafin SARS da MERS a kan samfuran dabbobi marasa ɗan adam.
A cikin 2020, babu magani ko rigakafin rigakafin SARS wanda aka nuna cewa yana da aminci da tasiri ga mutane.
A cewar takardun bincike da aka buga a shekarar 2005 da 2006, ganowa da kuma bunkasa sabbin alluran rigakafi da magunguna don maganin SARS ya kasance babban fifiko ga gwamnatoci da kungiyoyin kiwon lafiya na duniya. Babu wata hujja ta rigakafin cutar MERS.
Lokacin da cutar ta MERS ta bulla, an yi imanin cewa binciken SARS na iya samar da samfuri mai amfani don samar da allurar rigakafi da rigakafi a kan kamuwa da cutar MERS-CoV.
Har zuwa Maris 2020, akwai rigakafin MERS (wanda ya dogara da DNA) wanda ya kammala gwajin farko a cikin mutane, kuma akwai wasu uku da ke gudana, dukkansu allurar rigakafin ƙwayar cuta ce, biyu adenoviral-vector (ChAdOx1-MERS, BVRS-GamVac) da kuma MVA-vectored (MVA-MERS-S).
Rubutun kafofin watsa labarun sun ba da shawarar ka'idar makirci inda ake da'awar cewa an san kwayar cutar da ke bayan COVID-19 kuma riga-kafin ya riga ya kasance.
Takardun shaida da aka ambata a cikin wasu sakonnin kafofin watsa labarun sun shafi takardun shaida na yanzu don jerin kwayoyin halitta da kuma alluran rigakafi don wasu nau'ikan coronavirus kamar SARS coronavirus.
B'Coronovirus Disease 2019 (COVID-19) cuta ce mai saurin yaduwa da cutar ta SARS-CoV-2 ke haifarwa.
Alamun da aka saba da su sun hada da zazzabi, tari da kuma numfashi.
Sauran alamun na iya hada da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙanshi, da kuma ciwon ciki.
Lokaci na bayyanar cututtuka daga lokacin da aka kamu da kwayar cutar shine kusan kwanaki biyar, amma yana iya zama daga kwana biyu zuwa goma sha huɗu.
Ko da yake a mafi yawan lokuta ana samun saukin bayyanar cututtuka, a wasu lokuta ana iya samun ci gaba zuwa cutar sankarar bargo da kuma rashin aiki da gabobin jiki.
Ya zuwa 17 ga Afrilu, 2020, an sami sama da mutane miliyan 2.24 da suka kamu da cutar a cikin kasashe da yankuna 210, wanda ya haifar da mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 sun warke. An fara yada kwayar cutar ne ta hanyar ƙananan ƙwayoyin hanci da aka haifar ta hanyar tari, tari ko magana, sau da yawa a lokacin hulɗa ta kusa.
Sa'ad da aka yi taushi a lokacin numfashi, ƙwayoyin suna sauka a ƙasa ko kuma a saman ƙasa maimakon su yi nisa.
Mutane na iya kamuwa da cutar ta hanyar taɓa idanunsu, hanci, ko baki bayan sun taɓa gurɓataccen wuri.
Kwayar cutar na iya rayuwa har zuwa awanni 72 a saman kasa.
Yana da mafi yawan kamuwa da cuta a cikin kwanaki uku na farko da bayyanar cututtuka, kodayake yana iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar. Hanyar da aka saba da ita ita ce ta hanyar yin amfani da ainihin lokaci na jujjuyawar polymerase chain reaction (rRT-PCR) daga nasopharyngeal swab.
Ana ba da shawarar cewa duk wanda ake zargi da kamuwa da cutar da masu kula da su su sanya abin rufe fuska.
Shawarwarin amfani da abin rufe fuska ga talakawa sun bambanta, tare da wasu hukumomi suna ba da shawarar yin amfani da su, wasu suna ba da shawarar yin amfani da su, wasu kuma suna buƙatar yin amfani da su.
A halin yanzu babu allurar rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An sami yaduwar cutar a cikin kasashe da dama a duk yankuna shida na WHO.
Wadanda suka kamu da kwayar cutar na iya zama marasa alamun cutar ko kuma suna iya nuna alamun cutar kamar mura kamar zazzabi, tari, gajiya da kuma numfashi mai wuya.
Alamun gaggawa sun hada da numfashi, ciwon kirji ko matsi, rikicewa, wahalar farkawa da kuma fuska ko lebe mai launin shuɗi; idan akwai alamun, ana ba da shawarar neman magani nan da nan.
A wasu lokatai, ana iya samun wasu alamun numfashi na sama kamar tari, hanci da ke zubar da ruwa, ko kuma ciwon makogwaro.
An lura da bambancin kashi na bayyanar cututtukan gastrointestinal kamar su amai, amai, da kuma zawo.
Wasu daga cikin wadanda suka kamu da cutar a kasar Sin sun fara da bugun kirji da kuma bugun zuciya.
A wasu, cutar na iya kaiwa ga ciwon huhu, na iya kaiwa ga nakasa gabobin jiki da yawa, har ma ta kai ga mutuwa.
Ana kiransa matakin tsinkaye na kwayoyin.
Lokacin bayyanar cutar COVID-19 yawanci kwanaki biyar zuwa shida ne, amma zai iya zuwa kwanaki biyu zuwa 14.
97.5% na mutanen da ke nuna alamun cutar za su nuna a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba a nuna alamun cutar a cikin duk waɗanda suka kamu da cutar.
Ba a san cikakken matsayin waɗannan masu ɗaukar cutar ba a cikin kamuwa da cuta, amma hujjojin farko sun nuna cewa suna iya taka rawa wajen yaduwar cutar.
Yawan mutanen da suka kamu da cutar da ba su da alamun cutar ba a halin yanzu ba a sani ba kuma ana nazarin su, a cewar rahoton Cibiyoyin Kula da Cututtuka da Cututtuka na Koriya (KCDC), kashi 20% na dukkan wadanda aka tabbatar da cutar ba su da alamun cutar yayin da suke asibiti.
A ranar 1 ga Afrilu, Hukumar Lafiya ta Kasa ta China ta fara haɗa marasa cutar a cikin adadin masu cutar ta yau da kullun; 130 (78%) na mutanen 166 da suka kamu da cutar a wannan ranar ba su da alamun cutar.
Dukansu hawaye da kuma hanci suna iya ɗaukar ƙwayoyin cuta da yawa.
Idan ka yi magana da ƙarfi, za ka yi haushi fiye da yadda za ka yi.
Wani bincike a Singapore ya nuna cewa coughing ba tare da rufe fuska ba zai iya yada ƙananan raƙuman ruwa har zuwa mita 4.5 (15 feet).
Kodayake kwayar cutar ba ta da iska, National Academy of Sciences ta nuna cewa ana iya samun kwayar cutar ta hanyar bioaerosol, kuma masu tattara iska da aka sanya a cikin hallways na waje na mutane sun ba da samfurin RNA mai kyau.
Wasu hanyoyin kiwon lafiya kamar su intubation da cardiopulmonary resuscitation (CPR) na iya haifar da fitarwar numfashi zuwa cikin iska kuma hakan na haifar da yaduwar iska.
Ko da yake akwai damuwa cewa za a iya yada shi ta hanyar fitsari, an yi la'akari da cewa wannan hadarin yana da ƙananan. Idan akwai alamun cutar a cikin mutane, cutar tana da haɗari sosai; yana iya yiwuwa a yada shi kafin bayyanar bayyanar bayyanar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ke yaduwa ba amma mutum daya yakan kamu da mutane biyu zuwa uku.
Musamman, an gano kwayar cutar har zuwa kwana ɗaya a cikin kwali, har zuwa kwana uku a cikin filastik (polypropylene) da bakin karfe (AISI 304) da awanni huɗu a cikin 99% na jan ƙarfe.
Wannan yana canjawa dangane da zafi da kuma zafin jiki.
Sabulu da detergents ma na iya zama masu amfani idan aka yi amfani da su yadda ya kamata; kayan sabulu suna karya fatar kariya ta kwayar cutar, suna kashe ta, kuma suna kawar da ita daga fata da sauran wurare.
Sauran hanyoyin, kamar su benzalkonium chloride da chlorhexidine gluconate (masu kashe kwayoyin cuta). A cikin binciken da aka yi a Hong Kong, an dauki samfuran hanci tsakanin kwanaki biyu bayan fara asibiti.
A cikin marasa lafiya shida, biyar ne suka fi nuna yawan kwayar cutar a cikin samfurin farko, kuma a rana ta biyu, na shida ya fi nuna yawan kwayar cutar.
Cutar cutar sankara ta numfashi ta SARS-CoV-2 ita ce sabuwar cutar sankara ta coronavirus, wadda aka fara warewa daga mutane uku da suka kamu da cutar sankara da ke hade da wani rukunin mutane da ke fama da cutar sankara ta numfashi a Wuhan.
Dukkanin halayen kwayar cutar SARS-CoV-2 na faruwa ne a cikin kwayar cutar coronaviruses masu alaƙa da juna.
A waje da jikin mutum, kwayar cutar tana mutuwa a cikin sabulu na gida, wanda ke fashewar kumfa mai kariya. SARS-CoV-2 yana da dangantaka ta kusa da ainihin SARS-CoV.
Cutar COVID-19 ta fi rinjayar huhu saboda kwayar cutar ta shiga cikin kwayoyin da ke dauke da kwayar cutar ta hanyar maganin angiotensin-converting enzyme 2 (ACE2), wanda aka samo a cikin kwayar cutar ta alveolar ta nau'in II.
"Yana amfani da ƙwayoyin cuta na musamman da ake kira ""spikes"" (peplomers) don haɗawa da ACE2 don shiga cikin ƙwayoyin cuta".
Kashi 12% na waɗanda suka kamu da cutar da aka kwantar a asibiti a Wuhan, China, sun sami mummunan rauni na zuciya, kuma ya fi yawa a cikin mummunan cuta.
Akwai ƙaruwar cututtukan zuciya da jijiyoyin jini saboda halayen kumburi na tsarin cuta da kuma rashin lafiyar tsarin garkuwar jiki yayin ci gaban cutar, amma kuma za a iya danganta mummunan rauni na zuciya da masu karɓar ACE2 na zuciya.
Masu karɓar ACE2 suna tafiya cikin sauri zuwa zuciya kuma suna shiga cikin aikin zuciya.
An lura da thrombosis (31%) da kuma thromboembolism na jini (25%) a cikin marasa lafiya na ICU da ke dauke da COVID-19, kuma hakan na iya danganta da rashin ci gaba. An gano lalacewar alveolar (DAD) a cikin huhu, da kuma lymphocytes masu yaduwar kumburi a cikin jikin waɗanda suka mutu da COVID-19.
Kodayake SARS-COV-2 yana da halayyar zuwa kwayar epithelial -ACE2 mai haɗa hanyoyin numfashi, marasa lafiya masu cutar COVID-19 suna da alamun hyperinflammation na tsarin.
Musamman, a cikin marasa lafiya na COVID-19, kwayoyin T-cell masu ɓoye GM-CSF masu cutar sun kasance suna da alaƙa da ƙwayoyin cuta na IL-6 da ke ɓoye monocytes da kuma sake dawo da cututtukan huhu.
An gano cewa akwai cutar lymphocytic infiltrate a jikin mutum.
Hukumar Lafiya ta Duniya ta fitar da wasu ka'idojin gwaji don cutar.
Hanyar da aka saba amfani da ita ita ce yin amfani da halayen sarkar polymerase chain reaction (rRT-PCR) a ainihin lokacin.
Ana yin gwajin ne a kan samfuran numfashi da aka samu ta hanyar suturar nasopharyngeal; duk da haka, ana iya amfani da samfurin suturar hanci ko kuma hanci.
Ana samun sakamako a cikin sa'o'i da yawa zuwa kwana biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki misalai biyu na jini a tsakanin makonni biyu, kuma sakamakon yana da ƙarancin ƙimar nan take.
Masana kimiyya na kasar Sin sun sami damar ware kwayar cutar coronavirus da kuma bayyana jerin kwayoyin domin dakunan gwaje-gwaje a duniya su samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da kwayar cutar.
A ranar 4 ga Afrilu, 2020, gwajin rigakafi (wanda zai iya gano kamuwa da cuta mai aiki da kuma gano ko mutum ya kamu da cutar a baya) yana kan ci gaba, amma har yanzu ba a yi amfani da shi sosai ba.
Kwarewar kasar Sin a gwajin ta nuna cewa daidaito na kashi 60 zuwa 70 cikin dari ne kawai.
A ranar 21 ga Maris, 2020, FDA ta amince da gwajin tsabtace wuri na farko don amfani a ƙarshen watan a Amurka. Jagoran bincike da asibitin Zhongnan na Wuhan University ya ba da shawarar hanyoyin gano kamuwa da cuta bisa la'akari da alamun ganewar asali da kuma haɗarin cutar.
Yanayin biyu, multilobar ƙasa-gilashin opacity tare da iyaka, rashin daidaituwa da kuma rarraba baya-baya yana da mahimmanci a farkon kamuwa.
Ana iya ganin subplural dominance, irregular pavement (ƙaddamar da lobular septum ta hanyar cika alveolar mai canzawa) da kuma haɗuwa tare da ci gaban cutar.
Akwai bayanai kaɗan game da ilimin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Babban bayanan pathological na binciken gawawwakin sune:
Yin amfani da allon gani: Plurisy, pericarditis, lung consolidation, da kuma ciwon huhu
Akwai nau'o'i huɗu na cutar sankarar bargo:
Manyan ciwon huhu: ciwon huhu na huhu, ƙwayoyin cuta na huhu, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa.
Cutar ciwon huhu mai tsanani: Cutar ciwon huhu mai lalacewa (DAD) tare da ɓarkewar alveolar.
DAD na haifar da ciwon numfashi mai tsanani (ARDS) da kuma matsanancin hypoxemia.
Ciwon huhu na sarano: Ƙungiyoyin ƙwayoyin cuta a cikin alveolar cavity da kuma ciwon fibrosis na interstitial na huhu
Jinin: Ƙarƙashin ƙwayar cuta mai zurfi (DIC); halayen leukocytoblast
Matakan rigakafi na rage yiwuwar kamuwa da cutar sun hada da zama a gida, guje wa wuraren taruwa, wanke hannaye da sabulu da ruwa akai-akai na akalla sakan 20, da kuma kiyaye tsaftacewar numfashi, da kuma gujewa taɓa idanu, hanci, ko baki da hannu.
CDC ta ba da shawarar rufe baki da hanci da nama yayin tari ko tari, kuma idan babu wani abu da aka samu, amfani da ciki na cinya.
Ana ƙarfafa tsabtace hannu bayan tari ko tari.
CDC ta ba da shawarar yin amfani da rufe fuska a cikin jama'a don iyakance kamuwa da cutar ta hanyar mutanen da ba su da alamun cutar. An tsara dabarun nisantar da jama'a don rage hulɗa da mutane masu kamuwa da cuta tare da manyan rukuni ta hanyar rufe makarantu da wuraren aiki, taƙaita tafiye-tafiye, da soke manyan tarurruka.
Umurnin nisantarwa ya hada da cewa mutane su kasance aƙalla ƙafa 6 (1.8 m).
"Babu wani magani da aka sani wanda zai iya hana COVID-19. Tun da ba a sa ran samun allurar rigakafi kafin 2021, babban ɓangaren kula da COVID-19 shine ƙoƙarin rage ƙaruwar cutar, wanda aka sani da ""flattening the curve"".
CDC ta kuma shawarci mutane su wanke hannayensu da sabulu da ruwa na tsawon dakika 20, musamman bayan sun je bayan gida ko idan hannayensu suna da datti, kafin cin abinci da kuma bayan yin hanci, tari ko tari.
Ya kuma bada shawarar yin amfani da kayan aikin tsabtace hannu na giya wanda ya ƙunshi akalla kashi 60% na giya idan ba a samun sabulu da ruwa kawai. WHO ta ba da tsari biyu don samar da gida a wuraren da ba a samun sauƙin samun kayan aikin tsabtace hannu na kasuwanci.
A cikin waɗannan shirye-shiryen, aikin antimicrobial ya samo asali ne daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide a cikin barasa don kawar da ƙwayoyin cuta; ba shine ""abin aiki na maganin rigakafi na hannu"" ba".
An ƙara glycerol a matsayin mai shayarwa.
Ana motsa mutane ta hanyar kulawa mai taimako, wanda zai iya haɗawa da maganin ruwa, taimakon oxygen, da kuma taimakawa sauran sassan da ke fama da rauni.
CDC ta ba da shawarar cewa waɗanda ake zargin suna da kwayar cutar su sanya abin rufe fuska na yau da kullun.
An yi amfani da maganin oxygenation na membrane (ECMO) don magance matsalar rashin numfashi, amma amfaninsa har yanzu yana cikin la'akari.
An ba da shawarar yin amfani da tsaftace-tsabtace da kuma rayuwa mai kyau da abinci don inganta rigakafi.
Taimako na iya zama mai amfani ga waɗanda ke da alamun cutar a farkon lokacin kamuwa da cutar. WHO da Hukumar Lafiya ta Kasa ta China sun ba da shawarwari don kula da waɗanda ke cikin asibiti da ke fama da COVID-19.
Likitocin kulawa da masu kula da ƙwayar cuta da masu kula da ƙwayar cuta a Amurka sun tattara shawarwarin magani daga kungiyoyi daban-daban a cikin kayan aiki na kyauta, IBCC.
Babu takamaiman magani don COVID-19 har zuwa Afrilu 2020.
Don bayyanar cututtuka, wasu likitoci suna ba da shawarar paracetamol (acetaminophen) maimakon ibuprofen don amfani na farko.
Dole ne a yi taka tsantsan don rage haɗarin kamuwa da kwayar cutar, musamman a cikin yanayin kiwon lafiya lokacin aiwatar da hanyoyin kamar intubation ko iska mai iska wanda zai iya haifar da ƙwayoyin iska.
Ga ma'aikatan kiwon lafiya da ke kula da mutane da ke dauke da COVID-19, CDC ta ba da shawarar sanya mutum a cikin dakin keɓewa na kamuwa da cutar ta iska (AIIR) ban da amfani da gargaɗin shaida, gargaɗin tuntuɓar, da gargaɗin iska. CDC ta bayyana jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar duniya.
Kayan da aka ba da shawarar su ne: rigar PPE, mai numfashi ko abin rufe fuska, kariya ga idanu da safofin hannu na likita.
An amince da N95 respirators don yanayin masana'antu amma FDA ta amince da abin rufe fuska don amfani a ƙarƙashin izinin amfani da gaggawa (EUA).
An tsara su don kare su daga ƙwayoyin iska kamar ƙura amma ba a ba da tabbacin tasirin tasirin takamaiman kwayoyin ba don takamaiman amfani.
Idan ba a samun abin rufe fuska, CDC ta ba da shawarar yin amfani da abin rufe fuska ko abin rufe fuska da aka yi a gida a matsayin mafita ta ƙarshe.
Yawancin mutane ba su da cutar COVID-19 mai tsanani da za ta bukaci yin amfani da iska ko kuma wasu hanyoyin, amma kashi ɗari na mutane suna da cutar.
Ana yin nazarin irin taimakon numfashi a cikin waɗanda ke fama da rashin ƙarfi na numfashi na COVID-19 a cikin asibitoci tare da wasu shaidu na guje wa intubation ta hanyar babban kwararar hanci ko kuma ƙarfin iska mai ƙarfi.
Ba a san ko ko dai za su iya kawo irin wannan amfanin ba ga waɗanda ke fama da cututtuka masu tsanani.
Wasu likitoci sun zaɓi su bi ta hanyar iska mai guba idan akwai, saboda wannan fasaha tana iyakance yaduwar ƙwayoyin iska fiye da na canula na nasal mai gudana. Abubuwan da suka fi faruwa a cikin tsofaffi (waɗanda suka wuce shekaru 60 da kuma musamman ma waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isasshen gadajen asibiti a kowane mutum, wanda ke iyakance ikon kula da lafiya don magance ƙaruwar ƙaruwar adadin COVID-19 mai tsanani wanda ke buƙatar asibiti.
Wani bincike a kasar Sin ya nuna cewa kashi 5% sun shiga sashen kula da gaggawa, kashi 2.3% sun bukaci taimakon injin iska, kuma kashi 1.4% sun mutu.
A kasar Sin, kusan kashi 30 cikin dari na mutanen da ke fama da cutar COVID-19 a asibitoci suna zuwa ICU.
COVID-19 yana haifar da ciwon ciwon numfashi mai tsanani (ARDS) kuma iska mai iska yana da rikitarwa yayin da oxygenation ke ƙara zama mai wahala.
Ana buƙatar yanayin sarrafawa da kuma masu karfin PEEP masu ƙarfin iska don haɓaka isar da iskar oxygen, yayin da rage haɗarin raunin huhu da pneumothorax da ke tattare da masu amfani da iska.
Ba za a iya samun PEEP mai yawa a cikin tsofaffin na'urorin motsa jiki ba.
Binciken yiwuwar magani ya fara a watan Janairun 2020 kuma ana gudanar da gwajin gwaji na magungunan rigakafin cutar.
Remdesivir ya zama abin da ya fi dacewa.
Duk da yake zai iya ɗaukar har zuwa 2021 don ƙirƙirar sabbin magunguna, da yawa daga cikin magungunan da ake gwadawa an riga an amince da su don sauran amfani ko kuma suna cikin gwaji na gaba.
Ana iya gwada maganin rigakafin cutar a cikin mutane da ke da cututtuka masu tsanani.
WHO ta ba da shawarar masu sa kai su shiga gwajin inganci da amincin magani. FDA ta ba da izinin ɗan lokaci don maganin mai haɗari a matsayin magani na gwaji inda rayuwar mutum ke cikin haɗari ko haɗari.
Ba a gudanar da nazarin da ake buƙata don tabbatar da cewa yana da lafiya da tasiri ga cututtuka ba.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wata manhajar wayar salula don magance barkewar cutar.
Ana tambayar masu amfani da su su rubuta sunayensu da lambar ID.
Aikace-aikacen yana iya gano haɗarin kamuwa da cuta ta hanyar amfani da bayanan sa ido.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Ba wai kawai manhajar tana ba da shawarar keɓe kai ba idan an gano wata barazana, har ma tana faɗakar da jami'an kiwon lafiya na gida. Koriya ta Kudu, Taiwan da Singapore suna amfani da babban bayanan bayanai na wayar salula, fasahar gano fuska, bin diddigin wayar hannu da kuma ilimin kere kere don sa ido kan mutanen da ke da cutar da kuma waɗanda suka sadu da su.
A watan Maris na 2020, gwamnatin Isra'ila ta ba da izinin hukumomin tsaro su sanya ido kan bayanan wayar salula na mutanen da ake zargin suna da cutar coronavirus.
An dauki wannan matakin ne don kare mutanen da suka iya kasancewa tare da mutanen da ke da cutar da kuma tilasta musu keɓewa.
Hakanan a cikin Maris 2020, Deutsche Telekom ta raba bayanan wurin waya tare da Cibiyar Robert Koch, wata hukumar gwamnatin tarayya ta Jamus, don hana yaduwar cutar da kuma dalilai na bincike.
Rasha ta yi amfani da fasahar gano fuska don gano masu keta dokar keɓewa.
"Giulio Galera, kwamishinan kiwon lafiya na yankin Italiya ya ce masu samar da wayar salula sun gaya masa cewa ""40% na mutane suna tafiya a kowane hali"."
Gwamnatin Jamus ta shirya karshen mako na Hackathon na awanni 48 tare da mahalarta sama da 42,000
Shugaban Estonia Kersti Kaljulaid ya kuma yi kira ga duniya da ta dauki matakai masu kirkirar abubuwa don magance yaduwar cutar.
Mutane na iya jin rashin lafiya saboda keɓewa, ƙuntatawa na tafiya, sakamakon magani, ko kuma tsoron kamuwa da cutar da kansu.
"BBC ta nakalto Rory O'Connor tana cewa, ""ƙaruwar warewar jama'a, kadaici, damuwar lafiya, damuwa da koma bayan tattalin arziki, duk bala'i ne da ke lalata lafiyar mutum da kuma lafiyarsa"."
Kamar sauran cututtukan numfashi na sama kamar sanyi, cutar na iya ci gaba da ɗan ƙaramin ci gaba ko kuma ba tare da wata alama ba.
Masu saurin kamuwa da cutar sukan warke cikin makonni biyu, amma masu tsanani ko kuma masu ciwo mai tsanani na iya daukar makonni uku zuwa shida kafin su warke.
Bisa ga bayanan wasu irin kwayar cutar kamar SARS da MERS, mata masu juna biyu na iya fuskantar haɗarin kamuwa da cutar COVID-19, amma akwai ƙarancin bayanai game da COVID-19. A cikin wasu mutane, COVID-19 na iya haifar da cutar huhu ta hanyar lalata huhu.
A cikin mafi yawan waɗanda suka kamu da cutar, COVID-19 na iya haifar da saurin ciwon rashin lafiya na numfashi (ARDS) wanda zai iya haifar da rashin ƙarfi na numfashi, haɗarin haɗari, ko rashin ƙarfi da yawa.
Abubuwan da ke tattare da COVID-19 sun haɗa da cututtukan cututtukan jini, ƙwayoyin cuta da kuma ɓarnar zuciya, koda da hanta.
Kashi 6 cikin 100 na waɗanda aka kwantar da su a asibiti da COVID-19 sun nuna rashin daidaito na ƙarancin jini, musamman a cikin prothrombin, yayin da rashin daidaiton aikin koda ya bayyana a kashi 4 cikin 100 na wannan rukunin.
An sami karuwar ƙwayar hanta (transaminases) a cikin kusan kashi 20-30% na mutanen da ke da COVID-19.
A cewar wannan rahoton, lokacin tsakanin bayyanar cututtuka da mutuwa, ciki har da shigar da mutane biyar asibiti, kwanaki goma ne.
Koyaya, akwai tsakanin kwanaki bakwai tsakanin shigar da marasa lafiya cikin asibiti da mutuwa.
A cikin binciken da aka yi na farkon kamuwa da cutar, matsakaicin lokaci daga bayyanar alamun farko zuwa mutuwa ya kasance kwanaki 14, tare da tsawon kwanaki shida zuwa 41.
Wani bincike da hukumar lafiya ta kasar Sin (NHC) ta yi ya nuna cewa, mace mace ta mutu a kashi 2.8 cikin dari, yayin da mace ta mutu a kashi 1.7 cikin dari.
Binciken asibiti na samfurori na huhu ya nuna lalacewar alveolar da ke yaduwa tare da fitar da fibromyxide na salula a cikin huhu biyu.
An lura da canje-canje na kwayar cutar kwayar cuta a cikin pneumocytes.
Hoton da ke cikin huhu yana kama da na cututtukan numfashi na gaggawa (ARDS).
Kashi 11.8% na mutuwar da Hukumar Lafiya ta China ta sanar sun kunshi bugun zuciya ko kuma cutar zuciya da ke haifar da hauhawar troponin.
A cikin watan Maris na shekarar 2016, kashi 89% na waɗanda aka kwantar a asibiti sun riga sun kamu da cutar. Yanayin tattalin arziki da kuma wadatar hanyoyin kiwon lafiya na yankin na iya shafar yawan mutuwar.
Rashin daidaito na yawan mutuwar da ake samu daga wannan cuta ya bambanta ba kawai saboda bambancin yanki ba amma kuma saboda matsalolin da ake fuskanta.
Ƙididdigar ƙananan ƙwayoyin cuta na iya ƙididdige yawan mutuwar.
Amma gaskiyar ita ce, mutuwar ta kasance sakamakon cututtuka na baya, wanda ke nufin cewa ana raina yawan mutuwar yanzu.
Masu shan sigari sun fi masu shan sigari sau 1.4 cikin haɗarin samun mummunan bayyanar COVID-19 fiye da marasa shan sigari kuma kusan sau 2.4 sun fi buƙatar kulawa mai tsanani ko mutuwa.
Hukumomin asibitocin Hong Kong sun lura da raguwar karfin huhu da kashi 20% zuwa 30% a cikin wasu mutanen da suka warke daga cutar, kuma hotunan huhu sun nuna lalacewar gawar.
Wannan kuma na iya haifar da ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon.
Har zuwa Maris 2020, ba a san ko kamuwa da cuta ta baya tana ba da rigakafi mai tasiri da na dogon lokaci a cikin mutanen da suka warke daga cutar ba.
An yi la'akari da yiwuwar kamuwa da cuta bisa ga halayyar wasu ƙwayoyin cuta, amma an sami waraka daga COVID-19 bayan an sami sakamako mai kyau na gwajin COVID-19 a cikin waɗannan lokuta.
An yi fargabar cewa waɗannan abubuwan sun faru ne saboda ƙarancin kamuwa da cuta na yau da kullun fiye da sake kamuwa da cuta.
An yi imanin cewa kwayar cutar ta samo asali ne daga dabbobi, ta hanyar yaduwar kamuwa da cuta.
Ba a san ainihin asalin ba, amma a watan Disamba na 2019, yaduwar cutar ta kusan kai tsaye ta hanyar kamuwa da mutum zuwa mutum.
Wani bincike na farkon 41 da aka tabbatar da cutar ta COVID-19 ya bayyana a cikin Janairu 2020 a cikin The Lancet, inda aka ba da ranar farko ta bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Sanarwar hukuma daga WHO ta ce farkon bayyanar cututtuka ya fara ne a ranar 8 ga Disamba, 2019.
Ana amfani da wasu matakai don tantance yawan mutuwar.
Wannan adadi ya bambanta daga yanki zuwa yanki, kuma yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da aka kashe tun farkon barkewar cutar, da kuma halaye na alƙaluma kamar su shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar cutar ta gaggawa ta ICD-10 U07.1 ga mutuwar da aka tabbatar da ita ta hanyar SARS-CoV-2, da kuma lambar U07.2 ga mutuwar da aka tabbatar da ita ta hanyar SARS-CoV-2 da ba a tabbatar da ita ba ta hanyar asibiti ko ta hanyar annoba ta COVID-19.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar da kamuwa da cutar a duniya ya kai 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran matakan sun hada da yawan mutuwar mutane (Case Fatality Rate, CFR) wanda ke nuna yawan mutanen da suka kamu da cutar da suka mutu, da kuma yawan mutanen da suka kamu da cutar (Infection Fatality Rate, IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (waɗanda aka gano da waɗanda ba a gano su ba) da suka mutu.
Waɗannan ƙididdigar ba su da takamaiman lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta zuwa gano cutar.
Ko da yake ba a samar da kwayoyin cutar a cikin dukan mutanen da suka kamu da cutar ba, bayyanar kwayoyin cutar na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
Cibiyar annobar a Italiya, Casiglione Di'Adda, wani ƙaramin ƙauye na mutane 4600, inda mutane 80 (1.7%) suka riga sun mutu.
A Gangelet, cutar ta bazu ta hanyar bikin bikin bikin biki da kuma tsakanin matasa, wanda ke haifar da ƙananan mutuwar, kuma ba a iya rarraba duk mutuwar COVID-19 bisa hukuma ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai rushe ba.
A Netherlands, masu ba da jini suna iya samun rigakafi kusan kashi 3 cikin dari na waɗanda aka kimanta.
An tabbatar da mutuwar mutane 69 (kashi 0.004 cikin ɗari na yawan jama'a) daga COVID-19.
Cutar da kuma yawan mutuwar ta bambanta tsakanin maza da mata.
A cikin binciken da aka gudanar a China da Italiya, an samu yawan mutuwar maza.
Maza suna da haɗari sosai a cikin shekarunsu na 50, kuma bambancin tsakanin maza da mata ya ƙare a cikin shekarunsu na 90.
Yawan mutuwar mutane a kasar Sin ya kai kashi 2.8 cikin dari na maza da kuma kashi 1.7 cikin dari na mata.
Ba a san ainihin dalilin da ya sa ake da bambancin jinsi ba, amma ana iya ganin cewa akwai wasu dalilai na halitta da kuma halayyar mutane.
Bambancin rigakafin jinsi, ƙarancin shan sigari a cikin mata da kuma ci gaban cututtukan da ke tattare da su a cikin maza a cikin ƙuruciya kamar hawan jini na iya taka rawa a cikin yawan mutuwar maza.
A Turai, kashi 57% na waɗanda suka kamu da cutar maza ne, kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
Gwamnatin Amurka ba ta bin diddigin bayanan jinsi na kamuwa da COVID-19 tun daga watan Afrilu na 2020.
Bincike ya nuna cewa cututtukan da ke haifar da kwayar cuta kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya mata ne kuma suna iya kamuwa da cutar.
"A ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya ta sanar da cewa sunan cutar zai zama ""COVID-19"".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin corona, VI na nufin kwayar cuta, D na nufin cuta, kuma 19 na nufin lokacin da aka fara gano barkewar cutar: 31 ga Disamba, 2019.
An zaɓi sunan ne don bin ƙa'idodin ƙasashen duniya game da suna don hana ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙ
"A cikin sadarwa ta jama'a, WHO ta yi amfani da ƙarin ""kwayar COVID-19"" da ""kwayar cutar da ke haifar da COVID-19".
"An fi kiran cutar da kwayar cutar a matsayin "coronavirus".
"A lokacin da cutar ta fara bulla a Wuhan, China, an fi kiran cutar da cutar da ""coronavirus"" da kuma ""Wuhan coronavirus"".
A cikin Janairu 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV cututtukan numfashi na gaggawa a matsayin sunayen wucin gadi na ƙwayoyin cuta da cuta, bisa ga jagororin 2015 game da amfani da cutar da yanayin cuta.
An ba da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin ingantaccen sarkar samarwa, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su swat na hanci da sassan masu sanyaya numfashi.
A wani misali, lokacin da ake buƙatar bawul din iska a asibitin Italiya, kuma mai ba da sabis ɗin bai iya ba da shi a cikin lokacin da ake buƙata ba, wani sabon kamfani na gida ya gwada ƙirar masana'antar kuma ya samar da bawul 100 da ake buƙata a cikin dare.
Bayan barkewar COVID-19, ra'ayoyin maƙarƙashiya, kuskuren bayanai da jita-jita game da asalin cutar, girmanta, rigakafinta, magani da sauran fannoni sun bayyana kuma sun bazu cikin sauri ta yanar gizo.
An yi imanin cewa mutane na iya yada kwayar cutar zuwa wasu dabbobi.
Binciken ya kasa samun wata hujja da ke nuna cewa kwayar cutar ta bayyana a cikin aladu, duck da chicken.
Babu wani magani ko rigakafi da aka amince da shi don maganin cutar.
Ana gudanar da bincike na duniya kan allurar rigakafi da magunguna don COVID-19 ta hukumomin gwamnati, ƙungiyoyin ilimi, da masu bincike na masana'antu.
A watan Maris, WHO ta fara gwajin tallafi na juna don kimanta tasirin maganin maganin maganin antiviral guda huɗu da ke da mafi yawan alkawuran tasiri.
Babu allurar rigakafi, amma kamfanoni suna aiki sosai wajen samar da takardun rigakafi.
Ana amfani da aikin da aka yi a kan SARS-CoV saboda duka SARS-CoV da SARS-CoV-2 suna amfani da masu karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Ana binciken dabarun allurar rigakafi guda uku.
Da farko, masu bincike sun mai da hankali kan samar da cikakkiyar allurar rigakafin cutar.
Amfani da kwayar cutar, ko ta mutu, yana nufin samar da amsawar rigakafin gaggawa ga sabon kamuwa da cutar ta COVID-19.
Dabara ta biyu, allurar subunit, tana nufin samar da allurar rigakafi da ke sa tsarin garkuwar jikin mutum ya zama mai saukin kamuwa da wani takamaiman rukunin kwayar cutar.
A cikin SARS-CoV-2, binciken ya gano S-spike protein wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme ACE2.
Na uku shi ne maganin rigakafin nucleic acid (DNA ko RNA vaccine, sabuwar fasaha don yin allurar rigakafi).
Dole ne a gwada alluran rigakafin gwaji daga ɗayan waɗannan dabarun don aminci da tasiri. A ranar 16 ga Maris, 2020, an fara gwajin farko na rigakafin tare da masu sa kai huɗu a Seattle.
A cikin allurar rigakafin akwai kwayar halitta da ba ta cutar da kwafin cutar da ke haifar da cutar. An nuna cewa haɓakar ƙwayoyin cuta na iya zama ƙalubale ga ci gaban allurar rigakafin SARS-COV-2, amma wannan yana da rikici.
Fiye da gwaji na bincike 300 suna gudana tun daga watan Afrilu na 2020.
Gwaje-gwaje bakwai suna kimanta maganin da aka riga aka amince da shi don maganin zazzabin cizon sauro, ciki har da gwaje-gwaje huɗu akan hydroxychloroquine ko chloroquine.
Yawancin binciken da ake yi a China ana yin su ne don amfani da maganin rigakafin cutar don dalilai daban-daban, kuma ana sa ran rahoto kan gwajin kashi na uku na tara a kan Remdesivir a cikin kasashe daban-daban a ƙarshen Afrilu.
An shirya wani bita mai gudana na ci gaban rigakafin COVID-19 da kuma 'yan takarar magani a watan Afrilu 2020. Ana kimanta wasu magungunan rigakafin cutar da ke akwai don maganin COVID-19 ciki har da Remdesivir, Chloroquine da Hydroxychloroquine, Lopinavir/Ritonavir, da Interferon Bitter.
A watan Maris na 2020, an sami tabbacin gwajin tasirin Remdesivir.
An samu ci gaba a cikin masu shan magani da maganin Remdesivir.
Ana gudanar da gwajin gwaji na Phase III a Amurka, China da Italiya. Chloroquine, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, an yi nazari a China a watan Fabrairun 2020 tare da sakamakon farko.
Duk da haka, ana bukatar a sake duba tushen binciken.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayoyin cuta ta Wuhan, yayin da ke ba da shawarar yin amfani da allurar ƙwayoyi a kowace rana, ta lura cewa ninka wannan maganin zai iya zama mai haɗari da kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chloroquine bisa la'akari da likitocin da ke kula da mutanen da ke da COVID-19. A cikin jagororin na 7 na kasar Sin, an kuma haɗa da interferon, ribavirin ko umyfenovir a cikin yanayin COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban maganin ribavirin don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar yin nazarin Nitroxanide don ƙarin nazarin vivo bayan nuna ƙarancin ƙarancin SARS-CoV-2. Nazarin ya nuna cewa samar da furotin na farko ta hanyar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da matukar iyakancewa wanda ya hana jama'ar likitanci karɓar waɗannan magunguna ba tare da ƙarin nazarin su ba. Oseltamivir a cikin vitro baya hana SARS-CoV-2 kuma babu sanannen rawa a cikin maganin COVID-19.
Cutar cytokine na iya zama mawuyacin hali a cikin matakan COVID-19 na gaba.
Akwai tabbaci cewa hydroxychloroquine na iya samun tasirin anti-cytokine mai saurin saki. Tosilizumab ya kasance cikin jagororin likita na Hukumar Lafiya ta Kasa ta China bayan kammala karamin binciken.
Yana cikin gwajin Phase 2 na bazuwar gwaji a matakin ƙasa a Italiya bayan ganin sakamako mai kyau a cikin mutane masu mummunan cuta.
Yin gwajin jini tare da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin
A cikin 2017, maganin CAR T cell therapy an amince da shi ta FDA bisa la'akari da nazarin yanayin da ya gabata game da maganin cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Har zuwa yau, babu wani tabbataccen, tabbataccen tabbaci cewa tosilezumab magani ne mai amfani ga CRS.
Ana binciken hanyoyin da aka tace da kuma ƙwayoyin cuta masu ƙarfi da aka samar ta hanyar tsarin rigakafin waɗanda suka warke daga COVID-19 a matsayin hanyar da ba ta da allurar rigakafi don ba da rigakafin marasa lafiya ga waɗanda suke buƙata.
An gwada wannan dabarar don SARS tare da sakamakon da ba a tabbatar ba.
Rashin ƙwayar cuta shine tsarin da ake tsammani na musamman wanda maganin rigakafin mara aiki zai iya daidaita kariya daga SARS-CoV-2.
Amma wasu matakai kamar su antibody-dependent cellular cytotoxicity da/ko phagocytosis na iya faruwa.
Sauran nau'ikan maganin rigakafin da ba su da amfani, misali, amfani da maganin rigakafin monoclonal da aka samar, suna kan ci gaba.
Ana iya haɓaka samar da maganin da ke tattare da ruwan jini daga marasa lafiya da suka warke, kuma ana iya haɓaka su don saurin haɗa ƙwayoyin cuta na ƙwayoyin cuta.
Cutar Coronavirus, wani nau'in cututtukan da ke da alaƙa da juna
Li Wenliang, likita a asibitin Wuhan na tsakiya, wanda ya kamu da COVID-19 ya mutu bayan ya kara wayar da kan jama'a game da yaduwar cutar.
